<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Bupropion,American Psychiatric Association,CNN,Center for Drug Evaluation and Research,Digital object identifier,Escitalopram,Fluoxetine,Food and Drug Administration,GlaxoSmithKline,International Standard Serial Number,J. Chem. Ed." />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Bupropion&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Bupropion&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Bupropion - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Bupropion";
		var wgTitle = "Bupropion";
		var wgAction = "view";
		var wgArticleId = "378579";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 281583062;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Bupropion skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Bupropion</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border="0" cellpadding="1" align="right" width="280">
<tr>
<td align="center" colspan="2"><a href="/wiki/File:Bupropion_skeletal.svg" class="image" title="Bupropion skeletal.svg"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Bupropion_skeletal.svg/200px-Bupropion_skeletal.svg.png" width="200" height="153" border="0" /></a></td>
</tr>
<tr>
<td align="center" colspan="2"><a href="/wiki/File:Bupropion-3d-CPK.png" class="image" title="Bupropion-3d-CPK.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/c/ce/Bupropion-3d-CPK.png/200px-Bupropion-3d-CPK.png" width="200" height="128" border="0" /></a></td>
</tr>
<tr>
<td align="center" colspan="2">
<div style="font-size:medium; line-height:167%;">Bupropion</div>
</td>
</tr>
<tr>
<td align="center" colspan="2" bgcolor="#DDDDDD"><b>Systematic (<a href="/wiki/International_Union_of_Pure_and_Applied_Chemistry_nomenclature" title="International Union of Pure and Applied Chemistry nomenclature" class="mw-redirect">IUPAC</a>) name</b></td>
</tr>
<tr>
<td bgcolor="#EEEEEE" style="text-align: center; vertical-align: top;" colspan="2"><span style="font-size:11px">(±)-2-(<i>tert</i>-butylamino)-1-(3-chlorophenyl)propan-1-one</span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Identifiers</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" width="90"><a href="/wiki/CAS_registry_number" title="CAS registry number">CAS number</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=34841-39-9&amp;rn=1" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=34841-39-9&amp;rn=1" rel="nofollow">34841-39-9</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/ATC_code_N06" title="ATC code N06">N06</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N06AX12" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N06AX12" rel="nofollow">AX12</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/PubChem" title="PubChem">PubChem</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=444" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=444" rel="nofollow">444</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.drugbank.ca/cgi-bin/show_drug.cgi?CARD=APRD00621" class="external text" title="http://www.drugbank.ca/cgi-bin/show_drug.cgi?CARD=APRD00621" rel="nofollow">APRD00621</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/ChemSpider" title="ChemSpider">ChemSpider</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.chemspider.com/Chemical-Structure.431" class="external text" title="http://www.chemspider.com/Chemical-Structure.431" rel="nofollow">431</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Chemical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Chemical_formula" title="Chemical formula">Formula</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/Carbon" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>13</sub><a href="/wiki/Hydrogen" title="Hydrogen"><span style="color: rgb(77,77,77); font-weight: bold;">H</span></a><sub>18</sub><a href="/wiki/Chlorine" title="Chlorine"><span style="color: rgb(15,95,15); font-weight: bold;">Cl</span></a><a href="/wiki/Nitrogen" title="Nitrogen"><span style="color: rgb(0,0,128); font-weight: bold;">N</span></a><a href="/wiki/Oxygen" title="Oxygen"><span style="color: rgb(116,35,35); font-weight: bold;">O</span></a><sup>&#160;</sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Molecular_mass" title="Molecular mass">Mol. mass</a></td>
<td bgcolor="#EEEEEE">239.74 g/mol</td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Simplified_molecular_input_line_entry_specification" title="Simplified molecular input line entry specification">SMILES</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.emolecules.com/cgi-bin/search?t=ex&amp;q=CC%28NC%28C%29%28C%29C%29C%28%3DO%29c1cccc%28Cl%29c1" class="external text" title="http://www.emolecules.com/cgi-bin/search?t=ex&amp;q=CC%28NC%28C%29%28C%29C%29C%28%3DO%29c1cccc%28Cl%29c1" rel="nofollow">eMolecules</a></span> &amp; <span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/search/?smarts=CC%28NC%28C%29%28C%29C%29C%28%3DO%29c1cccc%28Cl%29c1" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/search/?smarts=CC%28NC%28C%29%28C%29C%29C%28%3DO%29c1cccc%28Cl%29c1" rel="nofollow">PubChem</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Pharmacokinetic data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Bioavailability" title="Bioavailability">Bioavailability</a></td>
<td bgcolor="#EEEEEE">5 to 20% in animals; no studies in humans</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/Liver" title="Liver">Hepatic</a>—important <a href="/wiki/CYP2B6" title="CYP2B6">CYP2B6</a> and <a href="/wiki/CYP2D6" title="CYP2D6">2D6</a> involvement</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Biological_half-life" title="Biological half-life">Half life</a></td>
<td bgcolor="#EEEEEE">20 hours</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Excretion" title="Excretion">Excretion</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/Kidney" title="Kidney">Renal</a> (87%), fecal (10%)</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Therapeutic considerations</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Pregnancy_category" title="Pregnancy category">Pregnancy cat.</a></td>
<td bgcolor="#EEEEEE">
<p>B2<small>(<a href="/wiki/Australia" title="Australia">AU</a>)</small> C<small>(<a href="/wiki/United_States" title="United States">US</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></td>
<td bgcolor="#EEEEEE">
<p><a href="/wiki/Prescription_drug" title="Prescription drug">POM</a><small>(<a href="/wiki/United_Kingdom" title="United Kingdom">UK</a>)</small> <a href="/wiki/Prescription_drug" title="Prescription drug"><span class="Unicode">℞</span><small>-only</small></a><small>(<a href="/wiki/United_States" title="United States">US</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Route_of_administration" title="Route of administration">Routes</a></td>
<td bgcolor="#EEEEEE">Oral</td>
</tr>
</table>
<p><b>Bupropion</b> (<a href="/wiki/International_Nonproprietary_Name" title="International Nonproprietary Name">INN</a>, previously known as <b>amfebutamone</b>;<sup id="cite_ref-0" class="reference"><a href="#cite_note-0" title=""><span>[</span>1<span>]</span></a></sup> <b>Wellbutrin</b>, <b>Zyban</b>) is an atypical <a href="/wiki/Antidepressant" title="Antidepressant">antidepressant</a> that acts as a <a href="/wiki/Norepinephrine_reuptake_inhibitor" title="Norepinephrine reuptake inhibitor">norepinephrine</a> and <a href="/wiki/Dopamine_reuptake_inhibitor" title="Dopamine reuptake inhibitor">dopamine reuptake inhibitor</a>, and <a href="/wiki/Nicotinic_antagonist" title="Nicotinic antagonist">nicotinic antagonist</a>.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1" title=""><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-2" class="reference"><a href="#cite_note-2" title=""><span>[</span>3<span>]</span></a></sup> Bupropion belongs to the chemical class of aminoketones and is similar in structure to the <a href="/wiki/Stimulant" title="Stimulant">stimulant</a> <a href="/wiki/Cathinone" title="Cathinone">cathinone</a>, to the <a href="/wiki/Anorectic" title="Anorectic">anorectic</a> <a href="/wiki/Diethylpropion" title="Diethylpropion" class="mw-redirect">diethylpropion</a>, and to <a href="/wiki/Phenethylamine" title="Phenethylamine">phenethylamines</a> in general.</p>
<p>Initially researched and marketed as an <a href="/wiki/Antidepressant" title="Antidepressant">antidepressant</a>, bupropion was subsequently found to be effective as a <a href="/wiki/Smoking_cessation" title="Smoking cessation">smoking cessation</a> aid. In 2007 it was the fourth-most prescribed antidepressant in the United States retail market, with 20.184 million retail prescriptions.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3" title=""><span>[</span>4<span>]</span></a></sup></p>
<p>Bupropion lowers seizure threshold and its potential to cause <a href="/wiki/Seizure" title="Seizure">seizures</a> was widely publicized. However, at the recommended dose the risk of seizures is comparable to that observed for other antidepressants. Bupropion is an effective antidepressant on its own but it is particularly popular as an add-on medication in the cases of incomplete response to the first-line <a href="/wiki/Selective_serotonin_reuptake_inhibitor" title="Selective serotonin reuptake inhibitor">SSRI</a> antidepressant. In contrast to many psychiatric drugs, including nearly all antidepressants, bupropion does not cause weight gain or <a href="/wiki/Sexual_dysfunction" title="Sexual dysfunction">sexual dysfunction</a>.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#Therapeutic_uses"><span class="tocnumber">2</span> <span class="toctext">Therapeutic uses</span></a>
<ul>
<li class="toclevel-2"><a href="#Depression"><span class="tocnumber">2.1</span> <span class="toctext">Depression</span></a></li>
<li class="toclevel-2"><a href="#Smoking_cessation"><span class="tocnumber">2.2</span> <span class="toctext">Smoking cessation</span></a></li>
<li class="toclevel-2"><a href="#Sexual_dysfunction"><span class="tocnumber">2.3</span> <span class="toctext">Sexual dysfunction</span></a></li>
<li class="toclevel-2"><a href="#Obesity"><span class="tocnumber">2.4</span> <span class="toctext">Obesity</span></a></li>
<li class="toclevel-2"><a href="#Attention-deficit_hyperactivity_disorder"><span class="tocnumber">2.5</span> <span class="toctext">Attention-deficit hyperactivity disorder</span></a></li>
<li class="toclevel-2"><a href="#Other_uses"><span class="tocnumber">2.6</span> <span class="toctext">Other uses</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Contraindications"><span class="tocnumber">3</span> <span class="toctext">Contraindications</span></a>
<ul>
<li class="toclevel-2"><a href="#Risk_of_suicide"><span class="tocnumber">3.1</span> <span class="toctext">Risk of suicide</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Adverse_effects"><span class="tocnumber">4</span> <span class="toctext">Adverse effects</span></a></li>
<li class="toclevel-1"><a href="#Overdose"><span class="tocnumber">5</span> <span class="toctext">Overdose</span></a></li>
<li class="toclevel-1"><a href="#Mechanism_of_action"><span class="tocnumber">6</span> <span class="toctext">Mechanism of action</span></a></li>
<li class="toclevel-1"><a href="#Pharmacokinetics"><span class="tocnumber">7</span> <span class="toctext">Pharmacokinetics</span></a></li>
<li class="toclevel-1"><a href="#Interactions"><span class="tocnumber">8</span> <span class="toctext">Interactions</span></a></li>
<li class="toclevel-1"><a href="#Availability_and_dose_forms"><span class="tocnumber">9</span> <span class="toctext">Availability and dose forms</span></a></li>
<li class="toclevel-1"><a href="#Abuse_liability"><span class="tocnumber">10</span> <span class="toctext">Abuse liability</span></a></li>
<li class="toclevel-1"><a href="#Synthesis"><span class="tocnumber">11</span> <span class="toctext">Synthesis</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">12</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">13</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=1" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>Bupropion was invented by Nariman Mehta of Burroughs Wellcome (now <a href="/wiki/GlaxoSmithKline" title="GlaxoSmithKline">GlaxoSmithKline</a>) in 1969, and the US patent for it was granted in 1974.<sup id="cite_ref-United_States_Patent:_3819706_4-0" class="reference"><a href="#cite_note-United_States_Patent:_3819706-4" title=""><span>[</span>5<span>]</span></a></sup> It was approved by the United States <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration" class="mw-redirect">Food and Drug Administration</a> (FDA) as an antidepressant on December 30, 1985 and marketed under the name Wellbutrin.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5" title=""><span>[</span>6<span>]</span></a></sup> However, a significant incidence of <a href="/wiki/Seizures" title="Seizures" class="mw-redirect">seizures</a> at the originally recommended dosage (400–600&#160;mg) caused the withdrawal of the drug in 1986. Subsequently, the risk of seizures was found to be highly dose-dependent, and bupropion was re-introduced to the market in 1989 with a maximum recommended dose of 450&#160;mg/day.</p>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Wellbutrin.jpg" class="image" title="Wellbutrin XL"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/8/89/Wellbutrin.jpg/180px-Wellbutrin.jpg" width="180" height="218" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Wellbutrin.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Wellbutrin XL</div>
</div>
</div>
<p>In 1996, the FDA approved a <a href="/wiki/Sustained_release" title="Sustained release" class="mw-redirect">sustained-release</a> formulation of bupropion called Wellbutrin SR, intended to be taken twice a day (as compared to three times a day for immediate-release Wellbutrin).<sup id="cite_ref-NIDA_notes_6-0" class="reference"><a href="#cite_note-NIDA_notes-6" title=""><span>[</span>7<span>]</span></a></sup> In 2003 the FDA approved another sustained-release formulation called Wellbutrin XL, intended for once-daily dosing. Wellbutrin SR and XL are available in <a href="/wiki/Generic_drug" title="Generic drug">generic</a> form in the United States, while in Canada, only the SR formulation is available in generic form. In 1997, bupropion was approved by the FDA for use as a <a href="/wiki/Smoking_cessation" title="Smoking cessation">smoking cessation</a> aid under the name Zyban.<sup id="cite_ref-NIDA_notes_6-1" class="reference"><a href="#cite_note-NIDA_notes-6" title=""><span>[</span>7<span>]</span></a></sup> In 2006, Wellbutrin XL was similarly approved as a treatment for <a href="/wiki/Seasonal_affective_disorder" title="Seasonal affective disorder">seasonal affective disorder</a>.<sup id="cite_ref-wellbutrin_seasonal_7-0" class="reference"><a href="#cite_note-wellbutrin_seasonal-7" title=""><span>[</span>8<span>]</span></a></sup></p>
<p><a name="Therapeutic_uses" id="Therapeutic_uses"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=2" title="Edit section: Therapeutic uses">edit</a>]</span> <span class="mw-headline">Therapeutic uses</span></h2>
<p><a name="Depression" id="Depression"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=3" title="Edit section: Depression">edit</a>]</span> <span class="mw-headline">Depression</span></h3>
<p><a href="/wiki/Placebo" title="Placebo">Placebo</a>-controlled <a href="/wiki/Double-blind" title="Double-blind" class="mw-redirect">double-blind</a> <a href="/wiki/Clinical_studies" title="Clinical studies" class="mw-redirect">clinical studies</a> have confirmed the efficacy of bupropion for <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">clinical depression</a>.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8" title=""><span>[</span>9<span>]</span></a></sup> Comparative clinical studies demonstrated the equivalency of bupropion and <a href="/wiki/Sertraline" title="Sertraline">sertraline</a> (Zoloft), <a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a> (Prozac), <a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a> (Paxil)<sup id="cite_ref-9" class="reference"><a href="#cite_note-9" title=""><span>[</span>10<span>]</span></a></sup> and <a href="/wiki/Escitalopram" title="Escitalopram">escitalopram</a> (Lexapro)<sup id="cite_ref-10" class="reference"><a href="#cite_note-10" title=""><span>[</span>11<span>]</span></a></sup> as antidepressants. A significantly higher <a href="/wiki/Remission_(medicine)" title="Remission (medicine)">remission</a> rate with bupropion treatment than for <a href="/wiki/Venlafaxine" title="Venlafaxine">venlafaxine</a> (Effexor) was observed in a recent study.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11" title=""><span>[</span>12<span>]</span></a></sup> Unlike all other antidepressants, except <a href="/wiki/Mirtazapine" title="Mirtazapine">mirtazapine</a> (Remeron), <a href="/wiki/Maprotiline" title="Maprotiline">maprotiline</a> (Ludiomil) and <a href="/wiki/Tianeptine" title="Tianeptine">tianeptine</a> (Stablon), bupropion does not cause sexual dysfunction and the occurrence of sexual side effects is not different from placebo.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12" title=""><span>[</span>13<span>]</span></a></sup><sup id="cite_ref-13" class="reference"><a href="#cite_note-13" title=""><span>[</span>14<span>]</span></a></sup> Bupropion treatment is not associated with weight gain; on the contrary, at the end of every study comparing bupropion with placebo or other antidepressants the bupropion group had a lower average weight.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14" title=""><span>[</span>15<span>]</span></a></sup> Bupropion is more effective than <a href="/wiki/SSRI" title="SSRI" class="mw-redirect">SSRIs</a> at improving symptoms of <a href="/wiki/Hypersomnia" title="Hypersomnia">hypersomnia</a> and <a href="/wiki/Fatigue_(medical)" title="Fatigue (medical)">fatigue</a> in depressed patients.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15" title=""><span>[</span>16<span>]</span></a></sup> In a comparative meta-analysis, there appeared to be a modest advantage for the SSRIs compared to bupropion in the treatment of depression with high anxiety, while these medications were equivalent for the depression with moderate or low anxiety.<sup id="cite_ref-pmid18605812_16-0" class="reference"><a href="#cite_note-pmid18605812-16" title=""><span>[</span>17<span>]</span></a></sup></p>
<p>According to several surveys, the <a href="/wiki/Augmentation" title="Augmentation" class="mw-redirect">augmentation</a> of a prescribed <a href="/wiki/SSRI" title="SSRI" class="mw-redirect">SSRI</a> with bupropion is the preferred strategy among clinicians when the patient does not respond to the SSRI.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17" title=""><span>[</span>18<span>]</span></a></sup> For example, the combination of bupropion and <a href="/wiki/Citalopram" title="Citalopram">citalopram</a> (Celexa) was observed to be more effective than switching to another antidepressant. The addition of bupropion to an SSRI (primarily fluoxetine or sertraline) resulted in a significant improvement in 70–80% of patients who had an incomplete response to the first-line antidepressant.<sup id="cite_ref-pmid9614595_18-0" class="reference"><a href="#cite_note-pmid9614595-18" title=""><span>[</span>19<span>]</span></a></sup><sup id="cite_ref-pmid9164423_19-0" class="reference"><a href="#cite_note-pmid9164423-19" title=""><span>[</span>20<span>]</span></a></sup> Bupropion improved ratings of "energy", which had decreased under the influence of the SSRI; also noted were improvements of mood and motivation, and some improvement of cognitive and sexual functions. Sleep quality and anxiety ratings in most cases were unchanged.<sup id="cite_ref-pmid9164423_19-1" class="reference"><a href="#cite_note-pmid9164423-19" title=""><span>[</span>20<span>]</span></a></sup> In the STAR*D study, the patients who did not respond to <a href="/wiki/Citalopram" title="Citalopram">citalopram</a> (Celexa) were randomly assigned to augmentation by bupropion or <a href="/wiki/Buspirone" title="Buspirone">buspirone</a> (Buspar). Approximately 30% of subjects in both groups achieved a remission. However, bupropion augmentation gave better results based on the patients' self-ratings and was much better tolerated. The authors observed that "these findings reveal a consistently more favorable outcome with sustained-release bupropion than with buspirone augmentation of citalopram."<sup id="cite_ref-pmid16554526_20-0" class="reference"><a href="#cite_note-pmid16554526-20" title=""><span>[</span>21<span>]</span></a></sup> The same study indicated a possibility of higher remission rate when the non-responders to citalopram received bupropion augmentation rather than were switched to bupropion (30% vs. 20%).<sup id="cite_ref-pmid16554525_21-0" class="reference"><a href="#cite_note-pmid16554525-21" title=""><span>[</span>22<span>]</span></a></sup></p>
<p><a name="Smoking_cessation" id="Smoking_cessation"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=4" title="Edit section: Smoking cessation">edit</a>]</span> <span class="mw-headline">Smoking cessation</span></h3>
<p>Bupropion reduces the severity of <a href="/wiki/Nicotine" title="Nicotine">nicotine</a> cravings and <a href="/wiki/Withdrawal" title="Withdrawal">withdrawal</a> symptoms. After a seven-week treatment, 27% of subjects who received bupropion reported that an urge to smoke was a problem, versus 56% of those who received <a href="/wiki/Placebo" title="Placebo">placebo</a>. In the same study, 21% of the bupropion group reported mood swings, versus 32% of the placebo group.<sup id="cite_ref-Tonnesen2003_22-0" class="reference"><a href="#cite_note-Tonnesen2003-22" title=""><span>[</span>23<span>]</span></a></sup> The bupropion treatment course lasts for seven to twelve weeks, with the patient halting the use of tobacco about ten days into the course. The efficacy of bupropion is similar to that of nicotine replacement therapy. Bupropion approximately doubles the chance of quitting smoking successfully after three months. One year after the treatment, the odds of sustaining smoking cessation are still 1.5 times higher in the bupropion group than in the placebo group.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23" title=""><span>[</span>24<span>]</span></a></sup> The combination of bupropion and nicotine appears not to further increase the cessation rate. In a direct comparison, <a href="/wiki/Varenicline" title="Varenicline">varenicline</a> (Chantix) showed superior efficacy: after one year, the rate of continuous abstinence was 10% for placebo, 15% for bupropion, and 23% for varenicline.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24" title=""><span>[</span>25<span>]</span></a></sup> Bupropion slows the weight gain that often occurs in the first weeks after quitting smoking (after seven weeks, the placebo group had an average 2.7 kg increase in weight, versus 1.5 kg for the bupropion group). With time, however, this effect becomes negligible (after 26 weeks, both groups recorded an average 4.8 kg weight gain).<sup id="cite_ref-Tonnesen2003_22-1" class="reference"><a href="#cite_note-Tonnesen2003-22" title=""><span>[</span>23<span>]</span></a></sup></p>
<p><a name="Sexual_dysfunction" id="Sexual_dysfunction"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=5" title="Edit section: Sexual dysfunction">edit</a>]</span> <span class="mw-headline">Sexual dysfunction</span></h3>
<p>According to a survey, bupropion is the drug of choice among psychiatrists for the treatment of SSRI-induced sexual dysfunction, although it is not an FDA-approved indication. Thirty-six percent of responding psychiatrists preferred switching patients with SSRI-induced sexual dysfunction to bupropion; however, 43 percent favored the augmentation of the current medication with bupropion.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25" title=""><span>[</span>26<span>]</span></a></sup> There are studies demonstrating the efficacy of both approaches; improvement of the desire and orgasm components of sexual function were the most often noted. For the augmentation approach, the addition of at least 200&#160;mg/day of bupropion to the SSRI regimen may be necessary to achieve an improvement since the addition of 150&#160;mg/day of bupropion did not produce a statistically significant difference from placebo.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26" title=""><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-27" class="reference"><a href="#cite_note-27" title=""><span>[</span>28<span>]</span></a></sup><sup id="cite_ref-28" class="reference"><a href="#cite_note-28" title=""><span>[</span>29<span>]</span></a></sup><sup id="cite_ref-29" class="reference"><a href="#cite_note-29" title=""><span>[</span>30<span>]</span></a></sup><sup id="cite_ref-30" class="reference"><a href="#cite_note-30" title=""><span>[</span>31<span>]</span></a></sup><sup id="cite_ref-31" class="reference"><a href="#cite_note-31" title=""><span>[</span>32<span>]</span></a></sup></p>
<p>Several studies have indicated that bupropion also relieves sexual dysfunction in people who do not have depression. In a mixed-gender double-blind study, 63% of subjects on a 12-week course of bupropion rated their condition as improved or much improved, versus 3% of subjects on placebo.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32" title=""><span>[</span>33<span>]</span></a></sup> Two studies, one of which was placebo-controlled, demonstrated the efficacy of bupropion for women with hypoactive sexual desire,<sup id="cite_ref-33" class="reference"><a href="#cite_note-33" title=""><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-34" class="reference"><a href="#cite_note-34" title=""><span>[</span>35<span>]</span></a></sup> resulting in significant improvement of arousal, orgasm and overall satisfaction. Bupropion also showed promise as a treatment for sexual dysfunction caused by <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a> for breast cancer<sup id="cite_ref-35" class="reference"><a href="#cite_note-35" title=""><span>[</span>36<span>]</span></a></sup> and for orgasmic dysfunction.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36" title=""><span>[</span>37<span>]</span></a></sup> As with the treatment of SSRI-induced sexual disorder, a higher dose of bupropion (300&#160;mg) may be necessary: a randomized study employing a lower dose (150&#160;mg) failed to find a significant difference between bupropion, sexual therapy or combined treatment.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37" title=""><span>[</span>38<span>]</span></a></sup> Bupropion does not affect any measures of sexual functioning in healthy men.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38" title=""><span>[</span>39<span>]</span></a></sup></p>
<p><a name="Obesity" id="Obesity"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=6" title="Edit section: Obesity">edit</a>]</span> <span class="mw-headline">Obesity</span></h3>
<p>A recent <a href="/wiki/Meta-analysis" title="Meta-analysis">meta-analysis</a> of <a href="/wiki/Anti-obesity_drug" title="Anti-obesity drug" class="mw-redirect">anti-obesity medications</a> pooled the results of three double-blind, placebo-controlled trials of bupropion. It confirmed the efficacy of bupropion given at 400 mg per day for treating <a href="/wiki/Obesity" title="Obesity">obesity</a>. Over a period of 6 to 12 months, weight loss in the bupropion group (4.4&#160;kg) was significantly greater than in the placebo group (1.7&#160;kg). The same review found the differences in weight loss between bupropion and other established weight-loss medications, such as <a href="/wiki/Sibutramine" title="Sibutramine">sibutramine</a>, <a href="/wiki/Orlistat" title="Orlistat">orlistat</a> and <a href="/wiki/Diethylpropion" title="Diethylpropion" class="mw-redirect">diethylpropion</a>, to be statistically insignificant.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39" title=""><span>[</span>40<span>]</span></a></sup></p>
<p><a name="Attention-deficit_hyperactivity_disorder" id="Attention-deficit_hyperactivity_disorder"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=7" title="Edit section: Attention-deficit hyperactivity disorder">edit</a>]</span> <span class="mw-headline">Attention-deficit hyperactivity disorder</span></h3>
<p>Although <a href="/wiki/Attention-deficit_hyperactivity_disorder" title="Attention-deficit hyperactivity disorder">attention-deficit hyperactivity disorder</a> (ADHD) is not an approved indication, bupropion was found to be effective for adult ADHD.<sup id="cite_ref-pmid15820237_40-0" class="reference"><a href="#cite_note-pmid15820237-40" title=""><span>[</span>41<span>]</span></a></sup> There have been many positive case studies and other uncontrolled clinical studies of bupropion for ADHD in minors.<sup id="cite_ref-pmid9554326_41-0" class="reference"><a href="#cite_note-pmid9554326-41" title=""><span>[</span>42<span>]</span></a></sup> However, in the largest to date double-blind study, which was conducted by GlaxoSmithKline, the results were inconclusive. Aggression and hyperactivity as rated by the children's teachers were significantly improved in comparison to placebo; in contrast, parents and clinicians could not distinguish between the effects of bupropion and placebo.<sup id="cite_ref-pmid9554326_41-1" class="reference"><a href="#cite_note-pmid9554326-41" title=""><span>[</span>42<span>]</span></a></sup> The 2007 guideline on the ADHD treatment from American Academy of Child and Adolescent Psychiatry notes that the evidence for bupropion is "far weaker" than for the FDA-approved treatments. Its effect may also be "considerably less than of the approved agents... Thus it may be prudent for the clinician to recommend a trial of behavior therapy at this point, before moving to these second-line agents."<sup id="cite_ref-42" class="reference"><a href="#cite_note-42" title=""><span>[</span>43<span>]</span></a></sup> Similarly, the 2006 guideline from the Texas Department of State Health Services recommends considering bupropion or a <a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">tricyclic antidepressant</a> as a fourth-line treatment after trying two different stimulants and <a href="/wiki/Atomoxetine" title="Atomoxetine">atomoxetine</a> (Strattera).<sup id="cite_ref-43" class="reference"><a href="#cite_note-43" title=""><span>[</span>44<span>]</span></a></sup><sup id="cite_ref-44" class="reference"><a href="#cite_note-44" title=""><span>[</span>45<span>]</span></a></sup></p>
<p>A study of prophylactic bupropion for the prevention of smoking among teenagers with <a href="/wiki/ADHD" title="ADHD" class="mw-redirect">ADHD</a> yielded unexpected results. The teenagers taking bupropion were two times more likely (close to statistical significance) to begin smoking than the teenagers in the placebo group. At the same time, the sub-group of patients taking stimulants in addition to bupropion or placebo had a five times lower risk of smoking initiation.<sup id="cite_ref-pmid17685748_45-0" class="reference"><a href="#cite_note-pmid17685748-45" title=""><span>[</span>46<span>]</span></a></sup></p>
<p><a name="Other_uses" id="Other_uses"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=8" title="Edit section: Other uses">edit</a>]</span> <span class="mw-headline">Other uses</span></h3>
<p>Bupropion has been approved by the FDA<sup id="cite_ref-pmid17328102_46-0" class="reference"><a href="#cite_note-pmid17328102-46" title=""><span>[</span>47<span>]</span></a></sup> for the prevention of <a href="/wiki/Seasonal_affective_disorder" title="Seasonal affective disorder">seasonal affective disorder</a>.<sup id="cite_ref-pmid16271314_47-0" class="reference"><a href="#cite_note-pmid16271314-47" title=""><span>[</span>48<span>]</span></a></sup> There is considerable disagreement regarding whether it is useful to add an antidepressant, including bupropion, to a <a href="/wiki/Mood_stabilizer" title="Mood stabilizer">mood stabilizer</a> in patients with <a href="/wiki/Bipolar_depression" title="Bipolar depression" class="mw-redirect">bipolar depression</a>.<sup id="cite_ref-pmid17392295_48-0" class="reference"><a href="#cite_note-pmid17392295-48" title=""><span>[</span>49<span>]</span></a></sup><sup id="cite_ref-pmid15337640_49-0" class="reference"><a href="#cite_note-pmid15337640-49" title=""><span>[</span>50<span>]</span></a></sup><sup id="cite_ref-pmid17156158_50-0" class="reference"><a href="#cite_note-pmid17156158-50" title=""><span>[</span>51<span>]</span></a></sup></p>
<p>No properly controlled double-blind studies of bupropion for <a href="/wiki/Parkinson%27s_disease" title="Parkinson's disease">Parkinson's disease</a> have been conducted. A small 1984 study funded by bupropion's manufacturer found that addition of bupropion to <a href="/wiki/Carbidopa" title="Carbidopa">carbidopa</a> or <a href="/wiki/Levodopa" title="Levodopa" class="mw-redirect">levodopa</a> improved Parkinson's symptoms in ten out of twenty patients; however, the side effects, particularly nausea and vomiting, were frequent.<sup id="cite_ref-pmid6431314_51-0" class="reference"><a href="#cite_note-pmid6431314-51" title=""><span>[</span>52<span>]</span></a></sup> The <a href="/wiki/American_Psychiatric_Association" title="American Psychiatric Association">American Psychiatric Association</a> notes that, "there is no evidence favoring any particular antidepressant medication from the standpoint of therapeutic efficacy in patients with Parkinson’s disease complicated by major depressive disorder."<sup id="cite_ref-52" class="reference"><a href="#cite_note-52" title=""><span>[</span>53<span>]</span></a></sup></p>
<p><a name="Contraindications" id="Contraindications"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=9" title="Edit section: Contraindications">edit</a>]</span> <span class="mw-headline">Contraindications</span></h2>
<p>GlaxoSmithKline advises that bupropion should not be prescribed to individuals with <a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a> or other conditions that lower the <a href="/wiki/Seizure" title="Seizure">seizure</a> threshold, such as alcohol or <a href="/wiki/Benzodiazepine" title="Benzodiazepine">benzodiazepine</a> discontinuation, <a href="/wiki/Anorexia_nervosa" title="Anorexia nervosa">anorexia nervosa</a>, <a href="/wiki/Bulimia" title="Bulimia" class="mw-redirect">bulimia</a>, or active <a href="/wiki/Brain_tumor" title="Brain tumor">brain tumors</a>. It should be avoided in individuals who are also taking <a href="/wiki/MAO_inhibitor" title="MAO inhibitor" class="mw-redirect">MAO inhibitors</a> (MAOIs). When switching from MAOIs to bupropion, it is important to include a washout period of about two weeks between the medications.<sup id="cite_ref-WellbutrinPI_53-0" class="reference"><a href="#cite_note-WellbutrinPI-53" title=""><span>[</span>54<span>]</span></a></sup> The prescribing information approved by the FDA recommends that caution should be exercised when treating patients with liver damage, severe <a href="/wiki/Kidney_disease" title="Kidney disease" class="mw-redirect">kidney disease</a>, and severe <a href="/wiki/Hypertension" title="Hypertension">hypertension</a>, as well as in pediatric patients, adolescents and young adults due to the increased risk of <a href="/wiki/Suicidal_ideation" title="Suicidal ideation">suicidal ideation</a>.<sup id="cite_ref-WellbutrinPI_53-1" class="reference"><a href="#cite_note-WellbutrinPI-53" title=""><span>[</span>54<span>]</span></a></sup></p>
<p>According to a <a href="/wiki/Retrospective" title="Retrospective">retrospective</a> <a href="/wiki/Case_series" title="Case series">case series</a> published in 1993, bupropion treatment may exacerbate <a href="/wiki/Tic" title="Tic">tics</a> in children with <a href="/wiki/Comorbidity" title="Comorbidity">co-occurring</a> <a href="/wiki/Attention-deficit_hyperactivity_disorder" title="Attention-deficit hyperactivity disorder">ADHD</a> and <a href="/wiki/Tourette_syndrome" title="Tourette syndrome">Tourette syndrome</a>.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54" title=""><span>[</span>55<span>]</span></a></sup> No further research of this side effect has been conducted.</p>
<p><a name="Risk_of_suicide" id="Risk_of_suicide"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=10" title="Edit section: Risk of suicide">edit</a>]</span> <span class="mw-headline">Risk of suicide</span></h3>
<p>The FDA requires all antidepressants, including bupropion, to carry a <a href="/wiki/Black_box_warning" title="Black box warning">black box warning</a> stating that antidepressants may increase the risk of suicide in persons younger than 25. This warning is based on a statistical analysis conducted by the FDA which found a 2-fold increase of the suicidal ideation and behavior in children and adolescents, and 1.5-fold increase of suicidality in the 18–24 age group.<sup id="cite_ref-FDA_55-0" class="reference"><a href="#cite_note-FDA-55" title=""><span>[</span>56<span>]</span></a></sup></p>
<p>Suicidal ideation and behavior in clinical trials are rare. For the above analysis, the FDA combined the results of 295 trials of 11 antidepressants for psychiatric indications in order to obtain <a href="/wiki/Statistically_significant" title="Statistically significant" class="mw-redirect">statistically significant</a> results. Considered separately, bupropion and nine other antidepressants were not statistically different from placebo. Only <a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a> caused a significant decrease in suicidal ideation.<sup id="cite_ref-FDA_55-1" class="reference"><a href="#cite_note-FDA-55" title=""><span>[</span>56<span>]</span></a></sup></p>
<p>Suicidal behavior is even less likely when bupropion is prescribed for smoking cessation. According to a <a href="/wiki/Cochrane_Library" title="Cochrane Library">Cochrane Database</a> review, there have been four suicides per one million prescriptions and one case of suicidal ideation per ten thousand prescriptions of bupropion for smoking cessation in the UK. The review concludes, "Although some suicides and deaths while taking bupropion have been reported, thus far there is insufficient evidence to suggest they were caused by bupropion."<sup id="cite_ref-56" class="reference"><a href="#cite_note-56" title=""><span>[</span>57<span>]</span></a></sup></p>
<p><a name="Adverse_effects" id="Adverse_effects"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=11" title="Edit section: Adverse effects">edit</a>]</span> <span class="mw-headline">Adverse effects</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:WellbutrinXL300MG_dec20.JPG" class="image" title="Brand-name Wellbutrin"><img alt="" src="http://upload.wikimedia.org/wikipedia/en/thumb/2/22/WellbutrinXL300MG_dec20.JPG/180px-WellbutrinXL300MG_dec20.JPG" width="180" height="240" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:WellbutrinXL300MG_dec20.JPG" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Brand-name Wellbutrin</div>
</div>
</div>
<p>The common <a href="/wiki/Adverse_drug_reaction" title="Adverse drug reaction">adverse effects</a> associated with 12-hour sustained-release bupropion (with the greatest difference from placebo) are <a href="/wiki/Dry_mouth" title="Dry mouth" class="mw-redirect">dry mouth</a>, <a href="/wiki/Nausea" title="Nausea">nausea</a>, <a href="/wiki/Insomnia" title="Insomnia">insomnia</a>, <a href="/wiki/Tremor" title="Tremor">tremor</a>, <a href="/wiki/Sweating" title="Sweating" class="mw-redirect">excessive sweating</a> and <a href="/wiki/Tinnitus" title="Tinnitus">tinnitus</a>. Those that most often resulted in interruption of the treatment in the same trial were rash (2.4%) and nausea (0.8%). The development of mild to moderate skin <a href="/wiki/Rash" title="Rash">rashes</a> is associated with sensitivity to dye components within the pill coating. This can often be alleviated simply by prescribing a differently colored pill.<sup id="cite_ref-WellbutrinPI_53-2" class="reference"><a href="#cite_note-WellbutrinPI-53" title=""><span>[</span>54<span>]</span></a></sup></p>
<p><a href="/wiki/Seizure" title="Seizure">Seizure</a> is the most controversial side effect of bupropion, and was responsible for its initial withdrawal from the market. The risk of seizure is highly dose-dependent: 0.1% at 100–300&#160;mg of bupropion, 0.4% at 300–450&#160;mg, and 2% at 600&#160;mg. For comparison, the incidence of the first unprovoked seizure in the general population is 0.07–0.09%. The risk of seizure for other antidepressants is as follows: 0.1–0.6% for <a href="/wiki/Imipramine" title="Imipramine">imipramine</a>, depending on dosage; 0–0.06% for <a href="/wiki/Amitriptyline" title="Amitriptyline">amitriptyline</a>, depending on dosage; 0.5% for <a href="/wiki/Clomipramine" title="Clomipramine">clomipramine</a>; 0.4% for <a href="/wiki/Maprotiline" title="Maprotiline">maprotiline</a>; and 0.2% for <a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a> and <a href="/wiki/Fluvoxamine" title="Fluvoxamine">fluvoxamine</a>.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57" title=""><span>[</span>58<span>]</span></a></sup> Experiments on mice indicate that increased susceptibility to seizure is a general side effect of chronically using antidepressants that inhibit norepinephrine transporter, such as <a href="/wiki/Imipramine" title="Imipramine">imipramine</a>, <a href="/wiki/Desipramine" title="Desipramine">desipramine</a> and <a href="/wiki/Reboxetine" title="Reboxetine">reboxetine</a>.<sup id="cite_ref-58" class="reference"><a href="#cite_note-58" title=""><span>[</span>59<span>]</span></a></sup> Clinical depression itself was reported to increase the occurrence of seizures two-to-sevenfold compared with the general population; in this light, the above statistics could indicate that low to moderate doses of antidepressants, including bupropion, may actually have an anti-convulsive action.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59" title=""><span>[</span>60<span>]</span></a></sup></p>
<p>There is evidence of several neuropsychiatric symptoms associated with bupropion in patients with depression, including delusions, <a href="/wiki/Hallucination" title="Hallucination">hallucinations</a>, <a href="/wiki/Psychosis" title="Psychosis">psychosis</a>, concentration disturbance, <a href="/wiki/Paranoia" title="Paranoia">paranoia</a>, and confusion. In some cases, these symptoms are reduced or eliminated by decreasing the dose or ceasing treatment. The prescribing information notes that "it is generally believed (though not established in controlled trials)" that, should an episode of depression actually be the first presentation of <a href="/wiki/Bipolar_disorder" title="Bipolar disorder">bipolar disorder</a>, treating it with antidepressants, including bupropion, may precipitate a manic episode.<sup id="cite_ref-WellbutrinPI_53-3" class="reference"><a href="#cite_note-WellbutrinPI-53" title=""><span>[</span>54<span>]</span></a></sup> More recent data indicate that the addition of newer antidepressants, including bupropion, to a <a href="/wiki/Mood_stabilizer" title="Mood stabilizer">mood stabilizer</a> does not cause the switch to mania more often than the addition of placebo.<sup id="cite_ref-pmid15337640_49-1" class="reference"><a href="#cite_note-pmid15337640-49" title=""><span>[</span>50<span>]</span></a></sup> Moreover, when added to a mood stabilizer, bupropion and sertraline had a twice lower switch risk than venlafaxine.<sup id="cite_ref-pmid16880481_60-0" class="reference"><a href="#cite_note-pmid16880481-60" title=""><span>[</span>61<span>]</span></a></sup></p>
<p>The prescribing information notes that <a href="/wiki/Hypertension" title="Hypertension">hypertension</a>, sometimes severe, was observed in some patients, both with and without pre-existing hypertension. The frequency of this adverse effect was under 1% and not significantly higher than that found with placebo.<sup id="cite_ref-WellbutrinPI_53-4" class="reference"><a href="#cite_note-WellbutrinPI-53" title=""><span>[</span>54<span>]</span></a></sup> In a group of cardiac patients with depression, high doses of bupropion (400–500&#160;mg/day) caused a rise in <a href="/wiki/Supine_position" title="Supine position">supine</a> blood pressure but had no effect on pulse rate.<sup id="cite_ref-pmid1900980_61-0" class="reference"><a href="#cite_note-pmid1900980-61" title=""><span>[</span>62<span>]</span></a></sup> No statistically significant changes in blood pressure or heart rate occurred in patients with or without heart conditions at a lower dose of 300 mg/day.<sup id="cite_ref-pmid12109935_62-0" class="reference"><a href="#cite_note-pmid12109935-62" title=""><span>[</span>63<span>]</span></a></sup> In a study of bupropion for <a href="/wiki/ADHD" title="ADHD" class="mw-redirect">ADHD</a>, a rise of <a href="/wiki/Systole_(medicine)" title="Systole (medicine)">systolic</a> blood pressure by 6 mm&#160;Hg and of heart rate by 7 beats per minute (both statistically significant) were observed.<sup id="cite_ref-pmid15705013_63-0" class="reference"><a href="#cite_note-pmid15705013-63" title=""><span>[</span>64<span>]</span></a></sup> A study of smokers hospitalized for heart disease found a 1.5-fold increase (close to being statistically significant) in subsequent cardiovascular events in the bupropion group, compared with the placebo group, but found no difference in blood pressure.<sup id="cite_ref-pmid17145253_64-0" class="reference"><a href="#cite_note-pmid17145253-64" title=""><span>[</span>65<span>]</span></a></sup> Although the cardiovascular side effects of bupropion appear to be mild, it cannot be recommended for patients with heart disease, since the safety comparison with SSRIs (such as <a href="/wiki/Sertraline" title="Sertraline">sertraline</a> and <a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a>, which may have a preventative effect after a <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a><sup id="cite_ref-pmid17112303_65-0" class="reference"><a href="#cite_note-pmid17112303-65" title=""><span>[</span>66<span>]</span></a></sup>) is not in its favor.</p>
<p>In the UK, more than 7,600 reports of suspected adverse reactions were collected in the first two years after bupropion's approval by the <a href="/wiki/Medicines_and_Healthcare_products_Regulatory_Agency" title="Medicines and Healthcare products Regulatory Agency">MHRA</a> as part of the <a href="/wiki/Yellow_Card_Scheme" title="Yellow Card Scheme">Yellow Card Scheme</a>, which monitored side effects. Approximately 540,000 people were treated with bupropion for smoking cessation during that period. The MHRA received 60 reports of "<i>suspected</i> [emphasis MHRA's] adverse reactions to Zyban which had a fatal outcome". The agency concluded that "in the majority of cases the individual’s underlying condition may provide an alternative explanation."<sup id="cite_ref-MHRA_66-0" class="reference"><a href="#cite_note-MHRA-66" title=""><span>[</span>67<span>]</span></a></sup> This is consistent with a large, 9,300-patient safety study that showed that the mortality of smokers taking bupropion is not higher than the natural mortality of smokers of the same age.<sup id="cite_ref-Hubbard_67-0" class="reference"><a href="#cite_note-Hubbard-67" title=""><span>[</span>68<span>]</span></a></sup></p>
<p>According to several case reports, stopping bupropion abruptly may result in <a href="/wiki/Withdrawal_syndrome" title="Withdrawal syndrome" class="mw-redirect">discontinuation syndrome</a> expressed as <a href="/wiki/Dystonia" title="Dystonia">dystonia</a>, <a href="/wiki/Irritability" title="Irritability">irritability</a>, <a href="/wiki/Anxiety" title="Anxiety">anxiety</a>, <a href="/wiki/Mania" title="Mania">mania</a>, <a href="/wiki/Headache" title="Headache">headache</a>, <a href="/wiki/Aches" title="Aches" class="mw-redirect">aches</a> and <a href="/wiki/Pains" title="Pains" class="mw-redirect">pains</a>.<sup id="cite_ref-68" class="reference"><a href="#cite_note-68" title=""><span>[</span>69<span>]</span></a></sup><sup id="cite_ref-69" class="reference"><a href="#cite_note-69" title=""><span>[</span>70<span>]</span></a></sup><sup id="cite_ref-70" class="reference"><a href="#cite_note-70" title=""><span>[</span>71<span>]</span></a></sup><sup id="cite_ref-71" class="reference"><a href="#cite_note-71" title=""><span>[</span>72<span>]</span></a></sup></p>
<p>Other isolated adverse affects have been reported. Three cases of liver toxicity have been described in the literature,<sup id="cite_ref-pmid11785718_72-0" class="reference"><a href="#cite_note-pmid11785718-72" title=""><span>[</span>73<span>]</span></a></sup> a very low incidence given the widespread use of the drug. A single case of clitoral <a href="/wiki/Priapism" title="Priapism">priapism</a> (<a href="/wiki/Clitorism" title="Clitorism">clitorism</a>) has been reported in the literature.<sup id="cite_ref-73" class="reference"><a href="#cite_note-73" title=""><span>[</span>74<span>]</span></a></sup></p>
<p><a name="Overdose" id="Overdose"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=12" title="Edit section: Overdose">edit</a>]</span> <span class="mw-headline">Overdose</span></h2>
<p><a href="/wiki/Overdose" title="Overdose" class="mw-redirect">Overdose</a> of bupropion results in significant clinical effects in over one-third of cases.<sup id="cite_ref-Balit_74-0" class="reference"><a href="#cite_note-Balit-74" title=""><span>[</span>75<span>]</span></a></sup> The most common symptoms include <a href="/wiki/Sinus_tachycardia" title="Sinus tachycardia">sinus tachycardia</a>, <a href="/wiki/Hypertension" title="Hypertension">hypertension</a>, drowsiness, lethargy, agitation, nausea and vomiting, and in particular <a href="/wiki/Delirium" title="Delirium">delirium</a> and <a href="/wiki/Seizure" title="Seizure">seizures</a>.<sup id="cite_ref-Balit_74-1" class="reference"><a href="#cite_note-Balit-74" title=""><span>[</span>75<span>]</span></a></sup><sup id="cite_ref-Buckley_75-0" class="reference"><a href="#cite_note-Buckley-75" title=""><span>[</span>76<span>]</span></a></sup><sup id="cite_ref-Spiller_76-0" class="reference"><a href="#cite_note-Spiller-76" title=""><span>[</span>77<span>]</span></a></sup> Less commonly additional symptoms include auditory and visual <a href="/wiki/Hallucination" title="Hallucination">hallucinations</a>,<sup id="cite_ref-77" class="reference"><a href="#cite_note-77" title=""><span>[</span>78<span>]</span></a></sup> <a href="/wiki/Coma" title="Coma">coma</a>,<sup id="cite_ref-Spiller_76-1" class="reference"><a href="#cite_note-Spiller-76" title=""><span>[</span>77<span>]</span></a></sup> and <a href="/wiki/Electrocardiogram" title="Electrocardiogram" class="mw-redirect">ECG</a> changes such as conduction disturbance or <a href="/wiki/Cardiac_arrhythmia" title="Cardiac arrhythmia">arrhythmia</a>.<sup id="cite_ref-Shepherd_78-0" class="reference"><a href="#cite_note-Shepherd-78" title=""><span>[</span>79<span>]</span></a></sup><sup id="cite_ref-79" class="reference"><a href="#cite_note-79" title=""><span>[</span>80<span>]</span></a></sup><sup id="cite_ref-80" class="reference"><a href="#cite_note-80" title=""><span>[</span>81<span>]</span></a></sup></p>
<p>In the majority of childhood exploratory ingestions involving one or two tablets, children will remain asymptomatic.<sup id="cite_ref-Shepherd2_81-0" class="reference"><a href="#cite_note-Shepherd2-81" title=""><span>[</span>82<span>]</span></a></sup><sup id="cite_ref-Colbridge_82-0" class="reference"><a href="#cite_note-Colbridge-82" title=""><span>[</span>83<span>]</span></a></sup> In teenagers and adults seizures are more commonly observed with the seizure rate increasing tenfold with doses of 600 mg daily.<sup id="cite_ref-Johnston_83-0" class="reference"><a href="#cite_note-Johnston-83" title=""><span>[</span>84<span>]</span></a></sup> One overdose study suggested a dose-dependent relationship with seizures; patients ingesting more than 4.5&#160;g were likely to have a seizure and nearly all patients ingesting more than 9&#160;g had a seizure.<sup id="cite_ref-Balit_74-2" class="reference"><a href="#cite_note-Balit-74" title=""><span>[</span>75<span>]</span></a></sup></p>
<p>There is no specific antidote for bupropion; treatment is supportive, and focuses on maintaining <a href="/wiki/Airway" title="Airway">airway</a> patency and controlling seizures with high dose intravenous <a href="/wiki/Benzodiazepine" title="Benzodiazepine">benzodiazepines</a> or <a href="/wiki/Barbiturate" title="Barbiturate">barbiturates</a> if seizures are refractory to benzodiazepines.<sup id="cite_ref-Buckley_75-1" class="reference"><a href="#cite_note-Buckley-75" title=""><span>[</span>76<span>]</span></a></sup> Gastric decontamination may be of little benefit given the risk of seizures and aspiration<sup id="cite_ref-Buckley_75-2" class="reference"><a href="#cite_note-Buckley-75" title=""><span>[</span>76<span>]</span></a></sup> but <a href="/wiki/Activated_charcoal" title="Activated charcoal" class="mw-redirect">activated charcoal</a> is recommended,<sup id="cite_ref-Balit_74-3" class="reference"><a href="#cite_note-Balit-74" title=""><span>[</span>75<span>]</span></a></sup> additionally <a href="/wiki/Whole_bowel_irrigation" title="Whole bowel irrigation">whole bowel irrigation</a> should be undertaken in those ingesting sustained release formulations.<sup id="cite_ref-Buckley_75-3" class="reference"><a href="#cite_note-Buckley-75" title=""><span>[</span>76<span>]</span></a></sup> Toxic effects may be delayed in onset, with seizures developing as late as 32&#160;hours,<sup id="cite_ref-Buckley_75-4" class="reference"><a href="#cite_note-Buckley-75" title=""><span>[</span>76<span>]</span></a></sup> subsequently patients should undergo <a href="/wiki/Electroencephalography" title="Electroencephalography">electroencephalographic</a> monitoring for 48&#160;hours.<sup id="cite_ref-WellbutrinPI_53-5" class="reference"><a href="#cite_note-WellbutrinPI-53" title=""><span>[</span>54<span>]</span></a></sup></p>
<p>Bupropion overdose rarely results in death, although cases have been reported.<sup id="cite_ref-Shepherd_78-1" class="reference"><a href="#cite_note-Shepherd-78" title=""><span>[</span>79<span>]</span></a></sup><sup id="cite_ref-84" class="reference"><a href="#cite_note-84" title=""><span>[</span>85<span>]</span></a></sup><sup id="cite_ref-85" class="reference"><a href="#cite_note-85" title=""><span>[</span>86<span>]</span></a></sup> Fatalities are typically associated with large overdosage and related to <a href="/wiki/Metabolic_acidosis" title="Metabolic acidosis">metabolic acidosis</a> and <a href="/wiki/Hypoxia_(medical)" title="Hypoxia (medical)">hypoxia</a> as complications of <a href="/wiki/Status_epilepticus" title="Status epilepticus">status epilepticus</a> with associated <a href="/wiki/Cardiorespiratory_arrest" title="Cardiorespiratory arrest" class="mw-redirect">cardiorespiratory arrest</a>.<sup id="cite_ref-86" class="reference"><a href="#cite_note-86" title=""><span>[</span>87<span>]</span></a></sup> There is one published case report of successful treatment of refractory cardiac arrest in overdose of bupropion and <a href="/wiki/Lamotrigine" title="Lamotrigine">lamotrigine</a> using <a href="/wiki/Lipid_rescue" title="Lipid rescue">lipid rescue</a>.<sup id="cite_ref-87" class="reference"><a href="#cite_note-87" title=""><span>[</span>88<span>]</span></a></sup></p>
<p><a name="Mechanism_of_action" id="Mechanism_of_action"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=13" title="Edit section: Mechanism of action">edit</a>]</span> <span class="mw-headline">Mechanism of action</span></h2>
<p>Bupropion is a <a href="/wiki/Dopamine_reuptake_inhibitor" title="Dopamine reuptake inhibitor">dopamine</a> and <a href="/wiki/Norepinephrine_reuptake_inhibitor" title="Norepinephrine reuptake inhibitor">norepinephrine reuptake inhibitor</a>.<sup id="cite_ref-88" class="reference"><a href="#cite_note-88" title=""><span>[</span>89<span>]</span></a></sup> It is about twice as potent an inhibitor of dopamine reuptake than of norepinephrine reuptake. As bupropion is rapidly converted in the body into several metabolites with differing activity, its action cannot be understood without reference to its metabolism. The occupancy of <a href="/wiki/Dopamine_transporter" title="Dopamine transporter">dopamine transporter</a> (DAT) by bupropion and its metabolites in the human brain as measured by <a href="/wiki/Positron_emission_tomography" title="Positron emission tomography">positron emission tomography</a> was 6–22% in an independent study<sup id="cite_ref-89" class="reference"><a href="#cite_note-89" title=""><span>[</span>90<span>]</span></a></sup> and 12–35% according to GlaxoSmithKline researchers.<sup id="cite_ref-90" class="reference"><a href="#cite_note-90" title=""><span>[</span>91<span>]</span></a></sup> Based on analogy with <a href="/wiki/Serotonin_reuptake_inhibitor" title="Serotonin reuptake inhibitor" class="mw-redirect">serotonin reuptake inhibitors</a>, higher than 50% inhibition of DAT would be needed for the dopamine reuptake mechanism to be a major mechanism of the drug's action. Bupropion does not inhibit <a href="/wiki/Monoamine_oxidase" title="Monoamine oxidase">monoamine oxidase</a> or <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> reuptake. However, it has been shown to indirectly enhance the firing of serotonergic neurons, via activation of downstream norepinephrine flow. Bupropion has also been shown to act as a noncompetitive <a href="/wiki/Nicotinic_acetylcholine_receptor#Subunits" title="Nicotinic acetylcholine receptor">α3β4</a> <a href="/wiki/Nicotinic_antagonist" title="Nicotinic antagonist">nicotinic antagonist</a>.<sup id="cite_ref-91" class="reference"><a href="#cite_note-91" title=""><span>[</span>92<span>]</span></a></sup> The degree of inhibition of α3β4 receptors correlates well with the decrease in self-administration of morphine and methamphetamine in rats,<sup id="cite_ref-92" class="reference"><a href="#cite_note-92" title=""><span>[</span>93<span>]</span></a></sup> and may be relevant to the effect of bupropion on nicotine addiction. The drug is supplied as a <a href="/wiki/Racemic" title="Racemic" class="mw-redirect">racemic</a> mixture, and no studies have been published on the activities of the individual enantiomers.<sup id="cite_ref-93" class="reference"><a href="#cite_note-93" title=""><span>[</span>94<span>]</span></a></sup></p>
<p><a name="Pharmacokinetics" id="Pharmacokinetics"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=14" title="Edit section: Pharmacokinetics">edit</a>]</span> <span class="mw-headline">Pharmacokinetics</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:178px;"><a href="/wiki/File:Metabolites_of_bupropion.png" class="image" title="Important metabolites of bupropion."><img alt="" src="http://upload.wikimedia.org/wikipedia/en/thumb/2/2e/Metabolites_of_bupropion.png/176px-Metabolites_of_bupropion.png" width="176" height="598" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Metabolites_of_bupropion.png" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Important metabolites of bupropion.</div>
</div>
</div>
<p>Bupropion is metabolized in the <a href="/wiki/Liver" title="Liver">liver</a>. It has several active <a href="/wiki/Metabolite" title="Metabolite">metabolites</a>: <i>R,R</i>-hydroxybupropion, <i>S,S</i>-hydroxybupropion, <i>threo</i>-hydrobupropion and <i>erythro</i>-hydrobupropion, which are further metabolized to inactive metabolites and eliminated through excretion into the urine. Pharmacological data on bupropion and its metabolites are presented in Table 1. Bupropion is known to weakly inhibit the α<sub>1</sub> <a href="/wiki/Adrenergic_receptor" title="Adrenergic receptor">adrenaline receptor</a>, with a 14% potency of its dopamine uptake inhibition, and the <a href="/wiki/Histamine_H1_receptor" title="Histamine H1 receptor">H<sub>1</sub> receptor</a>, with a 9% potency.<sup id="cite_ref-horst1998_94-0" class="reference"><a href="#cite_note-horst1998-94" title=""><span>[</span>95<span>]</span></a></sup></p>
<p>The biological activity of bupropion can be attributed to a significant degree to its active metabolites, in particular to <i>S,S</i>-hydroxybupropion. GlaxoSmithKline developed this metabolite as a separate drug called <a href="/wiki/Radafaxine" title="Radafaxine">radafaxine</a>,<sup id="cite_ref-95" class="reference"><a href="#cite_note-95" title=""><span>[</span>96<span>]</span></a></sup> but discontinued development in 2006 due to "an unfavourable risk/benefit assessment".<sup id="cite_ref-96" class="reference"><a href="#cite_note-96" title=""><span>[</span>97<span>]</span></a></sup></p>
<p>Bupropion is metabolized to hydroxybupropion by <a href="/wiki/CYP2B6" title="CYP2B6">CYP2B6</a>, an <a href="/wiki/Isoenzyme" title="Isoenzyme" class="mw-redirect">isoenzyme</a> of the <a href="/wiki/Cytochrome_P450" title="Cytochrome P450">cytochrome P450 system</a>. Alcohol causes an increase of CYP2B6 in the liver, and persons with a history of alcohol use metabolize bupropion faster. The mechanism of formation of <i>erythro</i>-hydrobupropion and <i>threo</i>-hydrobupropion has not been studied but is probably mediated by one of the carbonyl reductase enzymes. The metabolism of bupropion is highly variable: the effective doses of bupropion received by persons who ingest the same amount of the drug may differ by as much as 5.5 times (and the half-life from 3 to 16 hours), and of hydroxybupropion by as much as 7.5 times (and the half-life from 12 to 38 hours).<sup id="cite_ref-pmid14515060_97-0" class="reference"><a href="#cite_note-pmid14515060-97" title=""><span>[</span>98<span>]</span></a></sup><sup id="cite_ref-pmid15083067_98-0" class="reference"><a href="#cite_note-pmid15083067-98" title=""><span>[</span>99<span>]</span></a></sup> Based on this, some researchers have advocated monitoring of the blood level of bupropion and hydroxybupropion.<sup id="cite_ref-pmid1813908_99-0" class="reference"><a href="#cite_note-pmid1813908-99" title=""><span>[</span>100<span>]</span></a></sup></p>
<p>There are significant interspecies differences in the metabolism of bupropion, with <a href="/wiki/Guinea_pig" title="Guinea pig">guinea pigs</a>' metabolism of the drug being closest to that of humans.<sup id="cite_ref-100" class="reference"><a href="#cite_note-100" title=""><span>[</span>101<span>]</span></a></sup> Particular caution is needed when extrapolating the results of experiments on rats to humans since hydroxybupropion, the main metabolite of bupropion in humans, is absent in rats.<sup id="cite_ref-pharmacological287_101-0" class="reference"><a href="#cite_note-pharmacological287-101" title=""><span>[</span>102<span>]</span></a></sup></p>
<p>There have been two reported cases of false-positive urine amphetamine tests in persons taking bupropion. Bupropion metabolites <i>erythro</i>-hydrobupropion and <i>threo</i>-hydrobupropion, which have a <a href="/wiki/Phenethylamine" title="Phenethylamine">phenethylamine</a> structure resembling amphetamine are likely to have been responsible for this reaction. More specific follow-up tests were negative.<sup id="cite_ref-pmid10999247_102-0" class="reference"><a href="#cite_note-pmid10999247-102" title=""><span>[</span>103<span>]</span></a></sup><sup id="cite_ref-pmid7768026_103-0" class="reference"><a href="#cite_note-pmid7768026-103" title=""><span>[</span>104<span>]</span></a></sup></p>
<table class="wikitable" border="1" style="margin:auto; margin:1em auto 1em auto;">
<caption><b>Table 1. Pharmacology of bupropion and its metabolites.</b><sup id="cite_ref-104" class="reference"><a href="#cite_note-104" title=""><span>[</span>105<span>]</span></a></sup><sup id="cite_ref-105" class="reference"><a href="#cite_note-105" title=""><span>[</span>106<span>]</span></a></sup><sup id="cite_ref-106" class="reference"><a href="#cite_note-106" title=""><span>[</span>107<span>]</span></a></sup><sup id="cite_ref-horst1998_94-1" class="reference"><a href="#cite_note-horst1998-94" title=""><span>[</span>95<span>]</span></a></sup><sup id="cite_ref-107" class="reference"><a href="#cite_note-107" title=""><span>[</span>108<span>]</span></a></sup></caption>
<tr>
<td colspan="6">Exposure (concentration over time; bupropion exposure = 100%) and half-life</td>
</tr>
<tr style="text-align:center;">
<th></th>
<th>Bupropion</th>
<th><i>R,R</i>-<br />
Hydroxy<br />
bupropion</th>
<th><i>S,S</i>-<br />
Hydroxy<br />
bupropion</th>
<th><i>Threo</i>-<br />
hydro<br />
bupropion</th>
<th><i>Erythro</i>-<br />
hydro<br />
bupropion</th>
</tr>
<tr style="text-align:center;">
<th>Exposure</th>
<td>100%</td>
<td>800%</td>
<td>160%</td>
<td>310%</td>
<td>90%</td>
</tr>
<tr style="text-align:center;">
<th>Half-life</th>
<td>10&#160;h (IR)<br />
17&#160;h (SR)</td>
<td>21&#160;h</td>
<td>25&#160;h</td>
<td>26&#160;h</td>
<td>26&#160;h</td>
</tr>
<tr style="text-align:center;">
<td colspan="6">Inhibition potency (potency of DA uptake inhibition by bupropion = 100%)</td>
</tr>
<tr style="text-align:center;">
<th>DA uptake</th>
<td>100%</td>
<td>0% (rat)</td>
<td>70% (rat)</td>
<td>4% (rat)</td>
<td>No data</td>
</tr>
<tr style="text-align:center;">
<th>NE uptake</th>
<td>27%</td>
<td>0% (rat)</td>
<td>106% (rat)</td>
<td>16% (rat)</td>
<td>No data</td>
</tr>
<tr style="text-align:center;">
<th>Ser uptake</th>
<td>2%</td>
<td>0% (rat)</td>
<td>4%(rat)</td>
<td>3% (rat)</td>
<td>No data</td>
</tr>
<tr style="text-align:center;">
<th>α3β4 nicotinic</th>
<td>53%</td>
<td>15%</td>
<td>10%</td>
<td>7% (rat)</td>
<td>No data</td>
</tr>
<tr style="text-align:center;">
<th>α4β2 nicotinic</th>
<td>8%</td>
<td>3%</td>
<td>29%</td>
<td>No data</td>
<td>No data</td>
</tr>
<tr style="text-align:center;">
<th>α1* nicotinic</th>
<td>12%</td>
<td>13%</td>
<td>13%</td>
<td>No data</td>
<td>No data</td>
</tr>
<tr style="text-align:center;">
<td colspan="6"><small>DA = <a href="/wiki/Dopamine" title="Dopamine">dopamine</a>; NE = <a href="/wiki/Norepinephrine" title="Norepinephrine">norepinephrine</a>; Ser = <a href="/wiki/Serotonin" title="Serotonin">serotonin</a>.</small></td>
</tr>
</table>
<p><a name="Interactions" id="Interactions"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=15" title="Edit section: Interactions">edit</a>]</span> <span class="mw-headline">Interactions</span></h2>
<p>Since bupropion is metabolized to hydroxybupropion by the <a href="/wiki/CYP2B6" title="CYP2B6">CYP2B6</a> enzyme, drug interactions with CYP2B6 inhibitors are possible: this includes medications like paroxetine, sertraline, norfluoxetine (the active metabolite of fluoxetine), <a href="/wiki/Diazepam" title="Diazepam">diazepam</a>, <a href="/wiki/Clopidogrel" title="Clopidogrel">clopidogrel</a>, and <a href="/wiki/Orphenadrine" title="Orphenadrine">orphenadrine</a>. The expected result is the increase of bupropion and decrease of hydroxybupropion blood concentration. The reverse effect (decrease of bupropion and increase of hydroxybupropion) can be expected with CYP2B6 <a href="/wiki/Enzyme_induction_and_inhibition" title="Enzyme induction and inhibition" class="mw-redirect">inducers</a>, such as <a href="/wiki/Carbamazepine" title="Carbamazepine">carbamazepine</a>, <a href="/wiki/Clotrimazole" title="Clotrimazole">clotrimazole</a>, <a href="/wiki/Rifampicin" title="Rifampicin">rifampicin</a>, <a href="/wiki/Ritonavir" title="Ritonavir">ritonavir</a>, <a href="/wiki/St_John%27s_Wort" title="St John's Wort" class="mw-redirect">St John's Wort</a> and others.<sup id="cite_ref-pmid16368442_108-0" class="reference"><a href="#cite_note-pmid16368442-108" title=""><span>[</span>109<span>]</span></a></sup></p>
<p>Hydroxybupropion (but not bupropion) is itself an inhibitor of <a href="/wiki/CYP2D6" title="CYP2D6">CYP2D6</a>, as well as a substrate of that enzyme. A significant increase in the concentration of some drugs metabolized by CYP2D6 (venlafaxine, <a href="/wiki/Desipramine" title="Desipramine">desipramine</a> and <a href="/wiki/Dextromethorphan" title="Dextromethorphan">dextromethorphan</a>, but not fluoxetine or paroxetine) has been observed when they are taken with bupropion.<sup id="cite_ref-pmid16368442_108-1" class="reference"><a href="#cite_note-pmid16368442-108" title=""><span>[</span>109<span>]</span></a></sup><sup id="cite_ref-pmid11926715_109-0" class="reference"><a href="#cite_note-pmid11926715-109" title=""><span>[</span>110<span>]</span></a></sup> It is also important to note that prodrugs such as Codeine may not be effective when combined with Bupropion due to Hydroxybupropion's inhibition of CYP2D6.</p>
<p>Bupropion lowers the seizure threshold; accordingly, extreme care should be taken when prescribing bupropion with other medications that also lower it, such as antipsychotics, <a href="/wiki/Theophylline" title="Theophylline">theophylline</a>, <a href="/wiki/Steroid" title="Steroid">steroids</a>, and some <a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">tricyclic antidepressants</a>.<sup id="cite_ref-WellbutrinPI_53-6" class="reference"><a href="#cite_note-WellbutrinPI-53" title=""><span>[</span>54<span>]</span></a></sup> Its combination with <a href="/wiki/Nicotine_replacement_therapy" title="Nicotine replacement therapy">nicotine replacement therapies</a> can elevate blood pressure; since this combination is no more effective than either a nicotine patch or bupropion alone, it is not recommended.</p>
<p>The prescribing information recommends minimizing the use of alcohol, since in rare cases bupropion reduces alcohol tolerance, and because the excessive use of alcohol may lower the seizure threshold.<sup id="cite_ref-WellbutrinPI_53-7" class="reference"><a href="#cite_note-WellbutrinPI-53" title=""><span>[</span>54<span>]</span></a></sup> A small study conducted by GlaxoSmithKline indicated that bupropion (100&#160;mg) may counteract the subjective effects of small doses of alcohol (16–32&#160;mL, slightly less than 1–2 standard US drinks). The volunteers reported feeling more sober and clear-headed and less sedated. Bupropion also reduced the detrimental effect of alcohol on auditory vigilance. The combination of bupropion (100&#160;mg) and two drinks of alcohol increased heart rate by six beats per minute, a statistically significant increase.<sup id="cite_ref-110" class="reference"><a href="#cite_note-110" title=""><span>[</span>111<span>]</span></a></sup></p>
<p><a name="Availability_and_dose_forms" id="Availability_and_dose_forms"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=16" title="Edit section: Availability and dose forms">edit</a>]</span> <span class="mw-headline">Availability and dose forms</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Budeprion-XL-300mg.jpg" class="image" title="Generic Brand-name Budeprion XL"><img alt="" src="http://upload.wikimedia.org/wikipedia/en/thumb/7/73/Budeprion-XL-300mg.jpg/180px-Budeprion-XL-300mg.jpg" width="180" height="240" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Budeprion-XL-300mg.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Generic Brand-name <a href="/wiki/Budeprion" title="Budeprion">Budeprion</a> XL</div>
</div>
</div>
<p>Brand-name and generic bupropion tablets are available in three forms, each as the hydrochloride <a href="/wiki/Salt_(chemistry)" title="Salt (chemistry)">salt</a>: immediate release (Wellbutrin), <a href="/wiki/Sustained_release" title="Sustained release" class="mw-redirect">sustained release</a> (Wellbutrin SR), and extended release (Wellbutrin XL or XR). "Sustained release" and "extended release" are generally interchangeable terms, but in this case Wellbutrin SR is intended for twice-daily dosing and Wellbutrin XL is intended for once-daily dosing. Not all generics have retained this naming scheme, and the <a href="/wiki/United_States_Pharmacopeia" title="United States Pharmacopeia">United States Pharmacopeia</a> requires all prolonged-release drug formulations (including generics for Wellbutrin SR) to be labeled "extended release", which has caused confusion and medication errors.<sup id="cite_ref-USPnews_111-0" class="reference"><a href="#cite_note-USPnews-111" title=""><span>[</span>112<span>]</span></a></sup><sup id="cite_ref-112" class="reference"><a href="#cite_note-112" title=""><span>[</span>113<span>]</span></a></sup> According to GlaxoSmithKline, a 150&#160;mg Wellbutrin SR tablet can be split in two and retain its sustained-release characteristics.<sup id="cite_ref-113" class="reference"><a href="#cite_note-113" title=""><span>[</span>114<span>]</span></a></sup> An extended-release form of bupropion <a href="/wiki/Hydrobromide" title="Hydrobromide" class="mw-redirect">hydrobromide</a> was approved by the FDA in April 2008. It will be marketed under the trade name Aplenzin.<sup id="cite_ref-114" class="reference"><a href="#cite_note-114" title=""><span>[</span>115<span>]</span></a></sup></p>
<p>On October 11, 2007, two providers of consumer information on nutritional products and supplements, <a href="/wiki/ConsumerLab.com" title="ConsumerLab.com">ConsumerLab.com</a> and The People’s Pharmacy, released the results of comparative tests of different brands of bupropion.<sup id="cite_ref-peoples_115-0" class="reference"><a href="#cite_note-peoples-115" title=""><span>[</span>116<span>]</span></a></sup> The People's Pharmacy received multiple reports of increased side effects and decreased efficacy of generic bupropion, which prompted it to ask ConsumerLab.com to test the products in question. The tests showed that "one of a few generic versions of Wellbutrin XL 300 mg, sold as <a href="/wiki/Budeprion" title="Budeprion">Budeprion</a> XL 300 mg, didn't perform the same as the brand-name pill in the lab."<sup id="cite_ref-msnbc_116-0" class="reference"><a href="#cite_note-msnbc-116" title=""><span>[</span>117<span>]</span></a></sup> The FDA investigated these complaints and concluded that the <a href="/wiki/Budeprion" title="Budeprion">Budeprion</a> XL is equivalent to Wellbutrin XL in regard to bioavailability of bupropion and its main active metabolite hydroxybupropion. The FDA also noted that the coincidental natural mood variation is the most likely explanation for the apparent worsening of depression after the switch from Wellbutrin XL to <a href="/wiki/Budeprion" title="Budeprion">Budeprion</a> XL.<sup id="cite_ref-urlReview_of_Therapeutic_Equivalence:_Generic_Bupropion_XL_300_mg_and_Wellbutrin_XL_300_mg_117-0" class="reference"><a href="#cite_note-urlReview_of_Therapeutic_Equivalence:_Generic_Bupropion_XL_300_mg_and_Wellbutrin_XL_300_mg-117" title=""><span>[</span>118<span>]</span></a></sup></p>
<p>In France, marketing authorization was granted on August 3, 2001, also solely as a smoking cessation aid, and with a maximum daily dose of 300&#160;mg;<sup id="cite_ref-118" class="reference"><a href="#cite_note-118" title=""><span>[</span>119<span>]</span></a></sup> only sustained-release bupropion is available. Bupropion was granted a licence for use in adults with major depression in the Netherlands in early 2007, with GlaxoSmithKline expecting subsequent approval in other European countries.<sup id="cite_ref-119" class="reference"><a href="#cite_note-119" title=""><span>[</span>120<span>]</span></a></sup></p>
<p><a name="Abuse_liability" id="Abuse_liability"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=17" title="Edit section: Abuse liability">edit</a>]</span> <span class="mw-headline">Abuse liability</span></h2>
<p>According to the US government classification of psychiatric medications, bupropion is "non-abusable"<sup id="cite_ref-120" class="reference"><a href="#cite_note-120" title=""><span>[</span>121<span>]</span></a></sup> or has low abuse potential.<sup id="cite_ref-121" class="reference"><a href="#cite_note-121" title=""><span>[</span>122<span>]</span></a></sup> In animal studies, however, <a href="/wiki/Squirrel_monkey" title="Squirrel monkey">squirrel monkeys</a><sup id="cite_ref-pmid2529365_122-0" class="reference"><a href="#cite_note-pmid2529365-122" title=""><span>[</span>123<span>]</span></a></sup> and rats<sup id="cite_ref-pmid9103538_123-0" class="reference"><a href="#cite_note-pmid9103538-123" title=""><span>[</span>124<span>]</span></a></sup> maintained the <a href="/wiki/Intravenous" title="Intravenous" class="mw-redirect">intravenous</a> self-administration of bupropion, which may indicate abuse potential. However, significant interspecies differences of bupropion metabolism, particularly between rats and humans, make such extrapolations questionable.<sup id="cite_ref-pharmacological287_101-1" class="reference"><a href="#cite_note-pharmacological287-101" title=""><span>[</span>102<span>]</span></a></sup></p>
<p>Two studies on drug abusers indicated that the subjective effects of bupropion are markedly different from those of <a href="/wiki/Amphetamine" title="Amphetamine">amphetamine</a>.<sup id="cite_ref-pmid6412263_124-0" class="reference"><a href="#cite_note-pmid6412263-124" title=""><span>[</span>125<span>]</span></a></sup><sup id="cite_ref-pmid6406459_125-0" class="reference"><a href="#cite_note-pmid6406459-125" title=""><span>[</span>126<span>]</span></a></sup> Healthy volunteers trained to discriminate amphetamine and placebo recognized bupropion (400&#160;mg) as amphetamine 20% of the time, compared to 10% for placebo and 75% for <a href="/wiki/Methylphenidate" title="Methylphenidate">methylphenidate</a> (20&#160;mg). They also reported feeling alert, vigorous, elated and energetic, reflecting the general stimulating properties of bupropion. In contrast to amphetamine and methylphenidate, there was no feeling of "liking the drug" and no desire to take it again.<sup id="cite_ref-pmid9526144_126-0" class="reference"><a href="#cite_note-pmid9526144-126" title=""><span>[</span>127<span>]</span></a></sup> A comparison of bupropion SR (150&#160;mg) and <a href="/wiki/Caffeine" title="Caffeine">caffeine</a> (178&#160;mg) indicated that caffeine may have higher abuse liability since it resulted in more reports of pleasant feelings and a "high" than bupropion.<sup id="cite_ref-pmid15001822_127-0" class="reference"><a href="#cite_note-pmid15001822-127" title=""><span>[</span>128<span>]</span></a></sup></p>
<p>There have been four reports of bupropion abuse in the literature. Three cases described teenagers crushing and <a href="/wiki/Insufflation_(medicine)" title="Insufflation (medicine)">insufflating</a> (snorting) the drug, two of them resulting in seizures.<sup id="cite_ref-128" class="reference"><a href="#cite_note-128" title=""><span>[</span>129<span>]</span></a></sup><sup id="cite_ref-129" class="reference"><a href="#cite_note-129" title=""><span>[</span>130<span>]</span></a></sup><sup id="cite_ref-130" class="reference"><a href="#cite_note-130" title=""><span>[</span>131<span>]</span></a></sup> An additional case was reported where a teenager ingested bupropion believing the drug to be a stimulant.<sup id="cite_ref-131" class="reference"><a href="#cite_note-131" title=""><span>[</span>132<span>]</span></a></sup> An article on medication abuse in prisons mentions bupropion as one of the psychotropic medications commonly abused by inmates.<sup id="cite_ref-132" class="reference"><a href="#cite_note-132" title=""><span>[</span>133<span>]</span></a></sup></p>
<p><a name="Synthesis" id="Synthesis"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=18" title="Edit section: Synthesis">edit</a>]</span> <span class="mw-headline">Synthesis</span></h2>
<p>Bupropion is synthesized by brominating 3'-chloropropiophenone, followed by nucleophilic substitution with <a href="/wiki/T-butylamine" title="T-butylamine" class="mw-redirect">t-butylamine</a>.<sup id="cite_ref-United_States_Patent:_3819706_4-1" class="reference"><a href="#cite_note-United_States_Patent:_3819706-4" title=""><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-133" class="reference"><a href="#cite_note-133" title=""><span>[</span>134<span>]</span></a></sup></p>
<dl>
<dd><a href="/wiki/File:Synthesis_of_bupropion.png" class="image" title="Synthesis of bupropion.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/1/1d/Synthesis_of_bupropion.png/500px-Synthesis_of_bupropion.png" width="500" height="56" border="0" /></a></dd>
</dl>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=19" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-0"><b><a href="#cite_ref-0" title="">^</a></b> The INN originally assigned in 1974 by the <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> was "amfebutamone". In 2000, the INN was reassigned as <i>bupropion</i>. See <cite style="font-style:normal" class="" id="CITEREF.5B.5BWorld_Health_Organization.5D.5D2000"><a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (2000). "<a href="http://82.77.46.154/gsdldata/collect/whodruginfo/index/assoc/h1463e/h1463e.pdf" class="external text" title="http://82.77.46.154/gsdldata/collect/whodruginfo/index/assoc/h1463e/h1463e.pdf" rel="nofollow">International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 83</a>" (PDF). <i>WHO Drug Information</i> <b>14</b> (2)<span class="printonly">. <a href="http://82.77.46.154/gsdldata/collect/whodruginfo/index/assoc/h1463e/h1463e.pdf" class="external free" title="http://82.77.46.154/gsdldata/collect/whodruginfo/index/assoc/h1463e/h1463e.pdf" rel="nofollow">http://82.77.46.154/gsdldata/collect/whodruginfo/index/assoc/h1463e/h1463e.pdf</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=International+Nonproprietary+Names+for+Pharmaceutical+Substances+%28INN%29.+Proposed+INN%3A+List+83&amp;rft.jtitle=WHO+Drug+Information&amp;rft.aulast=%5B%5BWorld+Health+Organization%5D%5D&amp;rft.au=%5B%5BWorld+Health+Organization%5D%5D&amp;rft.date=2000&amp;rft.volume=14&amp;rft.issue=2&amp;rft_id=http%3A%2F%2F82.77.46.154%2Fgsdldata%2Fcollect%2Fwhodruginfo%2Findex%2Fassoc%2Fh1463e%2Fh1463e.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-1"><b><a href="#cite_ref-1" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSlemmer_J_E.2C_Martin_R_M.2C_Damaj_M_I2000">Slemmer J E, Martin R M, Damaj M I (2000). "Bupropion is a Nicotinic Antagonist". <i>J Pharmacol Exp Ther</i> <b>295</b> (1): 321–327.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+is+a+Nicotinic+Antagonist&amp;rft.jtitle=J+Pharmacol+Exp+Ther&amp;rft.aulast=Slemmer+J+E%2C+Martin+R+M%2C+Damaj+M+I&amp;rft.au=Slemmer+J+E%2C+Martin+R+M%2C+Damaj+M+I&amp;rft.date=2000&amp;rft.volume=295&amp;rft.issue=1&amp;rft.pages=321%E2%80%93327&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-2"><b><a href="#cite_ref-2" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFryer_J_D.2C_Lukas_R_J1999">Fryer J D, Lukas R J (1999). "Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine". <i>J Pharmacol Exp Ther</i> <b>288</b> (6): 88–92. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9862757" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9862757">PMID 9862757</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Noncompetitive+functional+inhibition+at+diverse%2C+human+nicotinic+acetylcholine+receptor+subtypes+by+bupropion%2C+phencyclidine%2C+and+ibogaine&amp;rft.jtitle=J+Pharmacol+Exp+Ther&amp;rft.aulast=Fryer+J+D%2C+Lukas+R+J&amp;rft.au=Fryer+J+D%2C+Lukas+R+J&amp;rft.date=1999&amp;rft.volume=288&amp;rft.issue=6&amp;rft.pages=88%E2%80%9392&amp;rft_id=info:pmid/9862757&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-3"><b><a href="#cite_ref-3" title="">^</a></b> After <a href="/wiki/Sertraline" title="Sertraline">sertraline</a>, <a href="/wiki/Escitalopram" title="Escitalopram">escitalopram</a> and <a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a>. The bupropion prescriptions were calculated as a total of prescriptions for Wellbutrin XL, Budeprion XL, Budeprion SR, Bupropion SR and Bupropion ER using data from the charts for generic and brand-name drugs, see: <cite style="font-style:normal" class="web"><a href="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491181" class="external text" title="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491181" rel="nofollow">"Top 200 Generic Drugs by Units in 2007"</a> (PDF). Drug Topics. 2008-02-18<span class="printonly">. <a href="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491181" class="external free" title="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491181" rel="nofollow">http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491181</a></span><span class="reference-accessdate">. Retrieved on 2008-03-30</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Top+200+Generic+Drugs+by+Units+in+2007&amp;rft.atitle=&amp;rft.date=2008-02-18&amp;rft.pub=Drug+Topics&amp;rft_id=http%3A%2F%2Fwww.drugtopics.com%2Fdrugtopics%2Farticle%2FarticleDetail.jsp%3Fid%3D491181&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span> and <cite style="font-style:normal" class="web" id="CITEREFVerispan2008">Verispan (2008-02-18). <a href="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491207" class="external text" title="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491207" rel="nofollow">"Top 200 Brand Drugs by Units in 2007"</a> (PDF). Drug Topics<span class="printonly">. <a href="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491207" class="external free" title="http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491207" rel="nofollow">http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=491207</a></span><span class="reference-accessdate">. Retrieved on 2008-03-30</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Top+200+Brand+Drugs+by+Units+in+2007&amp;rft.atitle=&amp;rft.aulast=Verispan&amp;rft.au=Verispan&amp;rft.date=2008-02-18&amp;rft.pub=Drug+Topics&amp;rft_id=http%3A%2F%2Fwww.drugtopics.com%2Fdrugtopics%2Farticle%2FarticleDetail.jsp%3Fid%3D491207&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-United_States_Patent:_3819706-4">^ <a href="#cite_ref-United_States_Patent:_3819706_4-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-United_States_Patent:_3819706_4-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="web" id="CITEREFMehta_NB1974">Mehta NB (1974-06-25). <a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&amp;Sect2=HITOFF&amp;d=PALL&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&amp;r=1&amp;f=G&amp;l=50&amp;s1=3819706.PN.&amp;OS=PN/3819706&amp;RS=PN/3819706" class="external text" title="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&amp;Sect2=HITOFF&amp;d=PALL&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&amp;r=1&amp;f=G&amp;l=50&amp;s1=3819706.PN.&amp;OS=PN/3819706&amp;RS=PN/3819706" rel="nofollow">"United States Patent 3,819,706: Meta-chloro substituted α-butylamino-propiophenones"</a>. USPTO<span class="printonly">. <a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&amp;Sect2=HITOFF&amp;d=PALL&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&amp;r=1&amp;f=G&amp;l=50&amp;s1=3819706.PN.&amp;OS=PN/3819706&amp;RS=PN/3819706" class="external free" title="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&amp;Sect2=HITOFF&amp;d=PALL&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&amp;r=1&amp;f=G&amp;l=50&amp;s1=3819706.PN.&amp;OS=PN/3819706&amp;RS=PN/3819706" rel="nofollow">http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&amp;Sect2=HITOFF&amp;d=PALL&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&amp;r=1&amp;f=G&amp;l=50&amp;s1=3819706.PN.&amp;OS=PN/3819706&amp;RS=PN/3819706</a></span><span class="reference-accessdate">. Retrieved on 2008-06-02</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=United+States+Patent+3%2C819%2C706%3A+Meta-chloro+substituted+%CE%B1-butylamino-propiophenones&amp;rft.atitle=&amp;rft.aulast=Mehta+NB&amp;rft.au=Mehta+NB&amp;rft.date=1974-06-25&amp;rft.pub=USPTO&amp;rft_id=http%3A%2F%2Fpatft.uspto.gov%2Fnetacgi%2Fnph-Parser%3FSect1%3DPTO1%26Sect2%3DHITOFF%26d%3DPALL%26p%3D1%26u%3D%252Fnetahtml%252FPTO%252Fsrchnum.htm%26r%3D1%26f%3DG%26l%3D50%26s1%3D3819706.PN.%26OS%3DPN%2F3819706%26RS%3DPN%2F3819706&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-5"><b><a href="#cite_ref-5" title="">^</a></b> WELLBUTRIN Label and Approval History. U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration" class="mw-redirect">Food and Drug Administration</a> <a href="/wiki/Center_for_Drug_Evaluation_and_Research" title="Center for Drug Evaluation and Research">Center for Drug Evaluation and Research</a>. Retrieved on 2007-08-18. Data available for download on <a href="http://www.fda.gov/cder/drugsatfda/datafiles/default.htm" class="external text" title="http://www.fda.gov/cder/drugsatfda/datafiles/default.htm" rel="nofollow">FDA website</a>.</li>
<li id="cite_note-NIDA_notes-6">^ <a href="#cite_ref-NIDA_notes_6-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NIDA_notes_6-1" title=""><sup><i><b>b</b></i></sup></a> "<a href="http://www.drugabuse.gov/NIDA_notes/NNvol20N5/Bupropion.html" class="external text" title="http://www.drugabuse.gov/NIDA_notes/NNvol20N5/Bupropion.html" rel="nofollow">Bupropion Helps People With Schizophrenia Quit Smoking</a>." <i><a href="/wiki/National_Institute_on_Drug_Abuse" title="National Institute on Drug Abuse">National Institute on Drug Abuse</a>.</i> <i>Research Findings</i>, Vol. 20, No. 5 (April 2006). Retrieved on August 19, 2007.</li>
<li id="cite_note-wellbutrin_seasonal-7"><b><a href="#cite_ref-wellbutrin_seasonal_7-0" title="">^</a></b> Staff Writer. "<a href="http://www.cnn.com/HEALTH/library/DI/00069.html" class="external text" title="http://www.cnn.com/HEALTH/library/DI/00069.html" rel="nofollow">Seasonal affective disorder drug Wellbutrin XL wins approval</a>." <i><a href="/wiki/CNN" title="CNN">CNN</a>.</i> June 14, 2006. Retrieved on August 19, 2007.</li>
<li id="cite_note-8"><b><a href="#cite_ref-8" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFava_M.2C_Rush_AJ.2C_Thase_ME.2C_Clayton_A.2C_Stahl_SM.2C_Pradko_JF.2C_Johnston_JA.2005">Fava M, Rush AJ, Thase ME, Clayton A, Stahl SM, Pradko JF, Johnston JA. (2005). "<a href="http://www.psychiatrist.com/pcc/pccpdf/v07n03/v07n0305.pdf" class="external text" title="http://www.psychiatrist.com/pcc/pccpdf/v07n03/v07n0305.pdf" rel="nofollow">15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL</a>" (PDF). <i>Prim Care Companion J Clin Psychiatry</i> <b>7</b> (3): 106–113. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16027765" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16027765">PMID 16027765</a><span class="printonly">. <a href="http://www.psychiatrist.com/pcc/pccpdf/v07n03/v07n0305.pdf" class="external free" title="http://www.psychiatrist.com/pcc/pccpdf/v07n03/v07n0305.pdf" rel="nofollow">http://www.psychiatrist.com/pcc/pccpdf/v07n03/v07n0305.pdf</a></span><span class="reference-accessdate">. Retrieved on 2008-12-30</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=15+years+of+clinical+experience+with+bupropion+HCl%3A+from+bupropion+to+bupropion+SR+to+bupropion+XL&amp;rft.jtitle=Prim+Care+Companion+J+Clin+Psychiatry&amp;rft.aulast=Fava+M%2C+Rush+AJ%2C+Thase+ME%2C+Clayton+A%2C+Stahl+SM%2C+Pradko+JF%2C+Johnston+JA.&amp;rft.au=Fava+M%2C+Rush+AJ%2C+Thase+ME%2C+Clayton+A%2C+Stahl+SM%2C+Pradko+JF%2C+Johnston+JA.&amp;rft.date=2005&amp;rft.volume=7&amp;rft.issue=3&amp;rft.pages=106%E2%80%93113&amp;rft_id=info:pmid/16027765&amp;rft_id=http%3A%2F%2Fwww.psychiatrist.com%2Fpcc%2Fpccpdf%2Fv07n03%2Fv07n0305.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-9"><b><a href="#cite_ref-9" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFThase_ME.2C_Haight_BR.2C_Richard_N.2C_Rockett_CB.2C_Mitton_M.2C_Modell_JG.2C_VanMeter_S.2C_Harriett_AE.2C_Wang_Y2005">Thase ME, Haight BR, Richard N, Rockett CB, Mitton M, Modell JG, VanMeter S, Harriett AE, Wang Y (2005). "Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials". <i>J Clin Psychiatry</i> <b>66</b> (6): 974–981. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16086611" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16086611">PMID 16086611</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Remission+rates+following+antidepressant+therapy+with+bupropion+or+selective+serotonin+reuptake+inhibitors%3A+a+meta-analysis+of+original+data+from+7+randomized+controlled+trials&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Thase+ME%2C+Haight+BR%2C+Richard+N%2C+Rockett+CB%2C+Mitton+M%2C+Modell+JG%2C+VanMeter+S%2C+Harriett+AE%2C+Wang+Y&amp;rft.au=Thase+ME%2C+Haight+BR%2C+Richard+N%2C+Rockett+CB%2C+Mitton+M%2C+Modell+JG%2C+VanMeter+S%2C+Harriett+AE%2C+Wang+Y&amp;rft.date=2005&amp;rft.volume=66&amp;rft.issue=6&amp;rft.pages=974%E2%80%93981&amp;rft_id=info:pmid/16086611&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-10"><b><a href="#cite_ref-10" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFClayton_AH.2C_Croft_HA.2C_Horrigan_JP.2C_Wightman_DS.2C_Krishen_A.2C_Richard_NE.2C_Modell_JG2006">Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG (2006). "Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies". <i>J Clin Psychiatry</i> <b>67</b> (5): 736–746. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1684162" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1684162">PMID 1684162</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+extended+release+compared+with+escitalopram%3A+effects+on+sexual+functioning+and+antidepressant+efficacy+in+2+randomized%2C+double-blind%2C+placebo-controlled+studies&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Clayton+AH%2C+Croft+HA%2C+Horrigan+JP%2C+Wightman+DS%2C+Krishen+A%2C+Richard+NE%2C+Modell+JG&amp;rft.au=Clayton+AH%2C+Croft+HA%2C+Horrigan+JP%2C+Wightman+DS%2C+Krishen+A%2C+Richard+NE%2C+Modell+JG&amp;rft.date=2006&amp;rft.volume=67&amp;rft.issue=5&amp;rft.pages=736%E2%80%93746&amp;rft_id=info:pmid/1684162&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-11"><b><a href="#cite_ref-11" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFThase_ME.2C_Clayton_AH.2C_Haight_BR.2C_Thompson_AH.2C_Modell_JG.2C_Johnston_JA2006">Thase ME, Clayton AH, Haight BR, Thompson AH, Modell JG, Johnston JA (2006). "A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability". <i>J Clin Psychopharmacol</i> <b>26</b> (5): 482–488. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F01.jcp.0000239790.83707.ab" class="external text" title="http://dx.doi.org/10.1097%2F01.jcp.0000239790.83707.ab" rel="nofollow">10.1097/01.jcp.0000239790.83707.ab</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16974189" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16974189">PMID 16974189</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+double-blind+comparison+between+bupropion+XL+and+venlafaxine+XR%3A+sexual+functioning%2C+antidepressant+efficacy%2C+and+tolerability&amp;rft.jtitle=J+Clin+Psychopharmacol&amp;rft.aulast=Thase+ME%2C+Clayton+AH%2C+Haight+BR%2C+Thompson+AH%2C+Modell+JG%2C+Johnston+JA&amp;rft.au=Thase+ME%2C+Clayton+AH%2C+Haight+BR%2C+Thompson+AH%2C+Modell+JG%2C+Johnston+JA&amp;rft.date=2006&amp;rft.volume=26&amp;rft.issue=5&amp;rft.pages=482%E2%80%93488&amp;rft_id=info:doi/10.1097%2F01.jcp.0000239790.83707.ab&amp;rft_id=info:pmid/16974189&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-12"><b><a href="#cite_ref-12" title="">^</a></b> For the review, see: <cite style="font-style:normal" class="" id="CITEREFClayton_AH2003">Clayton AH (2003). "Antidepressant-Associated Sexual Dysfunction: A Potentially Avoidable Therapeutic Challenge". <i>Primary Psychiatry</i> <b>10</b> (1): 55–61.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Antidepressant-Associated+Sexual+Dysfunction%3A+A+Potentially+Avoidable+Therapeutic+Challenge&amp;rft.jtitle=Primary+Psychiatry&amp;rft.aulast=Clayton+AH&amp;rft.au=Clayton+AH&amp;rft.date=2003&amp;rft.volume=10&amp;rft.issue=1&amp;rft.pages=55%E2%80%9361&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-13"><b><a href="#cite_ref-13" title="">^</a></b> For another review, see: <cite style="font-style:normal" class="" id="CITEREFKanaly_KA.2C_Berman_JR2002">Kanaly KA, Berman JR (2002). "Sexual side effects of SSRI medications: potential treatment strategies for SSRI-induced female sexual dysfunction". <i>Curr Women's Health Rep</i> <b>2</b> (6): 409–16. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12429073" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12429073">PMID 12429073</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sexual+side+effects+of+SSRI+medications%3A+potential+treatment+strategies+for+SSRI-induced+female+sexual+dysfunction&amp;rft.jtitle=Curr+Women%27s+Health+Rep&amp;rft.aulast=Kanaly+KA%2C+Berman+JR&amp;rft.au=Kanaly+KA%2C+Berman+JR&amp;rft.date=2002&amp;rft.volume=2&amp;rft.issue=6&amp;rft.pages=409%E2%80%9316&amp;rft_id=info:pmid/12429073&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-14"><b><a href="#cite_ref-14" title="">^</a></b> For a short review, see: <cite style="font-style:normal" class="" id="CITEREFZimmerman_M.2C_Posternak_MA.2C_Attiullah_N.2C_Friedman_M.2C_Boland_RJ.2C_Baymiller_S.2C_Berlowitz_SL.2C_Rahman_S.2C_Uy_KK.2C_Singer_S.2C_Chelminski_I.2C_Thongy.2C_T2005">Zimmerman M, Posternak MA, Attiullah N, Friedman M, Boland RJ, Baymiller S, Berlowitz SL, Rahman S, Uy KK, Singer S, Chelminski I, Thongy, T (2005). "Dr. Zimmerman and colleagues reply to MJ Menaster". <i>J Clin Psychiatry</i> <b>66</b> (10): 1336–9.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Dr.+Zimmerman+and+colleagues+reply+to+MJ+Menaster&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Zimmerman+M%2C+Posternak+MA%2C+Attiullah+N%2C+Friedman+M%2C+Boland+RJ%2C+Baymiller+S%2C+Berlowitz+SL%2C+Rahman+S%2C+Uy+KK%2C+Singer+S%2C+Chelminski+I%2C+Thongy%2C+T&amp;rft.au=Zimmerman+M%2C+Posternak+MA%2C+Attiullah+N%2C+Friedman+M%2C+Boland+RJ%2C+Baymiller+S%2C+Berlowitz+SL%2C+Rahman+S%2C+Uy+KK%2C+Singer+S%2C+Chelminski+I%2C+Thongy%2C+T&amp;rft.date=2005&amp;rft.volume=66&amp;rft.issue=10&amp;rft.pages=1336%E2%80%939&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-15"><b><a href="#cite_ref-15" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBaldwin_DS.2C_Papakostas_GI2006">Baldwin DS, Papakostas GI (2006). "Symptoms of Fatigue and Sleepiness in Major Depressive Disorder". <i>J Clin Psychiatry</i> <b>67 (suppl 6)</b>: 9–15. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16848671" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16848671">PMID 16848671</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Symptoms+of+Fatigue+and+Sleepiness+in+Major+Depressive+Disorder&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Baldwin+DS%2C+Papakostas+GI&amp;rft.au=Baldwin+DS%2C+Papakostas+GI&amp;rft.date=2006&amp;rft.volume=67+%28suppl+6%29&amp;rft.pages=9%E2%80%9315&amp;rft_id=info:pmid/16848671&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18605812-16"><b><a href="#cite_ref-pmid18605812_16-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPapakostas_GI.2C_Stahl_SM.2C_Krishen_A.2C_.27.27et_al.27.272008">Papakostas GI, Stahl SM, Krishen A, <i>et al</i> (July 2008). "<a href="http://article.psychiatrist.com/?ContentType=START&amp;ID=10003663" class="external text" title="http://article.psychiatrist.com/?ContentType=START&amp;ID=10003663" rel="nofollow">Efficacy of Bupropion and the Selective Serotonin Reuptake Inhibitors in the Treatment of Major Depressive Disorder With High Levels of Anxiety (Anxious Depression): A Pooled Analysis of 10 Studies</a>". <i>J Clin Psychiatry</i>: e1–e6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18605812" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18605812">PMID 18605812</a><span class="printonly">. <a href="http://article.psychiatrist.com/?ContentType=START&amp;ID=10003663" class="external free" title="http://article.psychiatrist.com/?ContentType=START&amp;ID=10003663" rel="nofollow">http://article.psychiatrist.com/?ContentType=START&amp;ID=10003663</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Efficacy+of+Bupropion+and+the+Selective+Serotonin+Reuptake+Inhibitors+in+the+Treatment+of+Major+Depressive+Disorder+With+High+Levels+of+Anxiety+%28Anxious+Depression%29%3A+A+Pooled+Analysis+of+10+Studies&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Papakostas+GI%2C+Stahl+SM%2C+Krishen+A%2C+%27%27et+al%27%27&amp;rft.au=Papakostas+GI%2C+Stahl+SM%2C+Krishen+A%2C+%27%27et+al%27%27&amp;rft.date=July+2008&amp;rft.pages=e1%E2%80%93e6&amp;rft_id=info:pmid/18605812&amp;rft_id=http%3A%2F%2Farticle.psychiatrist.com%2F%3FContentType%3DSTART%26ID%3D10003663&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-17"><b><a href="#cite_ref-17" title="">^</a></b> For the most recent review, see: <cite style="font-style:normal" class="" id="CITEREFZisook_S.2C_Rush_AJ.2C_Haight_BR.2C_Clines_DC.2C_Rockett_CB2006">Zisook S, Rush AJ, Haight BR, Clines DC, Rockett CB (2006). "Use of bupropion in combination with serotonin reuptake inhibitors". <i>Biol Psychiatry</i> <b>59</b> (3): 203–10. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.biopsych.2005.06.027" class="external text" title="http://dx.doi.org/10.1016%2Fj.biopsych.2005.06.027" rel="nofollow">10.1016/j.biopsych.2005.06.027</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16165100" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16165100">PMID 16165100</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Use+of+bupropion+in+combination+with+serotonin+reuptake+inhibitors&amp;rft.jtitle=Biol+Psychiatry&amp;rft.aulast=Zisook+S%2C+Rush+AJ%2C+Haight+BR%2C+Clines+DC%2C+Rockett+CB&amp;rft.au=Zisook+S%2C+Rush+AJ%2C+Haight+BR%2C+Clines+DC%2C+Rockett+CB&amp;rft.date=2006&amp;rft.volume=59&amp;rft.issue=3&amp;rft.pages=203%E2%80%9310&amp;rft_id=info:doi/10.1016%2Fj.biopsych.2005.06.027&amp;rft_id=info:pmid/16165100&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9614595-18"><b><a href="#cite_ref-pmid9614595_18-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSpier_SA1998">Spier SA (1998). "Use of bupropion with SRIs and venlafaxine". <i>Depression and anxiety</i> <b>7</b> (2): 73–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F%28SICI%291520-6394%281998%297%3A2%3C73%3A%3AAID-DA4%3E3.0.CO%3B2-6" class="external text" title="http://dx.doi.org/10.1002%2F%28SICI%291520-6394%281998%297%3A2%3C73%3A%3AAID-DA4%3E3.0.CO%3B2-6" rel="nofollow">10.1002/(SICI)1520-6394(1998)7:2&lt;73::AID-DA4&gt;3.0.CO;2-6</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9614595" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9614595">PMID 9614595</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Use+of+bupropion+with+SRIs+and+venlafaxine&amp;rft.jtitle=Depression+and+anxiety&amp;rft.aulast=Spier+SA&amp;rft.au=Spier+SA&amp;rft.date=1998&amp;rft.volume=7&amp;rft.issue=2&amp;rft.pages=73%E2%80%935&amp;rft_id=info:doi/10.1002%2F%28SICI%291520-6394%281998%297%3A2%3C73%3A%3AAID-DA4%3E3.0.CO%3B2-6&amp;rft_id=info:pmid/9614595&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9164423-19">^ <a href="#cite_ref-pmid9164423_19-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid9164423_19-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFBodkin_JA.2C_Lasser_RA.2C_Wines_JD.2C_Gardner_DM.2C_Baldessarini_RJ1997">Bodkin JA, Lasser RA, Wines JD, Gardner DM, Baldessarini RJ (1997). "Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy". <i>The Journal of clinical psychiatry</i> <b>58</b> (4): 137–45. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9164423" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9164423">PMID 9164423</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Combining+serotonin+reuptake+inhibitors+and+bupropion+in+partial+responders+to+antidepressant+monotherapy&amp;rft.jtitle=The+Journal+of+clinical+psychiatry&amp;rft.aulast=Bodkin+JA%2C+Lasser+RA%2C+Wines+JD%2C+Gardner+DM%2C+Baldessarini+RJ&amp;rft.au=Bodkin+JA%2C+Lasser+RA%2C+Wines+JD%2C+Gardner+DM%2C+Baldessarini+RJ&amp;rft.date=1997&amp;rft.volume=58&amp;rft.issue=4&amp;rft.pages=137%E2%80%9345&amp;rft_id=info:pmid/9164423&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16554526-20"><b><a href="#cite_ref-pmid16554526_20-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTrivedi_MH.2C_Fava_M.2C_Wisniewski_SR.2C_Thase_ME.2C_Quitkin_F.2C_Warden_D.2C_Ritz_L.2C_Nierenberg_AA.2C_Lebowitz_BD.2C_Biggs_MM.2C_Luther_JF.2C_Shores-Wilson_K.2C_Rush_AJ2006">Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ (2006). "Medication augmentation after the failure of SSRIs for depression". <i>N. Engl. J. Med.</i> <b>354</b> (12): 1243–52. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa052964" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa052964" rel="nofollow">10.1056/NEJMoa052964</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16554526" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16554526">PMID 16554526</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Medication+augmentation+after+the+failure+of+SSRIs+for+depression&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Trivedi+MH%2C+Fava+M%2C+Wisniewski+SR%2C+Thase+ME%2C+Quitkin+F%2C+Warden+D%2C+Ritz+L%2C+Nierenberg+AA%2C+Lebowitz+BD%2C+Biggs+MM%2C+Luther+JF%2C+Shores-Wilson+K%2C+Rush+AJ&amp;rft.au=Trivedi+MH%2C+Fava+M%2C+Wisniewski+SR%2C+Thase+ME%2C+Quitkin+F%2C+Warden+D%2C+Ritz+L%2C+Nierenberg+AA%2C+Lebowitz+BD%2C+Biggs+MM%2C+Luther+JF%2C+Shores-Wilson+K%2C+Rush+AJ&amp;rft.date=2006&amp;rft.volume=354&amp;rft.issue=12&amp;rft.pages=1243%E2%80%9352&amp;rft_id=info:doi/10.1056%2FNEJMoa052964&amp;rft_id=info:pmid/16554526&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16554525-21"><b><a href="#cite_ref-pmid16554525_21-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRush_AJ.2C_Trivedi_MH.2C_Wisniewski_SR.2C_Stewart_JW.2C_Nierenberg_AA.2C_Thase_ME.2C_Ritz_L.2C_Biggs_MM.2C_Warden_D.2C_Luther_JF.2C_Shores-Wilson_K.2C_Niederehe_G.2C_Fava_M2006">Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M (2006). "Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression". <i>N. Engl. J. Med.</i> <b>354</b> (12): 1231–42. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa052963" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa052963" rel="nofollow">10.1056/NEJMoa052963</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16554525" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16554525">PMID 16554525</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion-SR%2C+sertraline%2C+or+venlafaxine-XR+after+failure+of+SSRIs+for+depression&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Rush+AJ%2C+Trivedi+MH%2C+Wisniewski+SR%2C+Stewart+JW%2C+Nierenberg+AA%2C+Thase+ME%2C+Ritz+L%2C+Biggs+MM%2C+Warden+D%2C+Luther+JF%2C+Shores-Wilson+K%2C+Niederehe+G%2C+Fava+M&amp;rft.au=Rush+AJ%2C+Trivedi+MH%2C+Wisniewski+SR%2C+Stewart+JW%2C+Nierenberg+AA%2C+Thase+ME%2C+Ritz+L%2C+Biggs+MM%2C+Warden+D%2C+Luther+JF%2C+Shores-Wilson+K%2C+Niederehe+G%2C+Fava+M&amp;rft.date=2006&amp;rft.volume=354&amp;rft.issue=12&amp;rft.pages=1231%E2%80%9342&amp;rft_id=info:doi/10.1056%2FNEJMoa052963&amp;rft_id=info:pmid/16554525&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Tonnesen2003-22">^ <a href="#cite_ref-Tonnesen2003_22-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Tonnesen2003_22-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFTonnesen_P.2C_Tonstad_S.2C_Hjalmarson_A.2C_Lebargy_F.2C_Van_Spiegel_P_I.2C_Hider_A.2C_Sweet_R.2C_Townsend_J2003">Tonnesen P, Tonstad S, Hjalmarson A, Lebargy F, Van Spiegel P I, Hider A, Sweet R, Townsend J (2003). "A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation". <i>J Intern Med</i> <b>254</b> (2): 184–192. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1046%2Fj.1365-2796.2003.01185.x" class="external text" title="http://dx.doi.org/10.1046%2Fj.1365-2796.2003.01185.x" rel="nofollow">10.1046/j.1365-2796.2003.01185.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12859700" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12859700">PMID 12859700</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+multicentre%2C+randomized%2C+double-blind%2C+placebo-controlled%2C+1-year+study+of+bupropion+SR+for+smoking+cessation&amp;rft.jtitle=J+Intern+Med&amp;rft.aulast=Tonnesen+P%2C+Tonstad+S%2C+Hjalmarson+A%2C+Lebargy+F%2C+Van+Spiegel+P+I%2C+Hider+A%2C+Sweet+R%2C+Townsend+J&amp;rft.au=Tonnesen+P%2C+Tonstad+S%2C+Hjalmarson+A%2C+Lebargy+F%2C+Van+Spiegel+P+I%2C+Hider+A%2C+Sweet+R%2C+Townsend+J&amp;rft.date=2003&amp;rft.volume=254&amp;rft.issue=2&amp;rft.pages=184%E2%80%93192&amp;rft_id=info:doi/10.1046%2Fj.1365-2796.2003.01185.x&amp;rft_id=info:pmid/12859700&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-23"><b><a href="#cite_ref-23" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWu_P.2C_Wilson_K.2C_Dimoulas_P.2C_Mills_E_J2006">Wu P, Wilson K, Dimoulas P, Mills E J (2006). "Effectiveness of smoking cessation therapies: a systematic review and meta-analysis". <i>BMC Public Health</i> <b>6</b>: 300–315. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1186%2F1471-2458-6-300" class="external text" title="http://dx.doi.org/10.1186%2F1471-2458-6-300" rel="nofollow">10.1186/1471-2458-6-300</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effectiveness+of+smoking+cessation+therapies%3A+a+systematic+review+and+meta-analysis&amp;rft.jtitle=BMC+Public+Health&amp;rft.aulast=Wu+P%2C+Wilson+K%2C+Dimoulas+P%2C+Mills+E+J&amp;rft.au=Wu+P%2C+Wilson+K%2C+Dimoulas+P%2C+Mills+E+J&amp;rft.date=2006&amp;rft.volume=6&amp;rft.pages=300%E2%80%93315&amp;rft_id=info:doi/10.1186%2F1471-2458-6-300&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-24"><b><a href="#cite_ref-24" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJorenby_D_E.2C_Hays_J_T.2C_Rigotti_N_A.2C_Azoulay_S.2C_Watsky_E_J.2C_Williams_K_E.2C_Billing_C_B.2C_Gong_J.2C_Reeves_K_R2006">Jorenby D E, Hays J T, Rigotti N A, Azoulay S, Watsky E J, Williams K E, Billing C B, Gong J, Reeves K R (2006). "Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial". <i>JAMA</i> <b>296</b> (1): 56–63. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.296.1.56" class="external text" title="http://dx.doi.org/10.1001%2Fjama.296.1.56" rel="nofollow">10.1001/jama.296.1.56</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16820547" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16820547">PMID 16820547</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Efficacy+of+varenicline%2C+an+alpha4beta2+nicotinic+acetylcholine+receptor+partial+agonist%2C+vs+placebo+or+sustained-release+bupropion+for+smoking+cessation%3A+a+randomized+controlled+trial&amp;rft.jtitle=JAMA&amp;rft.aulast=Jorenby+D+E%2C+Hays+J+T%2C+Rigotti+N+A%2C+Azoulay+S%2C+Watsky+E+J%2C+Williams+K+E%2C+Billing+C+B%2C+Gong+J%2C+Reeves+K+R&amp;rft.au=Jorenby+D+E%2C+Hays+J+T%2C+Rigotti+N+A%2C+Azoulay+S%2C+Watsky+E+J%2C+Williams+K+E%2C+Billing+C+B%2C+Gong+J%2C+Reeves+K+R&amp;rft.date=2006&amp;rft.volume=296&amp;rft.issue=1&amp;rft.pages=56%E2%80%9363&amp;rft_id=info:doi/10.1001%2Fjama.296.1.56&amp;rft_id=info:pmid/16820547&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-25"><b><a href="#cite_ref-25" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDording_CM.2C_Mischoulon_D.2C_Petersen_TJ.2C_Kornbluh_R.2C_Gordon_J.2C_Nierenberg_AA.2C_Rosenbaum_JE.2C_Fava_M.2002">Dording CM, Mischoulon D, Petersen TJ, Kornbluh R, Gordon J, Nierenberg AA, Rosenbaum JE, Fava M. (2002). "The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists". <i>Ann Clin Psychiatry</i> <b>14</b> (3): 143–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.3109%2F10401230209147450" class="external text" title="http://dx.doi.org/10.3109%2F10401230209147450" rel="nofollow">10.3109/10401230209147450</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12585563" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12585563">PMID 12585563</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+pharmacologic+management+of+SSRI-induced+side+effects%3A+a+survey+of+psychiatrists&amp;rft.jtitle=Ann+Clin+Psychiatry&amp;rft.aulast=Dording+CM%2C+Mischoulon+D%2C+Petersen+TJ%2C+Kornbluh+R%2C+Gordon+J%2C+Nierenberg+AA%2C+Rosenbaum+JE%2C+Fava+M.&amp;rft.au=Dording+CM%2C+Mischoulon+D%2C+Petersen+TJ%2C+Kornbluh+R%2C+Gordon+J%2C+Nierenberg+AA%2C+Rosenbaum+JE%2C+Fava+M.&amp;rft.date=2002&amp;rft.volume=14&amp;rft.issue=3&amp;rft.pages=143%E2%80%937&amp;rft_id=info:doi/10.3109%2F10401230209147450&amp;rft_id=info:pmid/12585563&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-26"><b><a href="#cite_ref-26" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWalker_PW.2C_Cole_JO.2C_Gardner_EA.2C_Hughes_AR.2C_Johnston_JA.2C_Batey_SR.2C_Lineberry_CG1993">Walker PW, Cole JO, Gardner EA, Hughes AR, Johnston JA, Batey SR, Lineberry CG (1993). "Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion". <i>J Clin Psychiatry</i> <b>54</b> (12): 459–65. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8276736" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8276736">PMID 8276736</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Improvement+in+fluoxetine-associated+sexual+dysfunction+in+patients+switched+to+bupropion&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Walker+PW%2C+Cole+JO%2C+Gardner+EA%2C+Hughes+AR%2C+Johnston+JA%2C+Batey+SR%2C+Lineberry+CG&amp;rft.au=Walker+PW%2C+Cole+JO%2C+Gardner+EA%2C+Hughes+AR%2C+Johnston+JA%2C+Batey+SR%2C+Lineberry+CG&amp;rft.date=1993&amp;rft.volume=54&amp;rft.issue=12&amp;rft.pages=459%E2%80%9365&amp;rft_id=info:pmid/8276736&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-27"><b><a href="#cite_ref-27" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDobkin_RD.2C_Menza_M.2C_Marin_H.2C_Allen_LA.2C_Rousso_R.2C_Leiblum_SR2006">Dobkin RD, Menza M, Marin H, Allen LA, Rousso R, Leiblum SR (2006). "Bupropion improves sexual functioning in depressed minority women: an open-label switch study". <i>J Clin Psychiatry</i> <b>26</b> (1): 21–6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16415700" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16415700">PMID 16415700</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+improves+sexual+functioning+in+depressed+minority+women%3A+an+open-label+switch+study&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Dobkin+RD%2C+Menza+M%2C+Marin+H%2C+Allen+LA%2C+Rousso+R%2C+Leiblum+SR&amp;rft.au=Dobkin+RD%2C+Menza+M%2C+Marin+H%2C+Allen+LA%2C+Rousso+R%2C+Leiblum+SR&amp;rft.date=2006&amp;rft.volume=26&amp;rft.issue=1&amp;rft.pages=21%E2%80%936&amp;rft_id=info:pmid/16415700&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-28"><b><a href="#cite_ref-28" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMasand_PS.2C_Ashton_AK.2C_Gupta_S.2C_Frank_B2001">Masand PS, Ashton AK, Gupta S, Frank B (2001). "Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study". <i>Am J Psychiatry</i> <b>158</b> (5): 805–807. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.158.5.805" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.158.5.805" rel="nofollow">10.1176/appi.ajp.158.5.805</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11329407" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11329407">PMID 11329407</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sustained-release+bupropion+for+selective+serotonin+reuptake+inhibitor-induced+sexual+dysfunction%3A+a+randomized%2C+double-blind%2C+placebo-controlled%2C+parallel-group+study&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.aulast=Masand+PS%2C+Ashton+AK%2C+Gupta+S%2C+Frank+B&amp;rft.au=Masand+PS%2C+Ashton+AK%2C+Gupta+S%2C+Frank+B&amp;rft.date=2001&amp;rft.volume=158&amp;rft.issue=5&amp;rft.pages=805%E2%80%93807&amp;rft_id=info:doi/10.1176%2Fappi.ajp.158.5.805&amp;rft_id=info:pmid/11329407&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-29"><b><a href="#cite_ref-29" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDeBattista_C.2C_Solvason_B.2C_Poirier_J.2C_Kendrick_E.2C_Loraas_E2005">DeBattista C, Solvason B, Poirier J, Kendrick E, Loraas E (2005). "A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction". <i>J Clin Psychiatry</i> <b>66</b> (7): 844–8.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+placebo-controlled%2C+randomized%2C+double-blind+study+of+adjunctive+bupropion+sustained+release+in+the+treatment+of+SSRI-induced+sexual+dysfunction&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=DeBattista+C%2C+Solvason+B%2C+Poirier+J%2C+Kendrick+E%2C+Loraas+E&amp;rft.au=DeBattista+C%2C+Solvason+B%2C+Poirier+J%2C+Kendrick+E%2C+Loraas+E&amp;rft.date=2005&amp;rft.volume=66&amp;rft.issue=7&amp;rft.pages=844%E2%80%938&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-30"><b><a href="#cite_ref-30" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAshton_AK.2C_Rosen_RC1998">Ashton AK, Rosen RC (1998). "Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction". <i>J Clin Psychiatry</i> <b>59</b> (3): 112–5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9541153" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9541153">PMID 9541153</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+as+an+antidote+for+serotonin+reuptake+inhibitor-induced+sexual+dysfunction&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Ashton+AK%2C+Rosen+RC&amp;rft.au=Ashton+AK%2C+Rosen+RC&amp;rft.date=1998&amp;rft.volume=59&amp;rft.issue=3&amp;rft.pages=112%E2%80%935&amp;rft_id=info:pmid/9541153&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-31"><b><a href="#cite_ref-31" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFClayton_AH.2C_Warnock_JK.2C_Kornstein_SG.2C_Pinkerton_R.2C_Sheldon-Keller_A.2C_McGarvey_EL2004">Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL (2004). "A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction". <i>J Clin Psychiatry</i> <b>65</b> (1): 62–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14744170" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14744170">PMID 14744170</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+placebo-controlled+trial+of+bupropion+SR+as+an+antidote+for+selective+serotonin+reuptake+inhibitor-induced+sexual+dysfunction&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Clayton+AH%2C+Warnock+JK%2C+Kornstein+SG%2C+Pinkerton+R%2C+Sheldon-Keller+A%2C+McGarvey+EL&amp;rft.au=Clayton+AH%2C+Warnock+JK%2C+Kornstein+SG%2C+Pinkerton+R%2C+Sheldon-Keller+A%2C+McGarvey+EL&amp;rft.date=2004&amp;rft.volume=65&amp;rft.issue=1&amp;rft.pages=62%E2%80%937&amp;rft_id=info:pmid/14744170&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-32"><b><a href="#cite_ref-32" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCrenshaw_TL.2C_Goldberg_JP.2C_Stern_WC1987">Crenshaw TL, Goldberg JP, Stern WC (1987). "Pharmacologic modification of psychosexual dysfunction". <i>J Sex Marital Ther</i> <b>13</b> (4): 239–52. <a href="http://www.ncbi.nlm.nih.gov/pubmed/3121861" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/3121861">PMID 3121861</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pharmacologic+modification+of+psychosexual+dysfunction&amp;rft.jtitle=J+Sex+Marital+Ther&amp;rft.aulast=Crenshaw+TL%2C+Goldberg+JP%2C+Stern+WC&amp;rft.au=Crenshaw+TL%2C+Goldberg+JP%2C+Stern+WC&amp;rft.date=1987&amp;rft.volume=13&amp;rft.issue=4&amp;rft.pages=239%E2%80%9352&amp;rft_id=info:pmid/3121861&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-33"><b><a href="#cite_ref-33" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSegraves_RT.2C_Croft_H.2C_Kavoussi_R.2C_Ascher_JA.2C_Batey_SR.2C_Foster_VJ.2C_Bolden-Watson_C.2C_Metz_A2001">Segraves RT, Croft H, Kavoussi R, Ascher JA, Batey SR, Foster VJ, Bolden-Watson C, Metz A (2001). "Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women". <i>J Sex Marital Ther</i> <b>27</b> (3): 303–16. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1080%2F009262301750257155" class="external text" title="http://dx.doi.org/10.1080%2F009262301750257155" rel="nofollow">10.1080/009262301750257155</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11354935" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11354935">PMID 11354935</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+sustained+release+%28SR%29+for+the+treatment+of+hypoactive+sexual+desire+disorder+%28HSDD%29+in+nondepressed+women&amp;rft.jtitle=J+Sex+Marital+Ther&amp;rft.aulast=Segraves+RT%2C+Croft+H%2C+Kavoussi+R%2C+Ascher+JA%2C+Batey+SR%2C+Foster+VJ%2C+Bolden-Watson+C%2C+Metz+A&amp;rft.au=Segraves+RT%2C+Croft+H%2C+Kavoussi+R%2C+Ascher+JA%2C+Batey+SR%2C+Foster+VJ%2C+Bolden-Watson+C%2C+Metz+A&amp;rft.date=2001&amp;rft.volume=27&amp;rft.issue=3&amp;rft.pages=303%E2%80%9316&amp;rft_id=info:doi/10.1080%2F009262301750257155&amp;rft_id=info:pmid/11354935&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-34"><b><a href="#cite_ref-34" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSegraves_RT.2C_Clayton_A.2C_Croft_H.2C_Wolf_A.2C_Warnock_J.2004">Segraves RT, Clayton A, Croft H, Wolf A, Warnock J. (2004). "Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women". <i>J Clin Psychopharmacol</i> <b>24</b> (3): 339–42. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F01.jcp.0000125686.20338.c1" class="external text" title="http://dx.doi.org/10.1097%2F01.jcp.0000125686.20338.c1" rel="nofollow">10.1097/01.jcp.0000125686.20338.c1</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15118489" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15118489">PMID 15118489</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+sustained+release+for+the+treatment+of+hypoactive+sexual+desire+disorder+in+premenopausal+women&amp;rft.jtitle=J+Clin+Psychopharmacol&amp;rft.aulast=Segraves+RT%2C+Clayton+A%2C+Croft+H%2C+Wolf+A%2C+Warnock+J.&amp;rft.au=Segraves+RT%2C+Clayton+A%2C+Croft+H%2C+Wolf+A%2C+Warnock+J.&amp;rft.date=2004&amp;rft.volume=24&amp;rft.issue=3&amp;rft.pages=339%E2%80%9342&amp;rft_id=info:doi/10.1097%2F01.jcp.0000125686.20338.c1&amp;rft_id=info:pmid/15118489&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-35"><b><a href="#cite_ref-35" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMathias_C.2C_Cardeal_Mendes_CM.2C_Ponde_de_Sena_E.2C_Dias_de_Moraes_E.2C_Bastos_C.2C_Braghiroli_MI.2C_Nunez_G.2C_Athanazio_R.2C_Alban_L.2C_Moore_HC.2C_del_Giglio_A20060">Mathias C, Cardeal Mendes CM, Ponde de Sena E, Dias de Moraes E, Bastos C, Braghiroli MI, Nunez G, Athanazio R, Alban L, Moore HC, del Giglio A (20060). "An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer". <i>Ann Oncol</i> <b>17</b> (12): 1792–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Fannonc%2Fmdl304" class="external text" title="http://dx.doi.org/10.1093%2Fannonc%2Fmdl304" rel="nofollow">10.1093/annonc/mdl304</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16980597" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16980597">PMID 16980597</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=An+open-label%2C+fixed-dose+study+of+bupropion+effect+on+sexual+function+scores+in+women+treated+for+breast+cancer&amp;rft.jtitle=Ann+Oncol&amp;rft.aulast=Mathias+C%2C+Cardeal+Mendes+CM%2C+Ponde+de+Sena+E%2C+Dias+de+Moraes+E%2C+Bastos+C%2C+Braghiroli+MI%2C+Nunez+G%2C+Athanazio+R%2C+Alban+L%2C+Moore+HC%2C+del+Giglio+A&amp;rft.au=Mathias+C%2C+Cardeal+Mendes+CM%2C+Ponde+de+Sena+E%2C+Dias+de+Moraes+E%2C+Bastos+C%2C+Braghiroli+MI%2C+Nunez+G%2C+Athanazio+R%2C+Alban+L%2C+Moore+HC%2C+del+Giglio+A&amp;rft.date=20060&amp;rft.volume=17&amp;rft.issue=12&amp;rft.pages=1792%E2%80%936&amp;rft_id=info:doi/10.1093%2Fannonc%2Fmdl304&amp;rft_id=info:pmid/16980597&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-36"><b><a href="#cite_ref-36" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFModell_JG.2C_May_RS.2C_Katholi_CR2000">Modell JG, May RS, Katholi CR (2000). "Effect of bupropion-SR on orgasmic dysfunction in nondepressed subjects: a pilot study". <i>J Sex Marital Ther</i> <b>26</b> (3): 231–40. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1080%2F00926230050084623" class="external text" title="http://dx.doi.org/10.1080%2F00926230050084623" rel="nofollow">10.1080/00926230050084623</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10929571" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10929571">PMID 10929571</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effect+of+bupropion-SR+on+orgasmic+dysfunction+in+nondepressed+subjects%3A+a+pilot+study&amp;rft.jtitle=J+Sex+Marital+Ther&amp;rft.aulast=Modell+JG%2C+May+RS%2C+Katholi+CR&amp;rft.au=Modell+JG%2C+May+RS%2C+Katholi+CR&amp;rft.date=2000&amp;rft.volume=26&amp;rft.issue=3&amp;rft.pages=231%E2%80%9340&amp;rft_id=info:doi/10.1080%2F00926230050084623&amp;rft_id=info:pmid/10929571&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-37"><b><a href="#cite_ref-37" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCabello_F2006">Cabello F (February 2006). "<a href="http://www.findarticles.com/p/articles/mi_m2372/is_1_43/ai_n16102437" class="external text" title="http://www.findarticles.com/p/articles/mi_m2372/is_1_43/ai_n16102437" rel="nofollow">Effectiveness of the Treatment of Female Hypoactive Sexual Desire Disorder</a>". <i>J Sex Research</i><span class="printonly">. <a href="http://www.findarticles.com/p/articles/mi_m2372/is_1_43/ai_n16102437" class="external free" title="http://www.findarticles.com/p/articles/mi_m2372/is_1_43/ai_n16102437" rel="nofollow">http://www.findarticles.com/p/articles/mi_m2372/is_1_43/ai_n16102437</a></span><span class="reference-accessdate">. Retrieved on 2007-04-05</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effectiveness+of+the+Treatment+of+Female+Hypoactive+Sexual+Desire+Disorder&amp;rft.jtitle=J+Sex+Research&amp;rft.aulast=Cabello+F&amp;rft.au=Cabello+F&amp;rft.date=February+2006&amp;rft_id=http%3A%2F%2Fwww.findarticles.com%2Fp%2Farticles%2Fmi_m2372%2Fis_1_43%2Fai_n16102437&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-38"><b><a href="#cite_ref-38" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLabbate_LA.2C_Brodrick_PS.2C_Nelson_RP.2C_Lydiard_RB.2C_Arana_GW2001">Labbate LA, Brodrick PS, Nelson RP, Lydiard RB, Arana GW (2001). "Effects of bupropion sustained-release on sexual functioning and nocturnal erections in healthy men". <i>J Clin Psychopharmacol</i> <b>22</b> (1): 99–103. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00004714-200102000-00018" class="external text" title="http://dx.doi.org/10.1097%2F00004714-200102000-00018" rel="nofollow">10.1097/00004714-200102000-00018</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11199957" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11199957">PMID 11199957</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+bupropion+sustained-release+on+sexual+functioning+and+nocturnal+erections+in+healthy+men&amp;rft.jtitle=J+Clin+Psychopharmacol&amp;rft.aulast=Labbate+LA%2C+Brodrick+PS%2C+Nelson+RP%2C+Lydiard+RB%2C+Arana+GW&amp;rft.au=Labbate+LA%2C+Brodrick+PS%2C+Nelson+RP%2C+Lydiard+RB%2C+Arana+GW&amp;rft.date=2001&amp;rft.volume=22&amp;rft.issue=1&amp;rft.pages=99%E2%80%93103&amp;rft_id=info:doi/10.1097%2F00004714-200102000-00018&amp;rft_id=info:pmid/11199957&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-39"><b><a href="#cite_ref-39" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLi_Z.2C_Maglione_M.2C_Tu_W.2C_Mojica_W.2C_Arterburn_D.2C_Shugarman_LR.2C_Hilton_L.2C_Suttorp_M.2C_Solomon_V.2C_Shekelle_PG.2C_Morton_SC.2005">Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR, Hilton L, Suttorp M, Solomon V, Shekelle PG, Morton SC. (2005). "Meta-analysis: pharmacologic treatment of obesity". <i>Ann Intern Med</i> <b>142</b> (7): 532–46. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15809465" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15809465">PMID 15809465</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Meta-analysis%3A+pharmacologic+treatment+of+obesity&amp;rft.jtitle=Ann+Intern+Med&amp;rft.aulast=Li+Z%2C+Maglione+M%2C+Tu+W%2C+Mojica+W%2C+Arterburn+D%2C+Shugarman+LR%2C+Hilton+L%2C+Suttorp+M%2C+Solomon+V%2C+Shekelle+PG%2C+Morton+SC.&amp;rft.au=Li+Z%2C+Maglione+M%2C+Tu+W%2C+Mojica+W%2C+Arterburn+D%2C+Shugarman+LR%2C+Hilton+L%2C+Suttorp+M%2C+Solomon+V%2C+Shekelle+PG%2C+Morton+SC.&amp;rft.date=2005&amp;rft.volume=142&amp;rft.issue=7&amp;rft.pages=532%E2%80%9346&amp;rft_id=info:pmid/15809465&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15820237-40"><b><a href="#cite_ref-pmid15820237_40-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWilens_TE.2C_Haight_BR.2C_Horrigan_JP.2C_Hudziak_JJ.2C_Rosenthal_NE.2C_Connor_DF.2C_Hampton_KD.2C_Richard_NE.2C_Modell_JG2005">Wilens TE, Haight BR, Horrigan JP, Hudziak JJ, Rosenthal NE, Connor DF, Hampton KD, Richard NE, Modell JG (2005). "Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study". <i>Biol. Psychiatry</i> <b>57</b> (7): 793–801. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.biopsych.2005.01.027" class="external text" title="http://dx.doi.org/10.1016%2Fj.biopsych.2005.01.027" rel="nofollow">10.1016/j.biopsych.2005.01.027</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15820237" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15820237">PMID 15820237</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+XL+in+adults+with+attention-deficit%2Fhyperactivity+disorder%3A+a+randomized%2C+placebo-controlled+study&amp;rft.jtitle=Biol.+Psychiatry&amp;rft.aulast=Wilens+TE%2C+Haight+BR%2C+Horrigan+JP%2C+Hudziak+JJ%2C+Rosenthal+NE%2C+Connor+DF%2C+Hampton+KD%2C+Richard+NE%2C+Modell+JG&amp;rft.au=Wilens+TE%2C+Haight+BR%2C+Horrigan+JP%2C+Hudziak+JJ%2C+Rosenthal+NE%2C+Connor+DF%2C+Hampton+KD%2C+Richard+NE%2C+Modell+JG&amp;rft.date=2005&amp;rft.volume=57&amp;rft.issue=7&amp;rft.pages=793%E2%80%93801&amp;rft_id=info:doi/10.1016%2Fj.biopsych.2005.01.027&amp;rft_id=info:pmid/15820237&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9554326-41">^ <a href="#cite_ref-pmid9554326_41-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid9554326_41-1" title=""><sup><i><b>b</b></i></sup></a> For the review, see: <cite style="font-style:normal" class="" id="CITEREFCantwell_DP1998">Cantwell DP (1998). "ADHD through the life span: the role of bupropion in treatment". <i>The Journal of clinical psychiatry</i> <b>59 Suppl 4</b>: 92–4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9554326" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9554326">PMID 9554326</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=ADHD+through+the+life+span%3A+the+role+of+bupropion+in+treatment&amp;rft.jtitle=The+Journal+of+clinical+psychiatry&amp;rft.aulast=Cantwell+DP&amp;rft.au=Cantwell+DP&amp;rft.date=1998&amp;rft.volume=59+Suppl+4&amp;rft.pages=92%E2%80%934&amp;rft_id=info:pmid/9554326&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-42"><b><a href="#cite_ref-42" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFSteven_Pliszka_et_al2007">Steven Pliszka et al (2007). <a href="http://www.aacap.org/galleries/PracticeParameters/New_ADHD_Parameter.pdf" class="external text" title="http://www.aacap.org/galleries/PracticeParameters/New_ADHD_Parameter.pdf" rel="nofollow">"PRACTICE PARAMETER FOR THE ASSESSMENT AND TREATMENT OF CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER"</a> (PDF). American Academy of Child and Adolescent Psychiatry. 16<span class="printonly">. <a href="http://www.aacap.org/galleries/PracticeParameters/New_ADHD_Parameter.pdf" class="external free" title="http://www.aacap.org/galleries/PracticeParameters/New_ADHD_Parameter.pdf" rel="nofollow">http://www.aacap.org/galleries/PracticeParameters/New_ADHD_Parameter.pdf</a></span><span class="reference-accessdate">. Retrieved on 2007-09-02</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=PRACTICE+PARAMETER+FOR+THE+ASSESSMENT+AND+TREATMENT+OF+CHILDREN+AND+ADOLESCENTS+WITH+ATTENTION-DEFICIT%2FHYPERACTIVITY+DISORDER&amp;rft.atitle=&amp;rft.aulast=Steven+Pliszka+et+al&amp;rft.au=Steven+Pliszka+et+al&amp;rft.date=2007&amp;rft.pages=16&amp;rft.pub=American+Academy+of+Child+and+Adolescent+Psychiatry&amp;rft_id=http%3A%2F%2Fwww.aacap.org%2Fgalleries%2FPracticeParameters%2FNew_ADHD_Parameter.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-43"><b><a href="#cite_ref-43" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFPliszka_SR_et_al2006">Pliszka SR et al (2006). <a href="http://www.dshs.state.tx.us/mhprograms/adhdpage.shtm" class="external text" title="http://www.dshs.state.tx.us/mhprograms/adhdpage.shtm" rel="nofollow">"The Texas Children's Medication Algorithm Project: attention-deficit/hyperactivity disorder."</a>. Texas Department of State Health Services<span class="printonly">. <a href="http://www.dshs.state.tx.us/mhprograms/adhdpage.shtm" class="external free" title="http://www.dshs.state.tx.us/mhprograms/adhdpage.shtm" rel="nofollow">http://www.dshs.state.tx.us/mhprograms/adhdpage.shtm</a></span><span class="reference-accessdate">. Retrieved on 2007-09-02</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=The+Texas+Children%27s+Medication+Algorithm+Project%3A+attention-deficit%2Fhyperactivity+disorder.&amp;rft.atitle=&amp;rft.aulast=Pliszka+SR+et+al&amp;rft.au=Pliszka+SR+et+al&amp;rft.date=2006&amp;rft.pub=Texas+Department+of+State+Health+Services&amp;rft_id=http%3A%2F%2Fwww.dshs.state.tx.us%2Fmhprograms%2Fadhdpage.shtm&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-44"><b><a href="#cite_ref-44" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.dshs.state.tx.us/mhprograms/ADHD_Algo_Schematics_With_NO_Sig_Co_Dis.pdf" class="external text" title="http://www.dshs.state.tx.us/mhprograms/ADHD_Algo_Schematics_With_NO_Sig_Co_Dis.pdf" rel="nofollow">"Algorithm Stages Flowsheets. ADHD with no significant comorbidity algorithm"</a> (PDF). Texas Department of State Health Services. May 2006<span class="printonly">. <a href="http://www.dshs.state.tx.us/mhprograms/ADHD_Algo_Schematics_With_NO_Sig_Co_Dis.pdf" class="external free" title="http://www.dshs.state.tx.us/mhprograms/ADHD_Algo_Schematics_With_NO_Sig_Co_Dis.pdf" rel="nofollow">http://www.dshs.state.tx.us/mhprograms/ADHD_Algo_Schematics_With_NO_Sig_Co_Dis.pdf</a></span><span class="reference-accessdate">. Retrieved on 2007-09-02</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Algorithm+Stages+Flowsheets.+ADHD+with+no+significant+comorbidity+algorithm&amp;rft.atitle=&amp;rft.date=May+2006&amp;rft.pub=Texas+Department+of+State+Health+Services&amp;rft_id=http%3A%2F%2Fwww.dshs.state.tx.us%2Fmhprograms%2FADHD_Algo_Schematics_With_NO_Sig_Co_Dis.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17685748-45"><b><a href="#cite_ref-pmid17685748_45-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMonuteaux_MC.2C_Spencer_TJ.2C_Faraone_SV.2C_Wilson_AM.2C_Biederman_J2007">Monuteaux MC, Spencer TJ, Faraone SV, Wilson AM, Biederman J (2007). "A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder". <i>The Journal of clinical psychiatry</i> <b>68</b> (7): 1094–101. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17685748" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17685748">PMID 17685748</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+randomized%2C+placebo-controlled+clinical+trial+of+bupropion+for+the+prevention+of+smoking+in+children+and+adolescents+with+attention-deficit%2Fhyperactivity+disorder&amp;rft.jtitle=The+Journal+of+clinical+psychiatry&amp;rft.aulast=Monuteaux+MC%2C+Spencer+TJ%2C+Faraone+SV%2C+Wilson+AM%2C+Biederman+J&amp;rft.au=Monuteaux+MC%2C+Spencer+TJ%2C+Faraone+SV%2C+Wilson+AM%2C+Biederman+J&amp;rft.date=2007&amp;rft.volume=68&amp;rft.issue=7&amp;rft.pages=1094%E2%80%93101&amp;rft_id=info:pmid/17685748&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17328102-46"><b><a href="#cite_ref-pmid17328102_46-0" title="">^</a></b> <cite style="font-style:normal" class="">"First drug for seasonal depression". <i>FDA Consumer</i> <b>40</b> (5): 7. 2006. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17328102" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17328102">PMID 17328102</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=First+drug+for+seasonal+depression&amp;rft.jtitle=FDA+Consumer&amp;rft.date=2006&amp;rft.volume=40&amp;rft.issue=5&amp;rft.pages=7&amp;rft_id=info:pmid/17328102&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16271314-47"><b><a href="#cite_ref-pmid16271314_47-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFModell_JG.2C_Rosenthal_NE.2C_Harriett_AE.2C_Krishen_A.2C_Asgharian_A.2C_Foster_VJ.2C_Metz_A.2C_Rockett_CB.2C_Wightman_DS2005">Modell JG, Rosenthal NE, Harriett AE, Krishen A, Asgharian A, Foster VJ, Metz A, Rockett CB, Wightman DS (2005). "Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL". <i>Biol Psychiatry</i> <b>58</b> (8): 658–67. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.biopsych.2005.07.021" class="external text" title="http://dx.doi.org/10.1016%2Fj.biopsych.2005.07.021" rel="nofollow">10.1016/j.biopsych.2005.07.021</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16271314" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16271314">PMID 16271314</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Seasonal+affective+disorder+and+its+prevention+by+anticipatory+treatment+with+bupropion+XL&amp;rft.jtitle=Biol+Psychiatry&amp;rft.aulast=Modell+JG%2C+Rosenthal+NE%2C+Harriett+AE%2C+Krishen+A%2C+Asgharian+A%2C+Foster+VJ%2C+Metz+A%2C+Rockett+CB%2C+Wightman+DS&amp;rft.au=Modell+JG%2C+Rosenthal+NE%2C+Harriett+AE%2C+Krishen+A%2C+Asgharian+A%2C+Foster+VJ%2C+Metz+A%2C+Rockett+CB%2C+Wightman+DS&amp;rft.date=2005&amp;rft.volume=58&amp;rft.issue=8&amp;rft.pages=658%E2%80%9367&amp;rft_id=info:doi/10.1016%2Fj.biopsych.2005.07.021&amp;rft_id=info:pmid/16271314&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17392295-48"><b><a href="#cite_ref-pmid17392295_48-0" title="">^</a></b> For the review indicating that antidepressants are not better than placebo, see: <cite style="font-style:normal" class="" id="CITEREFSachs_GS.2C_Nierenberg_AA.2C_Calabrese_JR.2C_Marangell_LB.2C_Wisniewski_SR.2C_Gyulai_L.2C_Friedman_ES.2C_Bowden_CL.2C_Fossey_MD.2C_Ostacher_MJ.2C_Ketter_TA.2C_Patel_J.2C_Hauser_P.2C_Rapport_D.2C_Martinez_JM.2C_Allen_MH.2C_Miklowitz_DJ.2C_Otto_MW.2C_Dennehy_EB.2C_Thase_ME2007">Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME (2007). "Effectiveness of adjunctive antidepressant treatment for bipolar depression". <i>N. Engl. J. Med.</i> <b>356</b> (17): 1711–22. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa064135" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa064135" rel="nofollow">10.1056/NEJMoa064135</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17392295" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17392295">PMID 17392295</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effectiveness+of+adjunctive+antidepressant+treatment+for+bipolar+depression&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Sachs+GS%2C+Nierenberg+AA%2C+Calabrese+JR%2C+Marangell+LB%2C+Wisniewski+SR%2C+Gyulai+L%2C+Friedman+ES%2C+Bowden+CL%2C+Fossey+MD%2C+Ostacher+MJ%2C+Ketter+TA%2C+Patel+J%2C+Hauser+P%2C+Rapport+D%2C+Martinez+JM%2C+Allen+MH%2C+Miklowitz+DJ%2C+Otto+MW%2C+Dennehy+EB%2C+Thase+ME&amp;rft.au=Sachs+GS%2C+Nierenberg+AA%2C+Calabrese+JR%2C+Marangell+LB%2C+Wisniewski+SR%2C+Gyulai+L%2C+Friedman+ES%2C+Bowden+CL%2C+Fossey+MD%2C+Ostacher+MJ%2C+Ketter+TA%2C+Patel+J%2C+Hauser+P%2C+Rapport+D%2C+Martinez+JM%2C+Allen+MH%2C+Miklowitz+DJ%2C+Otto+MW%2C+Dennehy+EB%2C+Thase+ME&amp;rft.date=2007&amp;rft.volume=356&amp;rft.issue=17&amp;rft.pages=1711%E2%80%9322&amp;rft_id=info:doi/10.1056%2FNEJMoa064135&amp;rft_id=info:pmid/17392295&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15337640-49">^ <a href="#cite_ref-pmid15337640_49-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15337640_49-1" title=""><sup><i><b>b</b></i></sup></a> For the review in favor of the antidepressant use, see: <cite style="font-style:normal" class="" id="CITEREFGijsman_HJ.2C_Geddes_JR.2C_Rendell_JM.2C_Nolen_WA.2C_Goodwin_GM2004">Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM (2004). "Antidepressants for bipolar depression: a systematic review of randomized, controlled trials". <i>The American journal of psychiatry</i> <b>161</b> (9): 1537–47. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.161.9.1537" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.161.9.1537" rel="nofollow">10.1176/appi.ajp.161.9.1537</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15337640" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15337640">PMID 15337640</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Antidepressants+for+bipolar+depression%3A+a+systematic+review+of+randomized%2C+controlled+trials&amp;rft.jtitle=The+American+journal+of+psychiatry&amp;rft.aulast=Gijsman+HJ%2C+Geddes+JR%2C+Rendell+JM%2C+Nolen+WA%2C+Goodwin+GM&amp;rft.au=Gijsman+HJ%2C+Geddes+JR%2C+Rendell+JM%2C+Nolen+WA%2C+Goodwin+GM&amp;rft.date=2004&amp;rft.volume=161&amp;rft.issue=9&amp;rft.pages=1537%E2%80%9347&amp;rft_id=info:doi/10.1176%2Fappi.ajp.161.9.1537&amp;rft_id=info:pmid/15337640&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17156158-50"><b><a href="#cite_ref-pmid17156158_50-0" title="">^</a></b> For the guidelines recommending the use of bupropion with a mood stabilizer, see: <cite style="font-style:normal" class="" id="CITEREFYatham_LN.2C_Kennedy_SH.2C_O.27Donovan_C.2C_Parikh_SV.2C_MacQueen_G.2C_McIntyre_RS.2C_Sharma_V.2C_Beaulieu_S2006">Yatham LN, Kennedy SH, O'Donovan C, Parikh SV, MacQueen G, McIntyre RS, Sharma V, Beaulieu S (2006). "Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007". <i>Bipolar Disord</i> <b>8</b> (6): 721–39. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1399-5618.2006.00432.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1399-5618.2006.00432.x" rel="nofollow">10.1111/j.1399-5618.2006.00432.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17156158" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17156158">PMID 17156158</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Canadian+Network+for+Mood+and+Anxiety+Treatments+%28CANMAT%29+guidelines+for+the+management+of+patients+with+bipolar+disorder%3A+update+2007&amp;rft.jtitle=Bipolar+Disord&amp;rft.aulast=Yatham+LN%2C+Kennedy+SH%2C+O%27Donovan+C%2C+Parikh+SV%2C+MacQueen+G%2C+McIntyre+RS%2C+Sharma+V%2C+Beaulieu+S&amp;rft.au=Yatham+LN%2C+Kennedy+SH%2C+O%27Donovan+C%2C+Parikh+SV%2C+MacQueen+G%2C+McIntyre+RS%2C+Sharma+V%2C+Beaulieu+S&amp;rft.date=2006&amp;rft.volume=8&amp;rft.issue=6&amp;rft.pages=721%E2%80%9339&amp;rft_id=info:doi/10.1111%2Fj.1399-5618.2006.00432.x&amp;rft_id=info:pmid/17156158&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid6431314-51"><b><a href="#cite_ref-pmid6431314_51-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGoetz_CG.2C_Tanner_CM.2C_Klawans_HL1984">Goetz CG, Tanner CM, Klawans HL (1984). "Bupropion in Parkinson's disease". <i>Neurology</i> <b>34</b> (8): 1092–4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/6431314" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/6431314">PMID 6431314</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+in+Parkinson%27s+disease&amp;rft.jtitle=Neurology&amp;rft.aulast=Goetz+CG%2C+Tanner+CM%2C+Klawans+HL&amp;rft.au=Goetz+CG%2C+Tanner+CM%2C+Klawans+HL&amp;rft.date=1984&amp;rft.volume=34&amp;rft.issue=8&amp;rft.pages=1092%E2%80%934&amp;rft_id=info:pmid/6431314&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-52"><b><a href="#cite_ref-52" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFAmerican_Psychiatric_Association2000">American Psychiatric Association (2000). <a href="http://www.psych.org/psych_pract/treatg/pg/MDD2e_05-15-06.pdf" class="external text" title="http://www.psych.org/psych_pract/treatg/pg/MDD2e_05-15-06.pdf" rel="nofollow">"Practice guideline for the treatment of patients with major depressive disorder. Second edition."</a> (PDF). 37<span class="printonly">. <a href="http://www.psych.org/psych_pract/treatg/pg/MDD2e_05-15-06.pdf" class="external free" title="http://www.psych.org/psych_pract/treatg/pg/MDD2e_05-15-06.pdf" rel="nofollow">http://www.psych.org/psych_pract/treatg/pg/MDD2e_05-15-06.pdf</a></span><span class="reference-accessdate">. Retrieved on 2007-08-24</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Practice+guideline+for+the+treatment+of+patients+with+major+depressive+disorder.+Second+edition.&amp;rft.atitle=&amp;rft.aulast=American+Psychiatric+Association&amp;rft.au=American+Psychiatric+Association&amp;rft.date=2000&amp;rft.pages=37&amp;rft_id=http%3A%2F%2Fwww.psych.org%2Fpsych_pract%2Ftreatg%2Fpg%2FMDD2e_05-15-06.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-WellbutrinPI-53">^ <a href="#cite_ref-WellbutrinPI_53-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WellbutrinPI_53-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-WellbutrinPI_53-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-WellbutrinPI_53-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-WellbutrinPI_53-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-WellbutrinPI_53-5" title=""><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-WellbutrinPI_53-6" title=""><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-WellbutrinPI_53-7" title=""><sup><i><b>h</b></i></sup></a> <cite style="font-style:normal" class="web"><a href="http://us.gsk.com/products/assets/us_wellbutrinXL.pdf" class="external text" title="http://us.gsk.com/products/assets/us_wellbutrinXL.pdf" rel="nofollow">"Wellbutrin XL Prescribing Information"</a> (PDF). <a href="/wiki/GlaxoSmithKline" title="GlaxoSmithKline">GlaxoSmithKline</a>. June 2006<span class="printonly">. <a href="http://us.gsk.com/products/assets/us_wellbutrinXL.pdf" class="external free" title="http://us.gsk.com/products/assets/us_wellbutrinXL.pdf" rel="nofollow">http://us.gsk.com/products/assets/us_wellbutrinXL.pdf</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Wellbutrin+XL+Prescribing+Information&amp;rft.atitle=&amp;rft.date=June+2006&amp;rft.pub=%5B%5BGlaxoSmithKline%5D%5D&amp;rft_id=http%3A%2F%2Fus.gsk.com%2Fproducts%2Fassets%2Fus_wellbutrinXL.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-54"><b><a href="#cite_ref-54" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSpencer_T.2C_Biederman_J.2C_Steingard_R.2C_Wilens_T1993">Spencer T, Biederman J, Steingard R, Wilens T (1993). "Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome". <i>J Am Acad Child Adolesc Psychiatry</i> <b>32</b> (1): 211–4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8428875" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8428875">PMID 8428875</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+exacerbates+tics+in+children+with+attention-deficit+hyperactivity+disorder+and+Tourette%27s+syndrome&amp;rft.jtitle=J+Am+Acad+Child+Adolesc+Psychiatry&amp;rft.aulast=Spencer+T%2C+Biederman+J%2C+Steingard+R%2C+Wilens+T&amp;rft.au=Spencer+T%2C+Biederman+J%2C+Steingard+R%2C+Wilens+T&amp;rft.date=1993&amp;rft.volume=32&amp;rft.issue=1&amp;rft.pages=211%E2%80%934&amp;rft_id=info:pmid/8428875&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-FDA-55">^ <a href="#cite_ref-FDA_55-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA_55-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="web" id="CITEREFLevenson_M.2C_Holland_C">Levenson M, Holland C. <a href="http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4272s1-04-FDA.ppt" class="external text" title="http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4272s1-04-FDA.ppt" rel="nofollow">"Antidepressants and Suicidality in Adults: Statistical Evaluation. (Presentation at Psychopharmacologic Drugs Advisory Committee; December 13, 2006)"</a><span class="printonly">. <a href="http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4272s1-04-FDA.ppt" class="external free" title="http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4272s1-04-FDA.ppt" rel="nofollow">http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4272s1-04-FDA.ppt</a></span><span class="reference-accessdate">. Retrieved on 2007-05-13</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Antidepressants+and+Suicidality+in+Adults%3A+Statistical+Evaluation.+%28Presentation+at+Psychopharmacologic+Drugs+Advisory+Committee%3B+December+13%2C+2006%29&amp;rft.atitle=&amp;rft.aulast=Levenson+M%2C+Holland+C&amp;rft.au=Levenson+M%2C+Holland+C&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fohrms%2Fdockets%2Fac%2F06%2Fslides%2F2006-4272s1-04-FDA.ppt&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-56"><b><a href="#cite_ref-56" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHughes_JR.2C_Stead_LF.2C_Lancaster_T2007">Hughes JR, Stead LF, Lancaster T (2007). "Antidepressants for smoking cessation". <i>Cochrane Database Syst Rev.</i> <b>24</b> (1): CD000031. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F14651858.CD000031.pub3" class="external text" title="http://dx.doi.org/10.1002%2F14651858.CD000031.pub3" rel="nofollow">10.1002/14651858.CD000031.pub3</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17253443" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17253443">PMID 17253443</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Antidepressants+for+smoking+cessation&amp;rft.jtitle=Cochrane+Database+Syst+Rev.&amp;rft.aulast=Hughes+JR%2C+Stead+LF%2C+Lancaster+T&amp;rft.au=Hughes+JR%2C+Stead+LF%2C+Lancaster+T&amp;rft.date=2007&amp;rft.volume=24&amp;rft.issue=1&amp;rft.pages=CD000031&amp;rft_id=info:doi/10.1002%2F14651858.CD000031.pub3&amp;rft_id=info:pmid/17253443&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-57"><b><a href="#cite_ref-57" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPisani_F.2C_Oteri_G.2C_Costa_C.2C_Di_Raimondo_G.2C_Di_Perri_R2002">Pisani F, Oteri G, Costa C, Di Raimondo G, Di Perri R (2002). "Effects of Psychotropic Drugs on Seizure Threshold". <i>Drug Safety</i> <b>25</b> (2): 91–110. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2165%2F00002018-200225020-00004" class="external text" title="http://dx.doi.org/10.2165%2F00002018-200225020-00004" rel="nofollow">10.2165/00002018-200225020-00004</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+Psychotropic+Drugs+on+Seizure+Threshold&amp;rft.jtitle=Drug+Safety&amp;rft.aulast=Pisani+F%2C+Oteri+G%2C+Costa+C%2C+Di+Raimondo+G%2C+Di+Perri+R&amp;rft.au=Pisani+F%2C+Oteri+G%2C+Costa+C%2C+Di+Raimondo+G%2C+Di+Perri+R&amp;rft.date=2002&amp;rft.volume=25&amp;rft.issue=2&amp;rft.pages=91%E2%80%93110&amp;rft_id=info:doi/10.2165%2F00002018-200225020-00004&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-58"><b><a href="#cite_ref-58" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAhern_TH.2C_Javors_MA.2C_Eagles_DA.2C_Martillotti_J.2C_Mitchell_HA.2C_Liles_LC.2C_Weinshenker_D2006">Ahern TH, Javors MA, Eagles DA, Martillotti J, Mitchell HA, Liles LC, Weinshenker D (2006). "The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice". <i>Neuropsychopharmacology</i> <b>31</b> (4): 730–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fsj.npp.1300847" class="external text" title="http://dx.doi.org/10.1038%2Fsj.npp.1300847" rel="nofollow">10.1038/sj.npp.1300847</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16052243" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16052243">PMID 16052243</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+effects+of+chronic+norepinephrine+transporter+inactivation+on+seizure+susceptibility+in+mice&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.aulast=Ahern+TH%2C+Javors+MA%2C+Eagles+DA%2C+Martillotti+J%2C+Mitchell+HA%2C+Liles+LC%2C+Weinshenker+D&amp;rft.au=Ahern+TH%2C+Javors+MA%2C+Eagles+DA%2C+Martillotti+J%2C+Mitchell+HA%2C+Liles+LC%2C+Weinshenker+D&amp;rft.date=2006&amp;rft.volume=31&amp;rft.issue=4&amp;rft.pages=730%E2%80%938&amp;rft_id=info:doi/10.1038%2Fsj.npp.1300847&amp;rft_id=info:pmid/16052243&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-59"><b><a href="#cite_ref-59" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAlper_K.2C_Schwartz_KA.2C_Kolts_RL.2C_Khan_A2007">Alper K, Schwartz KA, Kolts RL, Khan A (2007). "Seizure Incidence in Psychopharmacological Clinical Trials: An Analysis of Food and Drug Administration (FDA) Summary Basis of Approval Reports". <i>Biol Psychiatry</i> <b>62</b> (4): 345–54. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.biopsych.2006.09.023" class="external text" title="http://dx.doi.org/10.1016%2Fj.biopsych.2006.09.023" rel="nofollow">10.1016/j.biopsych.2006.09.023</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17223086" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17223086">PMID 17223086</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Seizure+Incidence+in+Psychopharmacological+Clinical+Trials%3A+An+Analysis+of+Food+and+Drug+Administration+%28FDA%29+Summary+Basis+of+Approval+Reports&amp;rft.jtitle=Biol+Psychiatry&amp;rft.aulast=Alper+K%2C+Schwartz+KA%2C+Kolts+RL%2C+Khan+A&amp;rft.au=Alper+K%2C+Schwartz+KA%2C+Kolts+RL%2C+Khan+A&amp;rft.date=2007&amp;rft.volume=62&amp;rft.issue=4&amp;rft.pages=345%E2%80%9354&amp;rft_id=info:doi/10.1016%2Fj.biopsych.2006.09.023&amp;rft_id=info:pmid/17223086&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16880481-60"><b><a href="#cite_ref-pmid16880481_60-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPost_RM.2C_Altshuler_LL.2C_Leverich_GS.2C_Frye_MA.2C_Nolen_WA.2C_Kupka_RW.2C_Suppes_T.2C_McElroy_S.2C_Keck_PE.2C_Denicoff_KD.2C_Grunze_H.2C_Walden_J.2C_Kitchen_CM.2C_Mintz_J2006">Post RM, Altshuler LL, Leverich GS, Frye MA, Nolen WA, Kupka RW, Suppes T, McElroy S, Keck PE, Denicoff KD, Grunze H, Walden J, Kitchen CM, Mintz J (2006). "Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline". <i>Br J Psychiatry</i> <b>189</b>: 124–31. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16880481" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16880481">PMID 16880481</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Mood+switch+in+bipolar+depression%3A+comparison+of+adjunctive+venlafaxine%2C+bupropion+and+sertraline&amp;rft.jtitle=Br+J+Psychiatry&amp;rft.aulast=Post+RM%2C+Altshuler+LL%2C+Leverich+GS%2C+Frye+MA%2C+Nolen+WA%2C+Kupka+RW%2C+Suppes+T%2C+McElroy+S%2C+Keck+PE%2C+Denicoff+KD%2C+Grunze+H%2C+Walden+J%2C+Kitchen+CM%2C+Mintz+J&amp;rft.au=Post+RM%2C+Altshuler+LL%2C+Leverich+GS%2C+Frye+MA%2C+Nolen+WA%2C+Kupka+RW%2C+Suppes+T%2C+McElroy+S%2C+Keck+PE%2C+Denicoff+KD%2C+Grunze+H%2C+Walden+J%2C+Kitchen+CM%2C+Mintz+J&amp;rft.date=2006&amp;rft.volume=189&amp;rft.pages=124%E2%80%9331&amp;rft_id=info:pmid/16880481&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid1900980-61"><b><a href="#cite_ref-pmid1900980_61-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRoose_SP.2C_Dalack_GW.2C_Glassman_AH.2C_Woodring_S.2C_Walsh_BT.2C_Giardina_EG1991">Roose SP, Dalack GW, Glassman AH, Woodring S, Walsh BT, Giardina EG (1991). "Cardiovascular effects of bupropion in depressed patients with heart disease". <i>Am J Psychiatry</i> <b>148</b> (4): 512–6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1900980" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1900980">PMID 1900980</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cardiovascular+effects+of+bupropion+in+depressed+patients+with+heart+disease&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.aulast=Roose+SP%2C+Dalack+GW%2C+Glassman+AH%2C+Woodring+S%2C+Walsh+BT%2C+Giardina+EG&amp;rft.au=Roose+SP%2C+Dalack+GW%2C+Glassman+AH%2C+Woodring+S%2C+Walsh+BT%2C+Giardina+EG&amp;rft.date=1991&amp;rft.volume=148&amp;rft.issue=4&amp;rft.pages=512%E2%80%936&amp;rft_id=info:pmid/1900980&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12109935-62"><b><a href="#cite_ref-pmid12109935_62-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAubin_HJ2002">Aubin HJ (2002). "Tolerability and safety of sustained-release bupropion in the management of smoking cessation". <i>Drugs</i> <b>62 Suppl 2</b>: 45–52. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12109935" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12109935">PMID 12109935</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Tolerability+and+safety+of+sustained-release+bupropion+in+the+management+of+smoking+cessation&amp;rft.jtitle=Drugs&amp;rft.aulast=Aubin+HJ&amp;rft.au=Aubin+HJ&amp;rft.date=2002&amp;rft.volume=62+Suppl+2&amp;rft.pages=45%E2%80%9352&amp;rft_id=info:pmid/12109935&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15705013-63"><b><a href="#cite_ref-pmid15705013_63-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWilens_TE.2C_Hammerness_PG.2C_Biederman_J.2C_Kwon_A.2C_Spencer_TJ.2C_Clark_S.2C_Scott_M.2C_Podolski_A.2C_Ditterline_JW.2C_Morris_MC.2C_Moore_H2005">Wilens TE, Hammerness PG, Biederman J, Kwon A, Spencer TJ, Clark S, Scott M, Podolski A, Ditterline JW, Morris MC, Moore H (2005). "Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder". <i>J Clin Psychiatry</i> <b>66</b> (2): 253–9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15705013" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15705013">PMID 15705013</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Blood+pressure+changes+associated+with+medication+treatment+of+adults+with+attention-deficit%2Fhyperactivity+disorder&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Wilens+TE%2C+Hammerness+PG%2C+Biederman+J%2C+Kwon+A%2C+Spencer+TJ%2C+Clark+S%2C+Scott+M%2C+Podolski+A%2C+Ditterline+JW%2C+Morris+MC%2C+Moore+H&amp;rft.au=Wilens+TE%2C+Hammerness+PG%2C+Biederman+J%2C+Kwon+A%2C+Spencer+TJ%2C+Clark+S%2C+Scott+M%2C+Podolski+A%2C+Ditterline+JW%2C+Morris+MC%2C+Moore+H&amp;rft.date=2005&amp;rft.volume=66&amp;rft.issue=2&amp;rft.pages=253%E2%80%939&amp;rft_id=info:pmid/15705013&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17145253-64"><b><a href="#cite_ref-pmid17145253_64-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRigotti_NA.2C_Thorndike_AN.2C_Regan_S.2C_McKool_K.2C_Pasternak_RC.2C_Chang_Y.2C_Swartz_S.2C_Torres-Finnerty_N.2C_Emmons_KM.2C_Singer_DE2006">Rigotti NA, Thorndike AN, Regan S, McKool K, Pasternak RC, Chang Y, Swartz S, Torres-Finnerty N, Emmons KM, Singer DE (2006). "Bupropion for smokers hospitalized with acute cardiovascular disease". <i>Am J Med</i> <b>119</b> (12): 1080–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.amjmed.2006.04.024" class="external text" title="http://dx.doi.org/10.1016%2Fj.amjmed.2006.04.024" rel="nofollow">10.1016/j.amjmed.2006.04.024</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17145253" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17145253">PMID 17145253</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+for+smokers+hospitalized+with+acute+cardiovascular+disease&amp;rft.jtitle=Am+J+Med&amp;rft.aulast=Rigotti+NA%2C+Thorndike+AN%2C+Regan+S%2C+McKool+K%2C+Pasternak+RC%2C+Chang+Y%2C+Swartz+S%2C+Torres-Finnerty+N%2C+Emmons+KM%2C+Singer+DE&amp;rft.au=Rigotti+NA%2C+Thorndike+AN%2C+Regan+S%2C+McKool+K%2C+Pasternak+RC%2C+Chang+Y%2C+Swartz+S%2C+Torres-Finnerty+N%2C+Emmons+KM%2C+Singer+DE&amp;rft.date=2006&amp;rft.volume=119&amp;rft.issue=12&amp;rft.pages=1080%E2%80%937&amp;rft_id=info:doi/10.1016%2Fj.amjmed.2006.04.024&amp;rft_id=info:pmid/17145253&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17112303-65"><b><a href="#cite_ref-pmid17112303_65-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFvan_Melle_JP.2C_de_Jonge_P.2C_van_den_Berg_MP.2C_Pot_HJ.2C_van_Veldhuisen_DJ2006">van Melle JP, de Jonge P, van den Berg MP, Pot HJ, van Veldhuisen DJ (2006). "Treatment of depression in acute coronary syndromes with selective serotonin reuptake inhibitors". <i>Drugs</i> <b>66</b> (16): 2095–107. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17112303" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17112303">PMID 17112303</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Treatment+of+depression+in+acute+coronary+syndromes+with+selective+serotonin+reuptake+inhibitors&amp;rft.jtitle=Drugs&amp;rft.aulast=van+Melle+JP%2C+de+Jonge+P%2C+van+den+Berg+MP%2C+Pot+HJ%2C+van+Veldhuisen+DJ&amp;rft.au=van+Melle+JP%2C+de+Jonge+P%2C+van+den+Berg+MP%2C+Pot+HJ%2C+van+Veldhuisen+DJ&amp;rft.date=2006&amp;rft.volume=66&amp;rft.issue=16&amp;rft.pages=2095%E2%80%93107&amp;rft_id=info:pmid/17112303&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-MHRA-66"><b><a href="#cite_ref-MHRA_66-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&amp;dID=2556&amp;noSaveAs=0&amp;Rendition=WEB" class="external text" title="http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&amp;dID=2556&amp;noSaveAs=0&amp;Rendition=WEB" rel="nofollow">"Zyban (bupropion hydrochloride) – safety update"</a>. <a href="/wiki/Medicines_and_Healthcare_products_Regulatory_Agency" title="Medicines and Healthcare products Regulatory Agency">Medicines and Healthcare products Regulatory Agency</a>. 2002-07-24<span class="printonly">. <a href="http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&amp;dID=2556&amp;noSaveAs=0&amp;Rendition=WEB" class="external free" title="http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&amp;dID=2556&amp;noSaveAs=0&amp;Rendition=WEB" rel="nofollow">http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&amp;dID=2556&amp;noSaveAs=0&amp;Rendition=WEB</a></span><span class="reference-accessdate">. Retrieved on 2006-10-07</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Zyban+%28bupropion+hydrochloride%29+%26ndash%3B+safety+update&amp;rft.atitle=&amp;rft.date=2002-07-24&amp;rft.pub=%5B%5BMedicines+and+Healthcare+products+Regulatory+Agency%5D%5D&amp;rft_id=http%3A%2F%2Fwww.mhra.gov.uk%2Fhome%2Fidcplg%3FIdcService%3DGET_FILE%26dID%3D2556%26noSaveAs%3D0%26Rendition%3DWEB&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Hubbard-67"><b><a href="#cite_ref-Hubbard_67-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHubbard_R.2C_Lewis_S.2C_West_J.2C_Smith_C.2C_Godfrey_C.2C_Smeeth_L.2C_Farrington_P.2C_Britton_J2005">Hubbard R, Lewis S, West J, Smith C, Godfrey C, Smeeth L, Farrington P, Britton J (2005). "Bupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement Network". <i>Thorax</i> <b>60</b> (10): 848–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fthx.2005.041798" class="external text" title="http://dx.doi.org/10.1136%2Fthx.2005.041798" rel="nofollow">10.1136/thx.2005.041798</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16055620" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16055620">PMID 16055620</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+and+the+risk+of+sudden+death%3A+a+self-controlled+case-series+analysis+using+The+Health+Improvement+Network&amp;rft.jtitle=Thorax&amp;rft.aulast=Hubbard+R%2C+Lewis+S%2C+West+J%2C+Smith+C%2C+Godfrey+C%2C+Smeeth+L%2C+Farrington+P%2C+Britton+J&amp;rft.au=Hubbard+R%2C+Lewis+S%2C+West+J%2C+Smith+C%2C+Godfrey+C%2C+Smeeth+L%2C+Farrington+P%2C+Britton+J&amp;rft.date=2005&amp;rft.volume=60&amp;rft.issue=10&amp;rft.pages=848%E2%80%9350&amp;rft_id=info:doi/10.1136%2Fthx.2005.041798&amp;rft_id=info:pmid/16055620&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span> <a href="http://thorax.bmj.com/cgi/content/full/60/10/848" class="external text" title="http://thorax.bmj.com/cgi/content/full/60/10/848" rel="nofollow">Free full text</a></li>
<li id="cite_note-68"><b><a href="#cite_ref-68" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWang.2C_Hy.3B_Chou.2C_Wj.3B_Huang.2C_Ty.3B_Hung.2C_Cf2007">Wang, Hy; Chou, Wj; Huang, Ty; Hung, Cf (April 2007). "Acute dystonia resulting from abrupt bupropion discontinuation". <i>Progress in neuro-psychopharmacology &amp; biological psychiatry</i> <b>31</b> (3): 766–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.pnpbp.2006.12.003" class="external text" title="http://dx.doi.org/10.1016%2Fj.pnpbp.2006.12.003" rel="nofollow">10.1016/j.pnpbp.2006.12.003</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17218049" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17218049">PMID 17218049</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Acute+dystonia+resulting+from+abrupt+bupropion+discontinuation&amp;rft.jtitle=Progress+in+neuro-psychopharmacology+%26+biological+psychiatry&amp;rft.aulast=Wang%2C+Hy%3B+Chou%2C+Wj%3B+Huang%2C+Ty%3B+Hung%2C+Cf&amp;rft.au=Wang%2C+Hy%3B+Chou%2C+Wj%3B+Huang%2C+Ty%3B+Hung%2C+Cf&amp;rft.date=April+2007&amp;rft.volume=31&amp;rft.issue=3&amp;rft.pages=766%E2%80%938&amp;rft_id=info:doi/10.1016%2Fj.pnpbp.2006.12.003&amp;rft_id=info:pmid/17218049&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-69"><b><a href="#cite_ref-69" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBerigan.2C_Tr2002">Berigan, Tr (April 2002). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=15014751" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=15014751" rel="nofollow">Bupropion-Associated Withdrawal Symptoms Revisited: A Case Report</a>". <i>Primary care companion to the Journal of clinical psychiatry</i> <b>4</b> (2): 78. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a href="http://worldcat.org/issn/1523-5998" class="external text" title="http://worldcat.org/issn/1523-5998" rel="nofollow">1523-5998</a>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15014751" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15014751">PMID 15014751</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>: <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=181231" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=181231" rel="nofollow">181231</a><span class="printonly">. <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=15014751" class="external free" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=15014751" rel="nofollow">http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=15014751</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion-Associated+Withdrawal+Symptoms+Revisited%3A+A+Case+Report&amp;rft.jtitle=Primary+care+companion+to+the+Journal+of+clinical+psychiatry&amp;rft.aulast=Berigan%2C+Tr&amp;rft.au=Berigan%2C+Tr&amp;rft.date=April+2002&amp;rft.volume=4&amp;rft.issue=2&amp;rft.pages=78&amp;rft_id=info:pmid/15014751&amp;rft.issn=1523-5998&amp;rft_id=http%3A%2F%2Fwww.pubmedcentral.nih.gov%2Farticlerender.fcgi%3Ftool%3Dpubmed%26pubmedid%3D15014751&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-70"><b><a href="#cite_ref-70" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBerigan.2C_Tr.3B_Harazin.2C_Js1999">Berigan, Tr; Harazin, Js (April 1999). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=15014696" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=15014696" rel="nofollow">Bupropion-Associated Withdrawal Symptoms: A Case Report</a>". <i>Primary care companion to the Journal of clinical psychiatry</i> <b>1</b> (2): 50–51. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a href="http://worldcat.org/issn/1523-5998" class="external text" title="http://worldcat.org/issn/1523-5998" rel="nofollow">1523-5998</a>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15014696" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15014696">PMID 15014696</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>: <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=181057" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=181057" rel="nofollow">181057</a><span class="printonly">. <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=15014696" class="external free" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=15014696" rel="nofollow">http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=15014696</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion-Associated+Withdrawal+Symptoms%3A+A+Case+Report&amp;rft.jtitle=Primary+care+companion+to+the+Journal+of+clinical+psychiatry&amp;rft.aulast=Berigan%2C+Tr%3B+Harazin%2C+Js&amp;rft.au=Berigan%2C+Tr%3B+Harazin%2C+Js&amp;rft.date=April+1999&amp;rft.volume=1&amp;rft.issue=2&amp;rft.pages=50%E2%80%9351&amp;rft_id=info:pmid/15014696&amp;rft.issn=1523-5998&amp;rft_id=http%3A%2F%2Fwww.pubmedcentral.nih.gov%2Farticlerender.fcgi%3Ftool%3Dpubmed%26pubmedid%3D15014696&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-71"><b><a href="#cite_ref-71" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMichael.2C_N.3B_Erfurth.2C_A.3B_Bergant.2C_V2004">Michael, N; Erfurth, A; Bergant, V (February 2004). "A case report of mania related to discontinuation of bupropion therapy for smoking cessation". <i>The Journal of clinical psychiatry</i> <b>65</b> (2): 277. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a href="http://worldcat.org/issn/0160-6689" class="external text" title="http://worldcat.org/issn/0160-6689" rel="nofollow">0160-6689</a>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15003088" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15003088">PMID 15003088</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+case+report+of+mania+related+to+discontinuation+of+bupropion+therapy+for+smoking+cessation&amp;rft.jtitle=The+Journal+of+clinical+psychiatry&amp;rft.aulast=Michael%2C+N%3B+Erfurth%2C+A%3B+Bergant%2C+V&amp;rft.au=Michael%2C+N%3B+Erfurth%2C+A%3B+Bergant%2C+V&amp;rft.date=February+2004&amp;rft.volume=65&amp;rft.issue=2&amp;rft.pages=277&amp;rft_id=info:pmid/15003088&amp;rft.issn=0160-6689&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11785718-72"><b><a href="#cite_ref-pmid11785718_72-0" title="">^</a></b> For the most recent report, see: <cite style="font-style:normal" class="" id="CITEREFAlvaro_D.2C_Onetti-Muda_A.2C_Moscatelli_R.2C_Atili_AF2001">Alvaro D, Onetti-Muda A, Moscatelli R, Atili AF (2001). "Acute cholestatic hepatitis induced by bupropion prescribed as pharmacological support to stop smoking. A case report". <i>Digestive and liver disease</i> <b>33</b> (8): 703–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS1590-8658%2801%2980049-9" class="external text" title="http://dx.doi.org/10.1016%2FS1590-8658%2801%2980049-9" rel="nofollow">10.1016/S1590-8658(01)80049-9</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11785718" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11785718">PMID 11785718</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Acute+cholestatic+hepatitis+induced+by+bupropion+prescribed+as+pharmacological+support+to+stop+smoking.+A+case+report&amp;rft.jtitle=Digestive+and+liver+disease&amp;rft.aulast=Alvaro+D%2C+Onetti-Muda+A%2C+Moscatelli+R%2C+Atili+AF&amp;rft.au=Alvaro+D%2C+Onetti-Muda+A%2C+Moscatelli+R%2C+Atili+AF&amp;rft.date=2001&amp;rft.volume=33&amp;rft.issue=8&amp;rft.pages=703%E2%80%936&amp;rft_id=info:doi/10.1016%2FS1590-8658%2801%2980049-9&amp;rft_id=info:pmid/11785718&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-73"><b><a href="#cite_ref-73" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLevenson_JL1995">Levenson JL (1995). "Priapism associated with bupropion treatment". <i>Am J Psychiatry</i> <b>152</b> (5): 813. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7726332" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7726332">PMID 7726332</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Priapism+associated+with+bupropion+treatment&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.aulast=Levenson+JL&amp;rft.au=Levenson+JL&amp;rft.date=1995&amp;rft.volume=152&amp;rft.issue=5&amp;rft.pages=813&amp;rft_id=info:pmid/7726332&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Balit-74">^ <a href="#cite_ref-Balit_74-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Balit_74-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Balit_74-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Balit_74-3" title=""><sup><i><b>d</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFBalit_CR.2C_Lynch_CN.2C_Isbister_GK2003">Balit CR, Lynch CN, Isbister GK (2003). "Bupropion poisoning: a case series". <i>Med. J. Aust.</i> <b>178</b> (2): 61–3. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12526723" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12526723">PMID 12526723</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+poisoning%3A+a+case+series&amp;rft.jtitle=Med.+J.+Aust.&amp;rft.aulast=Balit+CR%2C+Lynch+CN%2C+Isbister+GK&amp;rft.au=Balit+CR%2C+Lynch+CN%2C+Isbister+GK&amp;rft.date=2003&amp;rft.volume=178&amp;rft.issue=2&amp;rft.pages=61%E2%80%933&amp;rft_id=info:pmid/12526723&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Buckley-75">^ <a href="#cite_ref-Buckley_75-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Buckley_75-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Buckley_75-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Buckley_75-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Buckley_75-4" title=""><sup><i><b>e</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFBuckley_NA.2C_Faunce_TA2003">Buckley NA, Faunce TA (2003). "'Atypical' antidepressants in overdose: clinical considerations with respect to safety". <i>Drug safety: an international journal of medical toxicology and drug experience</i> <b>26</b> (8): 539–51. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12825968" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12825968">PMID 12825968</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%27Atypical%27+antidepressants+in+overdose%3A+clinical+considerations+with+respect+to+safety&amp;rft.jtitle=Drug+safety%3A+an+international+journal+of+medical+toxicology+and+drug+experience&amp;rft.aulast=Buckley+NA%2C+Faunce+TA&amp;rft.au=Buckley+NA%2C+Faunce+TA&amp;rft.date=2003&amp;rft.volume=26&amp;rft.issue=8&amp;rft.pages=539%E2%80%9351&amp;rft_id=info:pmid/12825968&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Spiller-76">^ <a href="#cite_ref-Spiller_76-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Spiller_76-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFSpiller_HA.2C_Ramoska_EA.2C_Krenzelok_EP.2C_Sheen_SR.2C_Borys_DJ.2C_Villalobos_D.2C_Muir_S.2C_Jones-Easom_L1994">Spiller HA, Ramoska EA, Krenzelok EP, Sheen SR, Borys DJ, Villalobos D, Muir S, Jones-Easom L (1994). "Bupropion overdose: a 3-year multi-center retrospective analysis". <i>The American journal of emergency medicine</i> <b>12</b> (1): 43–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2F0735-6757%2894%2990195-3" class="external text" title="http://dx.doi.org/10.1016%2F0735-6757%2894%2990195-3" rel="nofollow">10.1016/0735-6757(94)90195-3</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8285970" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8285970">PMID 8285970</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+overdose%3A+a+3-year+multi-center+retrospective+analysis&amp;rft.jtitle=The+American+journal+of+emergency+medicine&amp;rft.aulast=Spiller+HA%2C+Ramoska+EA%2C+Krenzelok+EP%2C+Sheen+SR%2C+Borys+DJ%2C+Villalobos+D%2C+Muir+S%2C+Jones-Easom+L&amp;rft.au=Spiller+HA%2C+Ramoska+EA%2C+Krenzelok+EP%2C+Sheen+SR%2C+Borys+DJ%2C+Villalobos+D%2C+Muir+S%2C+Jones-Easom+L&amp;rft.date=1994&amp;rft.volume=12&amp;rft.issue=1&amp;rft.pages=43%E2%80%935&amp;rft_id=info:doi/10.1016%2F0735-6757%2894%2990195-3&amp;rft_id=info:pmid/8285970&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-77"><b><a href="#cite_ref-77" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMainie_I.2C_McGurk_C.2C_McClintock_G.2C_Robinson_J2001">Mainie I, McGurk C, McClintock G, Robinson J (2001). "Seizures after buproprion overdose". <i>Lancet</i> <b>357</b> (9268): 1624. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2800%2904770-X" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2800%2904770-X" rel="nofollow">10.1016/S0140-6736(00)04770-X</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11386326" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11386326">PMID 11386326</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Seizures+after+buproprion+overdose&amp;rft.jtitle=Lancet&amp;rft.aulast=Mainie+I%2C+McGurk+C%2C+McClintock+G%2C+Robinson+J&amp;rft.au=Mainie+I%2C+McGurk+C%2C+McClintock+G%2C+Robinson+J&amp;rft.date=2001&amp;rft.volume=357&amp;rft.issue=9268&amp;rft.pages=1624&amp;rft_id=info:doi/10.1016%2FS0140-6736%2800%2904770-X&amp;rft_id=info:pmid/11386326&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Shepherd-78">^ <a href="#cite_ref-Shepherd_78-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Shepherd_78-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFShepherd_G.2C_Velez_LI.2C_Keyes_DC2004">Shepherd G, Velez LI, Keyes DC (2004). "Intentional bupropion overdoses". <i>The Journal of emergency medicine</i> <b>27</b> (2): 147–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.jemermed.2004.02.017" class="external text" title="http://dx.doi.org/10.1016%2Fj.jemermed.2004.02.017" rel="nofollow">10.1016/j.jemermed.2004.02.017</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15261357" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15261357">PMID 15261357</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Intentional+bupropion+overdoses&amp;rft.jtitle=The+Journal+of+emergency+medicine&amp;rft.aulast=Shepherd+G%2C+Velez+LI%2C+Keyes+DC&amp;rft.au=Shepherd+G%2C+Velez+LI%2C+Keyes+DC&amp;rft.date=2004&amp;rft.volume=27&amp;rft.issue=2&amp;rft.pages=147%E2%80%9351&amp;rft_id=info:doi/10.1016%2Fj.jemermed.2004.02.017&amp;rft_id=info:pmid/15261357&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-79"><b><a href="#cite_ref-79" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCurry_SC.2C_Kashani_JS.2C_LoVecchio_F.2C_Holubek_W2005">Curry SC, Kashani JS, LoVecchio F, Holubek W (2005). "Intraventricular conduction delay after bupropion overdose". <i>The Journal of emergency medicine</i> <b>29</b> (3): 299–305. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.jemermed.2005.01.027" class="external text" title="http://dx.doi.org/10.1016%2Fj.jemermed.2005.01.027" rel="nofollow">10.1016/j.jemermed.2005.01.027</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16183450" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16183450">PMID 16183450</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Intraventricular+conduction+delay+after+bupropion+overdose&amp;rft.jtitle=The+Journal+of+emergency+medicine&amp;rft.aulast=Curry+SC%2C+Kashani+JS%2C+LoVecchio+F%2C+Holubek+W&amp;rft.au=Curry+SC%2C+Kashani+JS%2C+LoVecchio+F%2C+Holubek+W&amp;rft.date=2005&amp;rft.volume=29&amp;rft.issue=3&amp;rft.pages=299%E2%80%93305&amp;rft_id=info:doi/10.1016%2Fj.jemermed.2005.01.027&amp;rft_id=info:pmid/16183450&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-80"><b><a href="#cite_ref-80" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTracey_JA.2C_Cassidy_N.2C_Casey_PB.2C_Ali_I2002">Tracey JA, Cassidy N, Casey PB, Ali I (2002). "Bupropion (Zyban) toxicity". <i>Irish medical journal</i> <b>95</b> (1): 23–4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11928786" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11928786">PMID 11928786</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+%28Zyban%29+toxicity&amp;rft.jtitle=Irish+medical+journal&amp;rft.aulast=Tracey+JA%2C+Cassidy+N%2C+Casey+PB%2C+Ali+I&amp;rft.au=Tracey+JA%2C+Cassidy+N%2C+Casey+PB%2C+Ali+I&amp;rft.date=2002&amp;rft.volume=95&amp;rft.issue=1&amp;rft.pages=23%E2%80%934&amp;rft_id=info:pmid/11928786&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Shepherd2-81"><b><a href="#cite_ref-Shepherd2_81-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFShepherd_G.2C_Velez_LI.2C_James_DK.2C_Keyes_DC2001">Shepherd G, Velez LI, James DK, Keyes DC (2001). "Pediatric bupropion exposures reported in Texas: 1998–1999 [abstract]". <i>J Toxicol Clin Toxicol</i> <b>39</b>: 263.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pediatric+bupropion+exposures+reported+in+Texas%3A+1998%E2%80%931999+%5Babstract%5D&amp;rft.jtitle=J+Toxicol+Clin+Toxicol&amp;rft.aulast=Shepherd+G%2C+Velez+LI%2C+James+DK%2C+Keyes+DC&amp;rft.au=Shepherd+G%2C+Velez+LI%2C+James+DK%2C+Keyes+DC&amp;rft.date=2001&amp;rft.volume=39&amp;rft.pages=263&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Colbridge-82"><b><a href="#cite_ref-Colbridge_82-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFColbridge_MG.2C_Dargan_PI.2C_Jones_AL2002">Colbridge MG, Dargan PI, Jones AL (2002). "Bupropion - the experience of the National Poisons Information Service (London) [abstract]". <i>J Toxicol Clin Toxicol</i> <b>40</b>: 398–9.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+-+the+experience+of+the+National+Poisons+Information+Service+%28London%29+%5Babstract%5D&amp;rft.jtitle=J+Toxicol+Clin+Toxicol&amp;rft.aulast=Colbridge+MG%2C+Dargan+PI%2C+Jones+AL&amp;rft.au=Colbridge+MG%2C+Dargan+PI%2C+Jones+AL&amp;rft.date=2002&amp;rft.volume=40&amp;rft.pages=398%E2%80%939&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Johnston-83"><b><a href="#cite_ref-Johnston_83-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJohnston_JA.2C_Lineberry_CG.2C_Ascher_JA.2C_Davidson_J.2C_Khayrallah_MA.2C_Feighner_JP.2C_Stark_P1991">Johnston JA, Lineberry CG, Ascher JA, Davidson J, Khayrallah MA, Feighner JP, Stark P (1991). "A 102-center prospective study of seizure in association with bupropion". <i>The Journal of clinical psychiatry</i> <b>52</b> (11): 450–6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1744061" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1744061">PMID 1744061</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+102-center+prospective+study+of+seizure+in+association+with+bupropion&amp;rft.jtitle=The+Journal+of+clinical+psychiatry&amp;rft.aulast=Johnston+JA%2C+Lineberry+CG%2C+Ascher+JA%2C+Davidson+J%2C+Khayrallah+MA%2C+Feighner+JP%2C+Stark+P&amp;rft.au=Johnston+JA%2C+Lineberry+CG%2C+Ascher+JA%2C+Davidson+J%2C+Khayrallah+MA%2C+Feighner+JP%2C+Stark+P&amp;rft.date=1991&amp;rft.volume=52&amp;rft.issue=11&amp;rft.pages=450%E2%80%936&amp;rft_id=info:pmid/1744061&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-84"><b><a href="#cite_ref-84" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHarris_CR.2C_Gualtieri_J.2C_Stark_G1997">Harris CR, Gualtieri J, Stark G (1997). "Fatal bupropion overdose". <i>J Toxicol Clin Toxicol</i> <b>35</b> (3): 321–4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9140330" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9140330">PMID 9140330</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Fatal+bupropion+overdose&amp;rft.jtitle=J+Toxicol+Clin+Toxicol&amp;rft.aulast=Harris+CR%2C+Gualtieri+J%2C+Stark+G&amp;rft.au=Harris+CR%2C+Gualtieri+J%2C+Stark+G&amp;rft.date=1997&amp;rft.volume=35&amp;rft.issue=3&amp;rft.pages=321%E2%80%934&amp;rft_id=info:pmid/9140330&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-85"><b><a href="#cite_ref-85" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFriel_PN.2C_Logan_BK.2C_Fligner_CL1993">Friel PN, Logan BK, Fligner CL (1993). "Three fatal drug overdoses involving bupropion". <i>Journal of analytical toxicology</i> <b>17</b> (7): 436–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8309220" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8309220">PMID 8309220</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Three+fatal+drug+overdoses+involving+bupropion&amp;rft.jtitle=Journal+of+analytical+toxicology&amp;rft.aulast=Friel+PN%2C+Logan+BK%2C+Fligner+CL&amp;rft.au=Friel+PN%2C+Logan+BK%2C+Fligner+CL&amp;rft.date=1993&amp;rft.volume=17&amp;rft.issue=7&amp;rft.pages=436%E2%80%938&amp;rft_id=info:pmid/8309220&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-86"><b><a href="#cite_ref-86" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPaoloni_R.2C_Szekely_I2002">Paoloni R, Szekely I (2002). "Sustained-release bupropion overdose: a new entity for Australian emergency departments". <i>Emergency medicine (Fremantle, W.A.)</i> <b>14</b> (1): 109–12. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1046%2Fj.1442-2026.2002.00295.x" class="external text" title="http://dx.doi.org/10.1046%2Fj.1442-2026.2002.00295.x" rel="nofollow">10.1046/j.1442-2026.2002.00295.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11993828" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11993828">PMID 11993828</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sustained-release+bupropion+overdose%3A+a+new+entity+for+Australian+emergency+departments&amp;rft.jtitle=Emergency+medicine+%28Fremantle%2C+W.A.%29&amp;rft.aulast=Paoloni+R%2C+Szekely+I&amp;rft.au=Paoloni+R%2C+Szekely+I&amp;rft.date=2002&amp;rft.volume=14&amp;rft.issue=1&amp;rft.pages=109%E2%80%9312&amp;rft_id=info:doi/10.1046%2Fj.1442-2026.2002.00295.x&amp;rft_id=info:pmid/11993828&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-87"><b><a href="#cite_ref-87" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSirianni_AJ.2C_Osterhoudt_KC.2C_Calello_DP.2C_.27.27et_al.27.272007">Sirianni AJ, Osterhoudt KC, Calello DP, <i>et al</i> (2007). "Use of Lipid Emulsion in the Resuscitation of a Patient With Prolonged Cardiovascular Collapse After Overdose of Bupropion and Lamotrigine". <i>Ann Emerg Med</i> <b>51</b>: 412. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.annemergmed.2007.06.004" class="external text" title="http://dx.doi.org/10.1016%2Fj.annemergmed.2007.06.004" rel="nofollow">10.1016/j.annemergmed.2007.06.004</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17766009" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17766009">PMID 17766009</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Use+of+Lipid+Emulsion+in+the+Resuscitation+of+a+Patient+With+Prolonged+Cardiovascular+Collapse+After+Overdose+of+Bupropion+and+Lamotrigine&amp;rft.jtitle=Ann+Emerg+Med&amp;rft.aulast=Sirianni+AJ%2C+Osterhoudt+KC%2C+Calello+DP%2C+%27%27et+al%27%27&amp;rft.au=Sirianni+AJ%2C+Osterhoudt+KC%2C+Calello+DP%2C+%27%27et+al%27%27&amp;rft.date=2007&amp;rft.volume=51&amp;rft.pages=412&amp;rft_id=info:doi/10.1016%2Fj.annemergmed.2007.06.004&amp;rft_id=info:pmid/17766009&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-88"><b><a href="#cite_ref-88" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFStahl_S.2C_Pradko_J.2C_Haight_B.2C_Modell_J.2C_Rockett_C.2C_Learned-Coughlin_S2004">Stahl S, Pradko J, Haight B, Modell J, Rockett C, Learned-Coughlin S (2004). "<a href="http://www.psychiatrist.com/pcc/pccpdf/v06n04/v06n0403.pdf" class="external text" title="http://www.psychiatrist.com/pcc/pccpdf/v06n04/v06n0403.pdf" rel="nofollow">A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor</a>" (PDF). <i>Prim Care Companion J Clin Psychiatry</i> <b>6</b> (4): 159–166. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15361919" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15361919">PMID 15361919</a><span class="printonly">. <a href="http://www.psychiatrist.com/pcc/pccpdf/v06n04/v06n0403.pdf" class="external free" title="http://www.psychiatrist.com/pcc/pccpdf/v06n04/v06n0403.pdf" rel="nofollow">http://www.psychiatrist.com/pcc/pccpdf/v06n04/v06n0403.pdf</a></span><span class="reference-accessdate">. Retrieved on 2008-12-30</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+Review+of+the+Neuropharmacology+of+Bupropion%2C+a+Dual+Norepinephrine+and+Dopamine+Reuptake+Inhibitor&amp;rft.jtitle=Prim+Care+Companion+J+Clin+Psychiatry&amp;rft.aulast=Stahl+S%2C+Pradko+J%2C+Haight+B%2C+Modell+J%2C+Rockett+C%2C+Learned-Coughlin+S&amp;rft.au=Stahl+S%2C+Pradko+J%2C+Haight+B%2C+Modell+J%2C+Rockett+C%2C+Learned-Coughlin+S&amp;rft.date=2004&amp;rft.volume=6&amp;rft.issue=4&amp;rft.pages=159%E2%80%93166&amp;rft_id=info:pmid/15361919&amp;rft_id=http%3A%2F%2Fwww.psychiatrist.com%2Fpcc%2Fpccpdf%2Fv06n04%2Fv06n0403.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span> Full text at <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>: <a href="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=514842" class="external text" title="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=514842" rel="nofollow">514842</a></li>
<li id="cite_note-89"><b><a href="#cite_ref-89" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMeyer_J.2C_Goulding_V_S.2C_Wilson_A_A.2C_Hussey_D.2C_Christensen_B_K.2C_Houle_S2002">Meyer J, Goulding V S, Wilson A A, Hussey D, Christensen B K, Houle S (2002). "Bupropion occupancy of the dopamine transporter is low during clinical treatment". <i>Psychopharmacology</i> <b>163</b>: 102–105. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs00213-002-1166-3" class="external text" title="http://dx.doi.org/10.1007%2Fs00213-002-1166-3" rel="nofollow">10.1007/s00213-002-1166-3</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12185406" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12185406">PMID 12185406</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+occupancy+of+the+dopamine+transporter+is+low+during+clinical+treatment&amp;rft.jtitle=Psychopharmacology&amp;rft.aulast=Meyer+J%2C+Goulding+V+S%2C+Wilson+A+A%2C+Hussey+D%2C+Christensen+B+K%2C+Houle+S&amp;rft.au=Meyer+J%2C+Goulding+V+S%2C+Wilson+A+A%2C+Hussey+D%2C+Christensen+B+K%2C+Houle+S&amp;rft.date=2002&amp;rft.volume=163&amp;rft.pages=102%E2%80%93105&amp;rft_id=info:doi/10.1007%2Fs00213-002-1166-3&amp;rft_id=info:pmid/12185406&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-90"><b><a href="#cite_ref-90" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLearned-Coughkin_S_M.2C_Bergstrom_M.2C_Savitcheva_I.2C_Ascher_J.2C_Schmith_V_D.2C_Langstrom_B2003">Learned-Coughkin S M, Bergstrom M, Savitcheva I, Ascher J, Schmith V D, Langstrom B (2003). "<i>In vivo</i> activity of bupropion at the human dopamine transporter as measured by positron emission tomography". <i>Biol Psychiatry</i> <b>54</b>: 800–805. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0006-3223%2802%2901834-6" class="external text" title="http://dx.doi.org/10.1016%2FS0006-3223%2802%2901834-6" rel="nofollow">10.1016/S0006-3223(02)01834-6</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14550679" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14550679">PMID 14550679</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%27%27In+vivo%27%27+activity+of+bupropion+at+the+human+dopamine+transporter+as+measured+by+positron+emission+tomography&amp;rft.jtitle=Biol+Psychiatry&amp;rft.aulast=Learned-Coughkin+S+M%2C+Bergstrom+M%2C+Savitcheva+I%2C+Ascher+J%2C+Schmith+V+D%2C+Langstrom+B&amp;rft.au=Learned-Coughkin+S+M%2C+Bergstrom+M%2C+Savitcheva+I%2C+Ascher+J%2C+Schmith+V+D%2C+Langstrom+B&amp;rft.date=2003&amp;rft.volume=54&amp;rft.pages=800%E2%80%93805&amp;rft_id=info:doi/10.1016%2FS0006-3223%2802%2901834-6&amp;rft_id=info:pmid/14550679&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-91"><b><a href="#cite_ref-91" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFryer_J_D.2C.0ALukas_R_J1999">Fryer J D, Lukas R J (1999). "Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine". <i>J Pharmacol Exp Ther</i> <b>288</b> (6): 88–92. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9862757" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9862757">PMID 9862757</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Noncompetitive+functional+inhibition+at+diverse%2C+human+nicotinic+acetylcholine+receptor+subtypes+by+bupropion%2C+phencyclidine%2C+and+ibogaine&amp;rft.jtitle=J+Pharmacol+Exp+Ther&amp;rft.aulast=Fryer+J+D%2C%0ALukas+R+J&amp;rft.au=Fryer+J+D%2C%0ALukas+R+J&amp;rft.date=1999&amp;rft.volume=288&amp;rft.issue=6&amp;rft.pages=88%E2%80%9392&amp;rft_id=info:pmid/9862757&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-92"><b><a href="#cite_ref-92" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFGlick_S_D">Glick S D. <a href="http://www.csam-asam.org/pdf/misc/Glick.ppt" class="external text" title="http://www.csam-asam.org/pdf/misc/Glick.ppt" rel="nofollow">"Ibogaine Analogues: Drug Development for Addictive Disorders. (Presentation at Addiction Medicine State of the Art 2003 Conference October 8–11, 2003, Radisson-Miyako Hotel, San Francisco)"</a>. www.csam-asam.org<span class="printonly">. <a href="http://www.csam-asam.org/pdf/misc/Glick.ppt" class="external free" title="http://www.csam-asam.org/pdf/misc/Glick.ppt" rel="nofollow">http://www.csam-asam.org/pdf/misc/Glick.ppt</a></span><span class="reference-accessdate">. Retrieved on 2007-03-24</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Ibogaine+Analogues%3A+Drug+Development+for+Addictive+Disorders.+%28Presentation+at+Addiction+Medicine+State+of+the+Art+2003+Conference+October+8%E2%80%9311%2C+2003%2C+Radisson-Miyako+Hotel%2C+San+Francisco%29&amp;rft.atitle=&amp;rft.aulast=Glick+S+D&amp;rft.au=Glick+S+D&amp;rft.pub=www.csam-asam.org&amp;rft_id=http%3A%2F%2Fwww.csam-asam.org%2Fpdf%2Fmisc%2FGlick.ppt&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-93"><b><a href="#cite_ref-93" title="">^</a></b> <cite style="font-style:normal" class="book"><i><a href="/wiki/Physicians%27_Desk_Reference" title="Physicians' Desk Reference">Physicians' Desk Reference</a></i> (59 ed.). Montvale, NJ: Thompson. 2005. <a href="/wiki/Special:BookSources/156363497X" class="internal">ISBN 1-56363-497-X</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=%5B%5BPhysicians%27+Desk+Reference%5D%5D&amp;rft.date=2005&amp;rft.edition=59&amp;rft.place=Montvale%2C+NJ&amp;rft.pub=Thompson&amp;rft.isbn=1-56363-497-X&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-horst1998-94">^ <a href="#cite_ref-horst1998_94-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-horst1998_94-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFHorst_WD.2C_Preskorn_SH1998">Horst WD, Preskorn SH (1998). "Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion". <i>J Affect Disord</i> <b>51</b> (3): 237–54. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0165-0327%2898%2900222-5" class="external text" title="http://dx.doi.org/10.1016%2FS0165-0327%2898%2900222-5" rel="nofollow">10.1016/S0165-0327(98)00222-5</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10333980" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10333980">PMID 10333980</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Mechanisms+of+action+and+clinical+characteristics+of+three+atypical+antidepressants%3A+venlafaxine%2C+nefazodone%2C+bupropion&amp;rft.jtitle=J+Affect+Disord&amp;rft.aulast=Horst+WD%2C+Preskorn+SH&amp;rft.au=Horst+WD%2C+Preskorn+SH&amp;rft.date=1998&amp;rft.volume=51&amp;rft.issue=3&amp;rft.pages=237%E2%80%9354&amp;rft_id=info:doi/10.1016%2FS0165-0327%2898%2900222-5&amp;rft_id=info:pmid/10333980&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-95"><b><a href="#cite_ref-95" title="">^</a></b> <cite style="font-style:normal" class="press release" id="CITEREFPRNewswire2004">PRNewswire (November 23, 2004). <i><a href="http://www.biospace.com/news_story.aspx?StoryID=18222420&amp;full=1" class="external text" title="http://www.biospace.com/news_story.aspx?StoryID=18222420&amp;full=1" rel="nofollow">GlaxoSmithKline (GSK) Reviews Novel Therapeutics For CNS Disorders And Confirms Strong Pipeline Momentum</a></i>. <a href="/wiki/News_release" title="News release">Press release</a><span class="printonly">. <a href="http://www.biospace.com/news_story.aspx?StoryID=18222420&amp;full=1" class="external free" title="http://www.biospace.com/news_story.aspx?StoryID=18222420&amp;full=1" rel="nofollow">http://www.biospace.com/news_story.aspx?StoryID=18222420&amp;full=1</a></span><span class="reference-accessdate">. Retrieved on 2007-08-18</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=GlaxoSmithKline+%28GSK%29+Reviews+Novel+Therapeutics+For+CNS+Disorders+And+Confirms+Strong+Pipeline+Momentum&amp;rft.aulast=PRNewswire&amp;rft.au=PRNewswire&amp;rft.date=November+23%2C+2004&amp;rft.series=%5B%5BNews+release%7CPress+release%5D%5D&amp;rft_id=http%3A%2F%2Fwww.biospace.com%2Fnews_story.aspx%3FStoryID%3D18222420%26full%3D1&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-96"><b><a href="#cite_ref-96" title="">^</a></b> GlaxoSmithKline (July 26, 2006) <span class="PDFlink"><a href="http://www.gsk.com/investors/reports/gsk_q22006/q22006.pdf" class="external text" title="http://www.gsk.com/investors/reports/gsk_q22006/q22006.pdf" rel="nofollow"><i>Pipeline Update</i></a></span><span style="font-size:smaller;"><a href="/wiki/Portable_Document_Format" title="Portable Document Format">PDF</a>&#160;(136&#160;KB)</span>. <a href="/wiki/Press_release" title="Press release" class="mw-redirect">Press release</a>. Retrieved on 2007-08-18.</li>
<li id="cite_note-pmid14515060-97"><b><a href="#cite_ref-pmid14515060_97-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKirchheiner_J.2C_Klein_C.2C_Meineke_I.2C_Sasse_J.2C_Zanger_UM.2C_M.C3.BCrdter_TE.2C_Roots_I.2C_Brockm.C3.B6ller_J2003">Kirchheiner J, Klein C, Meineke I, Sasse J, Zanger UM, Mürdter TE, Roots I, Brockmöller J (2003). "Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6". <i>Pharmacogenetics</i> <b>13</b> (10): 619–26. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00008571-200310000-00005" class="external text" title="http://dx.doi.org/10.1097%2F00008571-200310000-00005" rel="nofollow">10.1097/00008571-200310000-00005</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14515060" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14515060">PMID 14515060</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+and+4-OH-bupropion+pharmacokinetics+in+relation+to+genetic+polymorphisms+in+CYP2B6&amp;rft.jtitle=Pharmacogenetics&amp;rft.aulast=Kirchheiner+J%2C+Klein+C%2C+Meineke+I%2C+Sasse+J%2C+Zanger+UM%2C+M%C3%BCrdter+TE%2C+Roots+I%2C+Brockm%C3%B6ller+J&amp;rft.au=Kirchheiner+J%2C+Klein+C%2C+Meineke+I%2C+Sasse+J%2C+Zanger+UM%2C+M%C3%BCrdter+TE%2C+Roots+I%2C+Brockm%C3%B6ller+J&amp;rft.date=2003&amp;rft.volume=13&amp;rft.issue=10&amp;rft.pages=619%E2%80%9326&amp;rft_id=info:doi/10.1097%2F00008571-200310000-00005&amp;rft_id=info:pmid/14515060&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15083067-98"><b><a href="#cite_ref-pmid15083067_98-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHesse_LM.2C_He_P.2C_Krishnaswamy_S.2C_Hao_Q.2C_Hogan_K.2C_von_Moltke_LL.2C_Greenblatt_DJ.2C_Court_MH2004">Hesse LM, He P, Krishnaswamy S, Hao Q, Hogan K, von Moltke LL, Greenblatt DJ, Court MH (2004). "Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes". <i>Pharmacogenetics</i> <b>14</b> (4): 225–38. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00008571-200404000-00002" class="external text" title="http://dx.doi.org/10.1097%2F00008571-200404000-00002" rel="nofollow">10.1097/00008571-200404000-00002</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15083067" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15083067">PMID 15083067</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pharmacogenetic+determinants+of+interindividual+variability+in+bupropion+hydroxylation+by+cytochrome+P450+2B6+in+human+liver+microsomes&amp;rft.jtitle=Pharmacogenetics&amp;rft.aulast=Hesse+LM%2C+He+P%2C+Krishnaswamy+S%2C+Hao+Q%2C+Hogan+K%2C+von+Moltke+LL%2C+Greenblatt+DJ%2C+Court+MH&amp;rft.au=Hesse+LM%2C+He+P%2C+Krishnaswamy+S%2C+Hao+Q%2C+Hogan+K%2C+von+Moltke+LL%2C+Greenblatt+DJ%2C+Court+MH&amp;rft.date=2004&amp;rft.volume=14&amp;rft.issue=4&amp;rft.pages=225%E2%80%9338&amp;rft_id=info:doi/10.1097%2F00008571-200404000-00002&amp;rft_id=info:pmid/15083067&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid1813908-99"><b><a href="#cite_ref-pmid1813908_99-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPreskorn_SH1991">Preskorn SH (1991). "Should bupropion dosage be adjusted based upon therapeutic drug monitoring?". <i>Psychopharmacology bulletin</i> <b>27</b> (4): 637–43. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1813908" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1813908">PMID 1813908</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Should+bupropion+dosage+be+adjusted+based+upon+therapeutic+drug+monitoring%3F&amp;rft.jtitle=Psychopharmacology+bulletin&amp;rft.aulast=Preskorn+SH&amp;rft.au=Preskorn+SH&amp;rft.date=1991&amp;rft.volume=27&amp;rft.issue=4&amp;rft.pages=637%E2%80%9343&amp;rft_id=info:pmid/1813908&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-100"><b><a href="#cite_ref-100" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSuckow_R_F.2C_Smith_T_M.2C_Perumal_A_S.2C_Cooper_T_B1986">Suckow R F, Smith T M, Perumal A S, Cooper T B (1986). "Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs". <i>Drug Metab Dispos</i> <b>14</b> (6): 692–697. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2877828" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/2877828">PMID 2877828</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pharmacokinetics+of+bupropion+and+metabolites+in+plasma+and+brain+of+rats%2C+mice%2C+and+guinea+pigs&amp;rft.jtitle=Drug+Metab+Dispos&amp;rft.aulast=Suckow+R+F%2C+Smith+T+M%2C+Perumal+A+S%2C+Cooper+T+B&amp;rft.au=Suckow+R+F%2C+Smith+T+M%2C+Perumal+A+S%2C+Cooper+T+B&amp;rft.date=1986&amp;rft.volume=14&amp;rft.issue=6&amp;rft.pages=692%E2%80%93697&amp;rft_id=info:pmid/2877828&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pharmacological287-101">^ <a href="#cite_ref-pharmacological287_101-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pharmacological287_101-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFWelch_R_M.2C_Lai_A_A.2C_Schroeder_D_H1987">Welch R M, Lai A A, Schroeder D H (1987). "Pharmacological significance of the species differences in bupropion metabolism". <i>Xenobiotica</i> <b>17</b> (3): 287–289. <a href="http://www.ncbi.nlm.nih.gov/pubmed/3107223" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/3107223">PMID 3107223</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pharmacological+significance+of+the+species+differences+in+bupropion+metabolism&amp;rft.jtitle=Xenobiotica&amp;rft.aulast=Welch+R+M%2C+Lai+A+A%2C+Schroeder+D+H&amp;rft.au=Welch+R+M%2C+Lai+A+A%2C+Schroeder+D+H&amp;rft.date=1987&amp;rft.volume=17&amp;rft.issue=3&amp;rft.pages=287%E2%80%93289&amp;rft_id=info:pmid/3107223&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10999247-102"><b><a href="#cite_ref-pmid10999247_102-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWeintraub_D.2C_Linder_MW2000">Weintraub D, Linder MW (2000). "Amphetamine positive toxicology screen secondary to bupropion". <i>Depress Anxiety</i> <b>12</b> (1): 53–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F1520-6394%282000%2912%3A1%3C53%3A%3AAID-DA8%3E3.0.CO%3B2-4" class="external text" title="http://dx.doi.org/10.1002%2F1520-6394%282000%2912%3A1%3C53%3A%3AAID-DA8%3E3.0.CO%3B2-4" rel="nofollow">10.1002/1520-6394(2000)12:1&lt;53::AID-DA8&gt;3.0.CO;2-4</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10999247" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10999247">PMID 10999247</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Amphetamine+positive+toxicology+screen+secondary+to+bupropion&amp;rft.jtitle=Depress+Anxiety&amp;rft.aulast=Weintraub+D%2C+Linder+MW&amp;rft.au=Weintraub+D%2C+Linder+MW&amp;rft.date=2000&amp;rft.volume=12&amp;rft.issue=1&amp;rft.pages=53%E2%80%934&amp;rft_id=info:doi/10.1002%2F1520-6394%282000%2912%3A1%3C53%3A%3AAID-DA8%3E3.0.CO%3B2-4&amp;rft_id=info:pmid/10999247&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid7768026-103"><b><a href="#cite_ref-pmid7768026_103-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNixon_AL.2C_Long_WH.2C_Puopolo_PR.2C_Flood_JG1995">Nixon AL, Long WH, Puopolo PR, Flood JG (1995). "Bupropion metabolites produce false-positive urine amphetamine results". <i>Clin. Chem.</i> <b>41</b> (6 Pt 1): 955–6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7768026" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7768026">PMID 7768026</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+metabolites+produce+false-positive+urine+amphetamine+results&amp;rft.jtitle=Clin.+Chem.&amp;rft.aulast=Nixon+AL%2C+Long+WH%2C+Puopolo+PR%2C+Flood+JG&amp;rft.au=Nixon+AL%2C+Long+WH%2C+Puopolo+PR%2C+Flood+JG&amp;rft.date=1995&amp;rft.volume=41&amp;rft.issue=6+Pt+1&amp;rft.pages=955%E2%80%936&amp;rft_id=info:pmid/7768026&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-104"><b><a href="#cite_ref-104" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJohnston_AJ.2C_Ascher_J.2C_Leadbetter_R.2C_Schmith_VD.2C_Patel_DK.2C_Durcan_M.2C_Bentley_B2002">Johnston AJ, Ascher J, Leadbetter R, Schmith VD, Patel DK, Durcan M, Bentley B (2002). "Pharmacokinetic optimisation of sustained-release bupropion for smoking cessation". <i>Drugs</i> <b>62</b> (Suppl 2): 11–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2165%2F00003495-200262002-00002" class="external text" title="http://dx.doi.org/10.2165%2F00003495-200262002-00002" rel="nofollow">10.2165/00003495-200262002-00002</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12109932" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12109932">PMID 12109932</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pharmacokinetic+optimisation+of+sustained-release+bupropion+for+smoking+cessation&amp;rft.jtitle=Drugs&amp;rft.aulast=Johnston+AJ%2C+Ascher+J%2C+Leadbetter+R%2C+Schmith+VD%2C+Patel+DK%2C+Durcan+M%2C+Bentley+B&amp;rft.au=Johnston+AJ%2C+Ascher+J%2C+Leadbetter+R%2C+Schmith+VD%2C+Patel+DK%2C+Durcan+M%2C+Bentley+B&amp;rft.date=2002&amp;rft.volume=62&amp;rft.issue=Suppl+2&amp;rft.pages=11%E2%80%9324&amp;rft_id=info:doi/10.2165%2F00003495-200262002-00002&amp;rft_id=info:pmid/12109932&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-105"><b><a href="#cite_ref-105" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFXu_H.2C_Loboz_KK.2C_Gross_AS.2C_McLachlan_AJ2007">Xu H, Loboz KK, Gross AS, McLachlan AJ (2007). "Stereoselective analysis of hydroxybupropion and application to drug interaction studies". <i>Chirality</i> <b>19</b> (3): 163–70. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fchir.20356" class="external text" title="http://dx.doi.org/10.1002%2Fchir.20356" rel="nofollow">10.1002/chir.20356</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17167747" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17167747">PMID 17167747</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Stereoselective+analysis+of+hydroxybupropion+and+application+to+drug+interaction+studies&amp;rft.jtitle=Chirality&amp;rft.aulast=Xu+H%2C+Loboz+KK%2C+Gross+AS%2C+McLachlan+AJ&amp;rft.au=Xu+H%2C+Loboz+KK%2C+Gross+AS%2C+McLachlan+AJ&amp;rft.date=2007&amp;rft.volume=19&amp;rft.issue=3&amp;rft.pages=163%E2%80%9370&amp;rft_id=info:doi/10.1002%2Fchir.20356&amp;rft_id=info:pmid/17167747&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-106"><b><a href="#cite_ref-106" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBondarev_ML.2C_Bondareva_TS.2C_Young_R.2C_Glennon_RA2003">Bondarev ML, Bondareva TS, Young R, Glennon RA (2003). "Behavioral and biochemical investigations of bupropion metabolites". <i>Eur J Pharmacol</i> <b>474</b> (1): 85–93. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0014-2999%2803%2902010-7" class="external text" title="http://dx.doi.org/10.1016%2FS0014-2999%2803%2902010-7" rel="nofollow">10.1016/S0014-2999(03)02010-7</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12909199" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12909199">PMID 12909199</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Behavioral+and+biochemical+investigations+of+bupropion+metabolites&amp;rft.jtitle=Eur+J+Pharmacol&amp;rft.aulast=Bondarev+ML%2C+Bondareva+TS%2C+Young+R%2C+Glennon+RA&amp;rft.au=Bondarev+ML%2C+Bondareva+TS%2C+Young+R%2C+Glennon+RA&amp;rft.date=2003&amp;rft.volume=474&amp;rft.issue=1&amp;rft.pages=85%E2%80%9393&amp;rft_id=info:doi/10.1016%2FS0014-2999%2803%2902010-7&amp;rft_id=info:pmid/12909199&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-107"><b><a href="#cite_ref-107" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDamaj_MI.2C_Carroll_FI.2C_Eaton_JB.2C_Navarro_HA.2C_Blough_BE.2C_Mirza_S.2C_Lukas_RJ.2C_Martin_BR2004">Damaj MI, Carroll FI, Eaton JB, Navarro HA, Blough BE, Mirza S, Lukas RJ, Martin BR (2004). "Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors". <i>Mol Pharmacol</i> <b>66</b> (3): 675–82. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1124%2Fmol.104.001313" class="external text" title="http://dx.doi.org/10.1124%2Fmol.104.001313" rel="nofollow">10.1124/mol.104.001313</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15322260" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15322260">PMID 15322260</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Enantioselective+effects+of+hydroxy+metabolites+of+bupropion+on+behavior+and+on+function+of+monoamine+transporters+and+nicotinic+receptors&amp;rft.jtitle=Mol+Pharmacol&amp;rft.aulast=Damaj+MI%2C+Carroll+FI%2C+Eaton+JB%2C+Navarro+HA%2C+Blough+BE%2C+Mirza+S%2C+Lukas+RJ%2C+Martin+BR&amp;rft.au=Damaj+MI%2C+Carroll+FI%2C+Eaton+JB%2C+Navarro+HA%2C+Blough+BE%2C+Mirza+S%2C+Lukas+RJ%2C+Martin+BR&amp;rft.date=2004&amp;rft.volume=66&amp;rft.issue=3&amp;rft.pages=675%E2%80%9382&amp;rft_id=info:doi/10.1124%2Fmol.104.001313&amp;rft_id=info:pmid/15322260&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16368442-108">^ <a href="#cite_ref-pmid16368442_108-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16368442_108-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFJefferson_JW.2C_Pradko_JF.2C_Muir_KT2005">Jefferson JW, Pradko JF, Muir KT (2005). "Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations". <i>Clin Ther</i> <b>27</b> (11): 1685–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.clinthera.2005.11.011" class="external text" title="http://dx.doi.org/10.1016%2Fj.clinthera.2005.11.011" rel="nofollow">10.1016/j.clinthera.2005.11.011</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16368442" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16368442">PMID 16368442</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+for+major+depressive+disorder%3A+Pharmacokinetic+and+formulation+considerations&amp;rft.jtitle=Clin+Ther&amp;rft.aulast=Jefferson+JW%2C+Pradko+JF%2C+Muir+KT&amp;rft.au=Jefferson+JW%2C+Pradko+JF%2C+Muir+KT&amp;rft.date=2005&amp;rft.volume=27&amp;rft.issue=11&amp;rft.pages=1685%E2%80%9395&amp;rft_id=info:doi/10.1016%2Fj.clinthera.2005.11.011&amp;rft_id=info:pmid/16368442&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11926715-109"><b><a href="#cite_ref-pmid11926715_109-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKennedy_SH.2C_McCann_SM.2C_Masellis_M.2C_McIntyre_RS.2C_Raskin_J.2C_McKay_G.2C_Baker_GB2002">Kennedy SH, McCann SM, Masellis M, McIntyre RS, Raskin J, McKay G, Baker GB (2002). "Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects". <i>J Clin Psychiatry</i> <b>63</b> (3): 181–6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11926715" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11926715">PMID 11926715</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Combining+bupropion+SR+with+venlafaxine%2C+paroxetine%2C+or+fluoxetine%3A+a+preliminary+report+on+pharmacokinetic%2C+therapeutic%2C+and+sexual+dysfunction+effects&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Kennedy+SH%2C+McCann+SM%2C+Masellis+M%2C+McIntyre+RS%2C+Raskin+J%2C+McKay+G%2C+Baker+GB&amp;rft.au=Kennedy+SH%2C+McCann+SM%2C+Masellis+M%2C+McIntyre+RS%2C+Raskin+J%2C+McKay+G%2C+Baker+GB&amp;rft.date=2002&amp;rft.volume=63&amp;rft.issue=3&amp;rft.pages=181%E2%80%936&amp;rft_id=info:pmid/11926715&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-110"><b><a href="#cite_ref-110" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://ctr.gsk.co.uk/Summary/bupropion/I_031.pdf" class="external text" title="http://ctr.gsk.co.uk/Summary/bupropion/I_031.pdf" rel="nofollow">"P02-31UK I Examination of Bupropion and Ethanol, Alone and in Combination, on Human Performance Tests, Subjective Rating Scales, EEG and Autonomic Responses"</a> (PDF). <i>GlaxoSmithKline Clinical Trial Register. Bupropion Studies</i><span class="printonly">. <a href="http://ctr.gsk.co.uk/Summary/bupropion/I_031.pdf" class="external free" title="http://ctr.gsk.co.uk/Summary/bupropion/I_031.pdf" rel="nofollow">http://ctr.gsk.co.uk/Summary/bupropion/I_031.pdf</a></span><span class="reference-accessdate">. Retrieved on 2007-06-04</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=P02-31UK+I+Examination+of+Bupropion+and+Ethanol%2C+Alone+and+in+Combination%2C+on+Human+Performance+Tests%2C+Subjective+Rating+Scales%2C+EEG+and+Autonomic+Responses&amp;rft.atitle=GlaxoSmithKline+Clinical+Trial+Register.+Bupropion+Studies&amp;rft_id=http%3A%2F%2Fctr.gsk.co.uk%2FSummary%2Fbupropion%2FI_031.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-USPnews-111"><b><a href="#cite_ref-USPnews_111-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.usp.org/hqi/practitionerPrograms/newsletters/practitionerReportingNews/prn1202004-09-30.html#14" class="external text" title="http://www.usp.org/hqi/practitionerPrograms/newsletters/practitionerReportingNews/prn1202004-09-30.html#14" rel="nofollow">"Practitioner's Reporting News"</a>. <a href="/wiki/United_States_Pharmacopeia" title="United States Pharmacopeia">United States Pharmacopeia</a>. 2004-09-30<span class="printonly">. <a href="http://www.usp.org/hqi/practitionerPrograms/newsletters/practitionerReportingNews/prn1202004-09-30.html#14" class="external free" title="http://www.usp.org/hqi/practitionerPrograms/newsletters/practitionerReportingNews/prn1202004-09-30.html#14" rel="nofollow">http://www.usp.org/hqi/practitionerPrograms/newsletters/practitionerReportingNews/prn1202004-09-30.html#14</a></span><span class="reference-accessdate">. Retrieved on 2007-08-20</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Practitioner%27s+Reporting+News&amp;rft.atitle=&amp;rft.date=2004-09-30&amp;rft.pub=%5B%5BUnited+States+Pharmacopeia%5D%5D&amp;rft_id=http%3A%2F%2Fwww.usp.org%2Fhqi%2FpractitionerPrograms%2Fnewsletters%2FpractitionerReportingNews%2Fprn1202004-09-30.html%2314&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-112"><b><a href="#cite_ref-112" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRosack2006">Rosack, Jim (2006-03-17). "<a href="http://pn.psychiatryonline.org/cgi/content/full/41/6/16" class="external text" title="http://pn.psychiatryonline.org/cgi/content/full/41/6/16" rel="nofollow">Company Tries to Clear Up Confusion About Bupropion</a>". <i>Psychiatric News</i> (<a href="/wiki/American_Psychiatric_Association" title="American Psychiatric Association">American Psychiatric Association</a>) <b>41</b> (6): 16<span class="printonly">. <a href="http://pn.psychiatryonline.org/cgi/content/full/41/6/16" class="external free" title="http://pn.psychiatryonline.org/cgi/content/full/41/6/16" rel="nofollow">http://pn.psychiatryonline.org/cgi/content/full/41/6/16</a></span><span class="reference-accessdate">. Retrieved on 2007-08-20</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Company+Tries+to+Clear+Up+Confusion+About+Bupropion&amp;rft.jtitle=Psychiatric+News&amp;rft.aulast=Rosack&amp;rft.aufirst=Jim&amp;rft.au=Rosack%2C+Jim&amp;rft.date=2006-03-17&amp;rft.volume=41&amp;rft.issue=6&amp;rft.pages=16&amp;rft.pub=%5B%5BAmerican+Psychiatric+Association%5D%5D&amp;rft_id=http%3A%2F%2Fpn.psychiatryonline.org%2Fcgi%2Fcontent%2Ffull%2F41%2F6%2F16&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-113"><b><a href="#cite_ref-113" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.merck.com/mmpe/print/lexicomp/bupropion.html" class="external text" title="http://www.merck.com/mmpe/print/lexicomp/bupropion.html" rel="nofollow">"BuPROPion: Drug Information Provided by Lexi-Comp: Merck Manual Professional"</a><span class="printonly">. <a href="http://www.merck.com/mmpe/print/lexicomp/bupropion.html" class="external free" title="http://www.merck.com/mmpe/print/lexicomp/bupropion.html" rel="nofollow">http://www.merck.com/mmpe/print/lexicomp/bupropion.html</a></span><span class="reference-accessdate">. Retrieved on 2007-06-16</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=BuPROPion%3A+Drug+Information+Provided+by+Lexi-Comp%3A+Merck+Manual+Professional&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww.merck.com%2Fmmpe%2Fprint%2Flexicomp%2Fbupropion.html&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-114"><b><a href="#cite_ref-114" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFWaknine.2C_Yael2008">Waknine, Yael (2008-05-08). <a href="http://www.medscape.com/viewarticle/574187" class="external text" title="http://www.medscape.com/viewarticle/574187" rel="nofollow">"FDA Approvals: Advair, Relistor, Aplenzin"</a>. <a href="/wiki/Medscape" title="Medscape">Medscape</a><span class="printonly">. <a href="http://www.medscape.com/viewarticle/574187" class="external free" title="http://www.medscape.com/viewarticle/574187" rel="nofollow">http://www.medscape.com/viewarticle/574187</a></span><span class="reference-accessdate">. Retrieved on 2008-05-09</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=FDA+Approvals%3A+Advair%2C+Relistor%2C+Aplenzin&amp;rft.atitle=&amp;rft.aulast=Waknine%2C+Yael&amp;rft.au=Waknine%2C+Yael&amp;rft.date=2008-05-08&amp;rft.pub=%5B%5BMedscape%5D%5D&amp;rft_id=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F574187&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-peoples-115"><b><a href="#cite_ref-peoples_115-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.peoplespharmacy.com/archives/generic_drug_problems/generic_drug_equality_questioned.php" class="external text" title="http://www.peoplespharmacy.com/archives/generic_drug_problems/generic_drug_equality_questioned.php" rel="nofollow">"Generic Drug Equality Questioned"</a><span class="printonly">. <a href="http://www.peoplespharmacy.com/archives/generic_drug_problems/generic_drug_equality_questioned.php" class="external free" title="http://www.peoplespharmacy.com/archives/generic_drug_problems/generic_drug_equality_questioned.php" rel="nofollow">http://www.peoplespharmacy.com/archives/generic_drug_problems/generic_drug_equality_questioned.php</a></span><span class="reference-accessdate">. Retrieved on 2007-10-13</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Generic+Drug+Equality+Questioned&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww.peoplespharmacy.com%2Farchives%2Fgeneric_drug_problems%2Fgeneric_drug_equality_questioned.php&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-msnbc-116"><b><a href="#cite_ref-msnbc_116-0" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFJacqueline_Stenson2007">Jacqueline Stenson (2007-10-12). <a href="http://www.msnbc.msn.com/id/21142869/" class="external text" title="http://www.msnbc.msn.com/id/21142869/" rel="nofollow">"Report questions generic antidepressant - Health Care - MSNBC.com"</a>. MSNBC<span class="printonly">. <a href="http://www.msnbc.msn.com/id/21142869/" class="external free" title="http://www.msnbc.msn.com/id/21142869/" rel="nofollow">http://www.msnbc.msn.com/id/21142869/</a></span><span class="reference-accessdate">. Retrieved on 2007-10-13</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Report+questions+generic+antidepressant+-+Health+Care+-+MSNBC.com&amp;rft.atitle=&amp;rft.aulast=Jacqueline+Stenson&amp;rft.au=Jacqueline+Stenson&amp;rft.date=2007-10-12&amp;rft.pub=MSNBC&amp;rft_id=http%3A%2F%2Fwww.msnbc.msn.com%2Fid%2F21142869%2F&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-urlReview_of_Therapeutic_Equivalence:_Generic_Bupropion_XL_300_mg_and_Wellbutrin_XL_300_mg-117"><b><a href="#cite_ref-urlReview_of_Therapeutic_Equivalence:_Generic_Bupropion_XL_300_mg_and_Wellbutrin_XL_300_mg_117-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.fda.gov/cder/drug/infopage/bupropion/TE_review.htm" class="external text" title="http://www.fda.gov/cder/drug/infopage/bupropion/TE_review.htm" rel="nofollow">"Review of Therapeutic Equivalence: Generic Bupropion XL 300 mg and Wellbutrin XL 300 mg"</a><span class="printonly">. <a href="http://www.fda.gov/cder/drug/infopage/bupropion/TE_review.htm" class="external free" title="http://www.fda.gov/cder/drug/infopage/bupropion/TE_review.htm" rel="nofollow">http://www.fda.gov/cder/drug/infopage/bupropion/TE_review.htm</a></span><span class="reference-accessdate">. Retrieved on 2008-04-19</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Review+of+Therapeutic+Equivalence%3A+Generic+Bupropion+XL+300+mg+and+Wellbutrin+XL+300+mg&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fcder%2Fdrug%2Finfopage%2Fbupropion%2FTE_review.htm&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-118"><b><a href="#cite_ref-118" title="">^</a></b> <cite style="font-style:normal" class="press release" id="CITEREFAgence_fran.C3.A7aise_de_s.C3.A9curit.C3.A9_sanitaire_des_produits_de_sant.C3.A92001">Agence française de sécurité sanitaire des produits de santé (January 18, 2001) (in French). <i><a href="http://afssaps.sante.fr/htm/10/filcoprs/020102c.htm" class="external text" title="http://afssaps.sante.fr/htm/10/filcoprs/020102c.htm" rel="nofollow">ZYBAN&#160;: sevrage tabagique et sécurité d’emploi</a></i>. <a href="/wiki/News_release" title="News release">Press release</a><span class="printonly">. <a href="http://afssaps.sante.fr/htm/10/filcoprs/020102c.htm" class="external free" title="http://afssaps.sante.fr/htm/10/filcoprs/020102c.htm" rel="nofollow">http://afssaps.sante.fr/htm/10/filcoprs/020102c.htm</a></span><span class="reference-accessdate">. Retrieved on 2007-08-19</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=ZYBAN+%3A+sevrage+tabagique+et+s%C3%A9curit%C3%A9+d%E2%80%99emploi&amp;rft.aulast=Agence+fran%C3%A7aise+de+s%C3%A9curit%C3%A9+sanitaire+des+produits+de+sant%C3%A9&amp;rft.au=Agence+fran%C3%A7aise+de+s%C3%A9curit%C3%A9+sanitaire+des+produits+de+sant%C3%A9&amp;rft.date=January+18%2C+2001&amp;rft.series=%5B%5BNews+release%7CPress+release%5D%5D&amp;rft_id=http%3A%2F%2Fafssaps.sante.fr%2Fhtm%2F10%2Ffilcoprs%2F020102c.htm&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-119"><b><a href="#cite_ref-119" title="">^</a></b> <cite style="font-style:normal" class="press release" id="CITEREFGlaxoSmithKline2007">GlaxoSmithKline (2007-01-16). <i><a href="http://www.gsk.com/ControllerServlet?appId=4&amp;pageId=402&amp;newsid=956" class="external text" title="http://www.gsk.com/ControllerServlet?appId=4&amp;pageId=402&amp;newsid=956" rel="nofollow">GlaxoSmithKline receives first European approval for Wellbutrin XR</a></i>. <a href="/wiki/News_release" title="News release">Press release</a><span class="printonly">. <a href="http://www.gsk.com/ControllerServlet?appId=4&amp;pageId=402&amp;newsid=956" class="external free" title="http://www.gsk.com/ControllerServlet?appId=4&amp;pageId=402&amp;newsid=956" rel="nofollow">http://www.gsk.com/ControllerServlet?appId=4&amp;pageId=402&amp;newsid=956</a></span><span class="reference-accessdate">. Retrieved on 2007-08-19</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=GlaxoSmithKline+receives+first+European+approval+for+Wellbutrin+XR&amp;rft.aulast=GlaxoSmithKline&amp;rft.au=GlaxoSmithKline&amp;rft.date=2007-01-16&amp;rft.series=%5B%5BNews+release%7CPress+release%5D%5D&amp;rft_id=http%3A%2F%2Fwww.gsk.com%2FControllerServlet%3FappId%3D4%26pageId%3D402%26newsid%3D956&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-120"><b><a href="#cite_ref-120" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat5.table.36258" class="external text" title="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat5.table.36258" rel="nofollow">"Exhibit 4-3 Abuse Potential of Common Psychiatric Medications"</a>. <i>Health Services/Technology Assessment Text (HSTAT)</i>. U.S. <a href="/wiki/National_Library_of_Medicine" title="National Library of Medicine" class="mw-redirect">National Library of Medicine</a><span class="printonly">. <a href="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat5.table.36258" class="external free" title="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat5.table.36258" rel="nofollow">http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat5.table.36258</a></span><span class="reference-accessdate">. Retrieved on 2007-05-25</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Exhibit+4-3+Abuse+Potential+of+Common+Psychiatric+Medications&amp;rft.atitle=Health+Services%2FTechnology+Assessment+Text+%28HSTAT%29&amp;rft.pub=U.S.+%5B%5BNational+Library+of+Medicine%5D%5D&amp;rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2Fbv.fcgi%3Frid%3Dhstat5.table.36258&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-121"><b><a href="#cite_ref-121" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat5.table.67504" class="external text" title="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat5.table.67504" rel="nofollow">"Figure 3-4: Abuse Potential of Common Psychiatric Medications"</a>. <i>Health Services/Technology Assessment Text (HSTAT)</i>. U.S. <a href="/wiki/National_Library_of_Medicine" title="National Library of Medicine" class="mw-redirect">National Library of Medicine</a><span class="printonly">. <a href="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat5.table.67504" class="external free" title="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat5.table.67504" rel="nofollow">http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat5.table.67504</a></span><span class="reference-accessdate">. Retrieved on 2007-05-25</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Figure+3-4%3A+Abuse+Potential+of+Common+Psychiatric+Medications&amp;rft.atitle=Health+Services%2FTechnology+Assessment+Text+%28HSTAT%29&amp;rft.pub=U.S.+%5B%5BNational+Library+of+Medicine%5D%5D&amp;rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2Fbv.fcgi%3Frid%3Dhstat5.table.67504&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid2529365-122"><b><a href="#cite_ref-pmid2529365_122-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBergman_J.2C_Madras_BK.2C_Johnson_SE.2C_Spealman_RD1989">Bergman J, Madras BK, Johnson SE, Spealman RD (1989). "Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by <a href="/wiki/Squirrel_monkey" title="Squirrel monkey">squirrel monkeys</a>". <i>J. Pharmacol. Exp. Ther.</i> <b>251</b> (1): 150–5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2529365" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/2529365">PMID 2529365</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+cocaine+and+related+drugs+in+nonhuman+primates.+III.+Self-administration+by+%5B%5Bsquirrel+monkey%5D%5Ds&amp;rft.jtitle=J.+Pharmacol.+Exp.+Ther.&amp;rft.aulast=Bergman+J%2C+Madras+BK%2C+Johnson+SE%2C+Spealman+RD&amp;rft.au=Bergman+J%2C+Madras+BK%2C+Johnson+SE%2C+Spealman+RD&amp;rft.date=1989&amp;rft.volume=251&amp;rft.issue=1&amp;rft.pages=150%E2%80%935&amp;rft_id=info:pmid/2529365&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9103538-123"><b><a href="#cite_ref-pmid9103538_123-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTella_SR.2C_Ladenheim_B.2C_Cadet_JL1997">Tella SR, Ladenheim B, Cadet JL (1997). "Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine". <i>J Pharmacol Exp Ther</i> <b>281</b> (1): 508–13. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9103538" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9103538">PMID 9103538</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Differential+regulation+of+dopamine+transporter+after+chronic+self-administration+of+bupropion+and+nomifensine&amp;rft.jtitle=J+Pharmacol+Exp+Ther&amp;rft.aulast=Tella+SR%2C+Ladenheim+B%2C+Cadet+JL&amp;rft.au=Tella+SR%2C+Ladenheim+B%2C+Cadet+JL&amp;rft.date=1997&amp;rft.volume=281&amp;rft.issue=1&amp;rft.pages=508%E2%80%9313&amp;rft_id=info:pmid/9103538&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid6412263-124"><b><a href="#cite_ref-pmid6412263_124-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMiller_L.2C_Griffith_J1983">Miller L, Griffith J (1983). "A comparison of bupropion, dextroamphetamine, and placebo in mixed-substance abusers". <i>Psychopharmacology (Berl.)</i> <b>80</b> (3): 199–205. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2FBF00436152" class="external text" title="http://dx.doi.org/10.1007%2FBF00436152" rel="nofollow">10.1007/BF00436152</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/6412263" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/6412263">PMID 6412263</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+comparison+of+bupropion%2C+dextroamphetamine%2C+and+placebo+in+mixed-substance+abusers&amp;rft.jtitle=Psychopharmacology+%28Berl.%29&amp;rft.aulast=Miller+L%2C+Griffith+J&amp;rft.au=Miller+L%2C+Griffith+J&amp;rft.date=1983&amp;rft.volume=80&amp;rft.issue=3&amp;rft.pages=199%E2%80%93205&amp;rft_id=info:doi/10.1007%2FBF00436152&amp;rft_id=info:pmid/6412263&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid6406459-125"><b><a href="#cite_ref-pmid6406459_125-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGriffith_JD.2C_Carranza_J.2C_Griffith_C.2C_Miller_LL1983">Griffith JD, Carranza J, Griffith C, Miller LL (1983). "Bupropion: clinical assay for amphetamine-like abuse potential". <i>J Clin Psychiatry</i> <b>44</b> (5 Pt 2): 206–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/6406459" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/6406459">PMID 6406459</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion%3A+clinical+assay+for+amphetamine-like+abuse+potential&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Griffith+JD%2C+Carranza+J%2C+Griffith+C%2C+Miller+LL&amp;rft.au=Griffith+JD%2C+Carranza+J%2C+Griffith+C%2C+Miller+LL&amp;rft.date=1983&amp;rft.volume=44&amp;rft.issue=5+Pt+2&amp;rft.pages=206%E2%80%938&amp;rft_id=info:pmid/6406459&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9526144-126"><b><a href="#cite_ref-pmid9526144_126-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRush_CR.2C_Kollins_SH.2C_Pazzaglia_PJ1998">Rush CR, Kollins SH, Pazzaglia PJ (1998). "Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans". <i>Experimental and clinical psychopharmacology</i> <b>6</b> (1): 32–44. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1037%2F1064-1297.6.1.32" class="external text" title="http://dx.doi.org/10.1037%2F1064-1297.6.1.32" rel="nofollow">10.1037/1064-1297.6.1.32</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9526144" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9526144">PMID 9526144</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Discriminative-stimulus+and+participant-rated+effects+of+methylphenidate%2C+bupropion%2C+and+triazolam+in+d-amphetamine-trained+humans&amp;rft.jtitle=Experimental+and+clinical+psychopharmacology&amp;rft.aulast=Rush+CR%2C+Kollins+SH%2C+Pazzaglia+PJ&amp;rft.au=Rush+CR%2C+Kollins+SH%2C+Pazzaglia+PJ&amp;rft.date=1998&amp;rft.volume=6&amp;rft.issue=1&amp;rft.pages=32%E2%80%9344&amp;rft_id=info:doi/10.1037%2F1064-1297.6.1.32&amp;rft_id=info:pmid/9526144&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15001822-127"><b><a href="#cite_ref-pmid15001822_127-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFZernig_G.2C_De_Wit_H.2C_Telser_S.2C_.27.27et_al.27.272004">Zernig G, De Wit H, Telser S, <i>et al</i> (2004). "Subjective effects of slow-release bupropion versus caffeine as determined in a quasi-naturalistic setting". <i>Pharmacology</i> <b>70</b> (4): 206–15. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1159%2F000075550" class="external text" title="http://dx.doi.org/10.1159%2F000075550" rel="nofollow">10.1159/000075550</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15001822" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15001822">PMID 15001822</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Subjective+effects+of+slow-release+bupropion+versus+caffeine+as+determined+in+a+quasi-naturalistic+setting&amp;rft.jtitle=Pharmacology&amp;rft.aulast=Zernig+G%2C+De+Wit+H%2C+Telser+S%2C+%27%27et+al%27%27&amp;rft.au=Zernig+G%2C+De+Wit+H%2C+Telser+S%2C+%27%27et+al%27%27&amp;rft.date=2004&amp;rft.volume=70&amp;rft.issue=4&amp;rft.pages=206%E2%80%9315&amp;rft_id=info:doi/10.1159%2F000075550&amp;rft_id=info:pmid/15001822&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-128"><b><a href="#cite_ref-128" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKhurshid_KA.2C_Decker_DH2004">Khurshid KA, Decker DH (2004). "Bupropion insufflation in a teenager". <i>J Child Adolesc Psychopharmacol</i> <b>14</b> (1): 157–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1089%2F104454604773840634" class="external text" title="http://dx.doi.org/10.1089%2F104454604773840634" rel="nofollow">10.1089/104454604773840634</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15142406" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15142406">PMID 15142406</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bupropion+insufflation+in+a+teenager&amp;rft.jtitle=J+Child+Adolesc+Psychopharmacol&amp;rft.aulast=Khurshid+KA%2C+Decker+DH&amp;rft.au=Khurshid+KA%2C+Decker+DH&amp;rft.date=2004&amp;rft.volume=14&amp;rft.issue=1&amp;rft.pages=157%E2%80%938&amp;rft_id=info:doi/10.1089%2F104454604773840634&amp;rft_id=info:pmid/15142406&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-129"><b><a href="#cite_ref-129" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLu_JJ.2C_Thompson_TM.2C_Narunatvanich_D.2C_Fischbein_CB.2C_Mycyk_MB2007">Lu JJ, Thompson TM, Narunatvanich D, Fischbein CB, Mycyk MB (2007). "Seizure after Nasal Insufflation of Bupropion [abstract]". <i>Clin Toxicol (Phila)</i> <b>45</b>: 632.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Seizure+after+Nasal+Insufflation+of+Bupropion+%5Babstract%5D&amp;rft.jtitle=Clin+Toxicol+%28Phila%29&amp;rft.aulast=Lu+JJ%2C+Thompson+TM%2C+Narunatvanich+D%2C+Fischbein+CB%2C+Mycyk+MB&amp;rft.au=Lu+JJ%2C+Thompson+TM%2C+Narunatvanich+D%2C+Fischbein+CB%2C+Mycyk+MB&amp;rft.date=2007&amp;rft.volume=45&amp;rft.pages=632&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-130"><b><a href="#cite_ref-130" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWelsh_CJ.2C_Doyon_S2002">Welsh CJ, Doyon S (2002). "Seizure induced by insufflation of bupropion". <i>N. Engl. J. Med.</i> <b>347</b> (12): 951. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJM200209193471222" class="external text" title="http://dx.doi.org/10.1056%2FNEJM200209193471222" rel="nofollow">10.1056/NEJM200209193471222</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12239274" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12239274">PMID 12239274</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Seizure+induced+by+insufflation+of+bupropion&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Welsh+CJ%2C+Doyon+S&amp;rft.au=Welsh+CJ%2C+Doyon+S&amp;rft.date=2002&amp;rft.volume=347&amp;rft.issue=12&amp;rft.pages=951&amp;rft_id=info:doi/10.1056%2FNEJM200209193471222&amp;rft_id=info:pmid/12239274&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-131"><b><a href="#cite_ref-131" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMcCormick_J2002">McCormick J (2002). "Recreational bupropion abuse in a teenager". <i>Br J Clin Pharmacol</i> <b>53</b> (2): 214. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1046%2Fj.0306-5251.2001.01538.x" class="external text" title="http://dx.doi.org/10.1046%2Fj.0306-5251.2001.01538.x" rel="nofollow">10.1046/j.0306-5251.2001.01538.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11851650" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11851650">PMID 11851650</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Recreational+bupropion+abuse+in+a+teenager&amp;rft.jtitle=Br+J+Clin+Pharmacol&amp;rft.aulast=McCormick+J&amp;rft.au=McCormick+J&amp;rft.date=2002&amp;rft.volume=53&amp;rft.issue=2&amp;rft.pages=214&amp;rft_id=info:doi/10.1046%2Fj.0306-5251.2001.01538.x&amp;rft_id=info:pmid/11851650&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-132"><b><a href="#cite_ref-132" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFVolpe_KD">Volpe KD. <a href="http://www.cnsnewsonline.com/index.asp?section_id=113&amp;show=dept&amp;article_id=4907" class="external text" title="http://www.cnsnewsonline.com/index.asp?section_id=113&amp;show=dept&amp;article_id=4907" rel="nofollow">"Intervention Reduces Psychotropic Abuse in Correctional Facility; CNS News, JUNE 2005, VOLUME: 07:06"</a><span class="printonly">. <a href="http://www.cnsnewsonline.com/index.asp?section_id=113&amp;show=dept&amp;article_id=4907" class="external free" title="http://www.cnsnewsonline.com/index.asp?section_id=113&amp;show=dept&amp;article_id=4907" rel="nofollow">http://www.cnsnewsonline.com/index.asp?section_id=113&amp;show=dept&amp;article_id=4907</a></span><span class="reference-accessdate">. Retrieved on 2007-05-27</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Intervention+Reduces+Psychotropic+Abuse+in+Correctional+Facility%3B+CNS+News%2C+JUNE+2005%2C+VOLUME%3A+07%3A06&amp;rft.atitle=&amp;rft.aulast=Volpe+KD&amp;rft.au=Volpe+KD&amp;rft_id=http%3A%2F%2Fwww.cnsnewsonline.com%2Findex.asp%3Fsection_id%3D113%26show%3Ddept%26article_id%3D4907&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-133"><b><a href="#cite_ref-133" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDaniel_M._Perrine.2C_Jason_T._Ross.2C_Stephen_J._Nervi.2C_and_Richard_H._Zimmerman2000">Daniel M. Perrine, Jason T. Ross, Stephen J. Nervi, and Richard H. Zimmerman (2000). "<a href="http://jchemed.chem.wisc.edu/Journal/Issues/2000/nov/PlusSub/V77N11/p1479.pdf" class="external text" title="http://jchemed.chem.wisc.edu/Journal/Issues/2000/nov/PlusSub/V77N11/p1479.pdf" rel="nofollow">A Short, One-Pot Synthesis of Bupropion</a>". <i><a href="/wiki/J._Chem._Ed." title="J. Chem. Ed." class="mw-redirect">J. Chem. Ed.</a></i> <b>77</b> (11): 1479<span class="printonly">. <a href="http://jchemed.chem.wisc.edu/Journal/Issues/2000/nov/PlusSub/V77N11/p1479.pdf" class="external free" title="http://jchemed.chem.wisc.edu/Journal/Issues/2000/nov/PlusSub/V77N11/p1479.pdf" rel="nofollow">http://jchemed.chem.wisc.edu/Journal/Issues/2000/nov/PlusSub/V77N11/p1479.pdf</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+Short%2C+One-Pot+Synthesis+of+Bupropion&amp;rft.jtitle=%5B%5BJ.+Chem.+Ed.%5D%5D&amp;rft.aulast=Daniel+M.+Perrine%2C+Jason+T.+Ross%2C+Stephen+J.+Nervi%2C+and+Richard+H.+Zimmerman&amp;rft.au=Daniel+M.+Perrine%2C+Jason+T.+Ross%2C+Stephen+J.+Nervi%2C+and+Richard+H.+Zimmerman&amp;rft.date=2000&amp;rft.volume=77&amp;rft.issue=11&amp;rft.pages=1479&amp;rft_id=http%3A%2F%2Fjchemed.chem.wisc.edu%2FJournal%2FIssues%2F2000%2Fnov%2FPlusSub%2FV77N11%2Fp1479.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Bupropion"><span style="display: none;">&#160;</span></span></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Bupropion&amp;action=edit&amp;section=20" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<div class="noprint tright portal" style="border:solid #aaa 1px;margin:0.5em 0 0.5em 0.5em;">
<table style="background:#f9f9f9; font-size:85%; line-height:110%;">
<tr>
<td><a href="/wiki/File:Tabletten.JPG" class="image" title="Tabletten.JPG"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/5/5f/Tabletten.JPG/32px-Tabletten.JPG" width="32" height="26" border="0" /></a></td>
<td style="padding:0 0.2em;"><i><b><a href="/wiki/Portal:Pharmacy_and_Pharmacology" title="Portal:Pharmacy and Pharmacology">Pharmacy and Pharmacology portal</a></b></i></td>
</tr>
</table>
</div>
<ul>
<li><a href="http://www.wellbutrin-xl.com" class="external text" title="http://www.wellbutrin-xl.com" rel="nofollow">Wellbutrin official website</a></li>
<li><a href="http://www.merck.com/mmpe/lexicomp/bupropion.html" class="external text" title="http://www.merck.com/mmpe/lexicomp/bupropion.html" rel="nofollow">List of international brand names for bupropion</a></li>
<li><a href="http://www.dmoz.org/Health/Pharmacy/Drugs_and_Medications/B/Bupropion//" class="external text" title="http://www.dmoz.org/Health/Pharmacy/Drugs_and_Medications/B/Bupropion//" rel="nofollow">Bupropion</a> at the <a href="/wiki/Open_Directory_Project" title="Open Directory Project">Open Directory Project</a></li>
<li><a href="http://www.rxlist.com/cgi/generic/buprop_cp.htm" class="external text" title="http://www.rxlist.com/cgi/generic/buprop_cp.htm" rel="nofollow">Wellbutrin Pharmacology, Pharmacokinetics, Studies, Metabolism - Bupropion - RxList Monographs</a></li>
<li><a href="http://www.nami.org/Template.cfm?Section=About_Medications&amp;template=/ContentManagement/ContentDisplay.cfm&amp;ContentID=7388" class="external text" title="http://www.nami.org/Template.cfm?Section=About_Medications&amp;template=/ContentManagement/ContentDisplay.cfm&amp;ContentID=7388" rel="nofollow">NAMI Wellbutrin</a></li>
<li><a href="http://www.mentalhealth.com/drug/p30-b04.html" class="external text" title="http://www.mentalhealth.com/drug/p30-b04.html" rel="nofollow">Bupropion article from mentalhealth.com</a></li>
</ul>
<p><br clear="all" /></p>
<div style="right:10px; display:none;" class="metadata topicon" id="featured-star">
<div><a href="/wiki/Wikipedia:Featured_articles" title="This is a featured article. Click here for more information."><img alt="Featured article" src="http://upload.wikimedia.org/wikipedia/en/6/60/LinkFA-star.png" width="14" height="14" border="0" /></a></div>
</div>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible collapsed" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;;border:none;; font-size:xx-small;"><a href="/wiki/Template:Stimulants" title="Template:Stimulants"><span title="View this template" style=";;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Stimulants" title="Template talk:Stimulants"><span title="Discussion about this template" style=";;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Stimulants&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Stimulants&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Stimulant" title="Stimulant">Stimulants</a></span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">Alkylamines</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Cyclopentamine" title="Cyclopentamine">Cyclopentamine</a>&#160;• <a href="/wiki/Geranamine" title="Geranamine">Geranamine</a>&#160;• <a href="/wiki/Heptaminol" title="Heptaminol">Heptaminol</a>&#160;• <a href="/wiki/Isometheptene" title="Isometheptene">Isometheptene</a>&#160;• <a href="/wiki/Octodrine" title="Octodrine">Octodrine</a>&#160;• <a href="/wiki/Propylhexedrine" title="Propylhexedrine">Propylhexedrine</a>&#160;• <a href="/wiki/Tuaminoheptane" title="Tuaminoheptane">Tuaminoheptane (Tuamine)</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">Pyrrolidinophenones</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em">
<div>
<p><a href="/wiki/Alpha-Pyrrolidinopropiophenone" title="Alpha-Pyrrolidinopropiophenone">α-PPP</a>&#160;• <a href="/wiki/3%27,4%27-Methylenedioxy-%CE%B1-pyrrolidinopropiophenone" title="3',4'-Methylenedioxy-α-pyrrolidinopropiophenone">MDPPP</a>&#160;• <a href="/wiki/MDPV" title="MDPV">MDPV</a>&#160;• <a href="/w/index.php?title=4%27-Methyl-%CE%B1-pyrrolidinobutiophenone&amp;action=edit&amp;redlink=1" class="new" title="4'-Methyl-α-pyrrolidinobutiophenone (page does not exist)">MPBP</a>&#160;• <a href="/w/index.php?title=4%27-Methyl-%CE%B1-pyrrolidinohexiophenone&amp;action=edit&amp;redlink=1" class="new" title="4'-Methyl-α-pyrrolidinohexiophenone (page does not exist)">MPHP</a>&#160;• <a href="/wiki/4%27-Methyl-%CE%B1-pyrrolidinopropiophenone" title="4'-Methyl-α-pyrrolidinopropiophenone">MPPP</a>&#160;• <a href="/wiki/4%27-Methoxy-%CE%B1-pyrrolidinopropiophenone" title="4'-Methoxy-α-pyrrolidinopropiophenone">MOPPP</a>&#160;• <a href="/wiki/Pyrovalerone" title="Pyrovalerone">Pyrovalerone</a></p>
</div>
</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Acetylcholine" title="Acetylcholine">Cholinergics</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em">
<div>
<p><a href="/wiki/ABT-089" title="ABT-089">ABT-089</a>&#160;• <a href="/wiki/ABT-418" title="ABT-418">ABT-418</a>&#160;• <a href="/wiki/Anabasine" title="Anabasine">Anabasine</a>&#160;• <a href="/wiki/Arecoline" title="Arecoline">Arecoline</a>&#160;• <a href="/wiki/Cotinine" title="Cotinine">Cotinine</a>&#160;• <a href="/wiki/Cytisine" title="Cytisine">Cytisine</a>&#160;• <a href="/wiki/Dianicline" title="Dianicline">Dianicline</a>&#160;• <a href="/wiki/Epibatidine" title="Epibatidine">Epibatidine</a>&#160;• <a href="/wiki/Epiboxidine" title="Epiboxidine">Epiboxidine</a>&#160;• <a href="/wiki/GTS-21" title="GTS-21">GTS-21</a>&#160;• <a href="/wiki/Ispronicline" title="Ispronicline">Ispronicline</a>&#160;• <a href="/wiki/Nicotine" title="Nicotine">Nicotine</a>&#160;• <a href="/wiki/Rivanicline" title="Rivanicline">Rivanicline</a>&#160;• <a href="/wiki/TC-5619" title="TC-5619">TC-5619</a>&#160;• <a href="/wiki/Tebanicline" title="Tebanicline">Tebanicline</a>&#160;• <a href="/wiki/Varenicline" title="Varenicline">Varenicline</a></p>
</div>
</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Convulsion" title="Convulsion">Convulsants</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Bicuculline" title="Bicuculline">Bicuculline</a>&#160;• <a href="/wiki/DMCM" title="DMCM">DMCM</a>&#160;• <a href="/wiki/Flurothyl" title="Flurothyl">Flurothyl</a>&#160;• <a href="/wiki/Gabazine" title="Gabazine">Gabazine</a>&#160;• <a href="/wiki/Pentylenetetrazol" title="Pentylenetetrazol">Pentetrazol</a>&#160;• <a href="/wiki/Picrotoxin" title="Picrotoxin">Picrotoxin</a>&#160;• <a href="/wiki/Strychnine" title="Strychnine">Strychnine</a>&#160;• <a href="/wiki/Thujone" title="Thujone">Thujone</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">Eugeroics</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Adrafinil" title="Adrafinil">Adrafinil</a>&#160;• <a href="/wiki/Armodafinil" title="Armodafinil">Armodafinil</a>&#160;• <a href="/wiki/Phenylpiracetam" title="Phenylpiracetam">Carphedon</a>&#160;• <a href="/wiki/Modafinil" title="Modafinil">Modafinil</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Phenethylamine" title="Phenethylamine">Phenethylamines</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em">
<div>
<p><a href="/w/index.php?title=1-Phenyl-2-methylaminobutan-1-one&amp;action=edit&amp;redlink=1" class="new" title="1-Phenyl-2-methylaminobutan-1-one (page does not exist)">1-Phenyl-2-methylaminobutan-1-one</a>&#160;• <a href="/w/index.php?title=2-Phenyl-3-aminobutane&amp;action=edit&amp;redlink=1" class="new" title="2-Phenyl-3-aminobutane (page does not exist)">2-Phenyl-3-aminobutane</a>&#160;• <a href="/w/index.php?title=2-Phenyl-3-methylaminobutane&amp;action=edit&amp;redlink=1" class="new" title="2-Phenyl-3-methylaminobutane (page does not exist)">2-Phenyl-3-methylaminobutane</a>&#160;• <a href="/wiki/4-Bromomethcathinone" title="4-Bromomethcathinone">4-Bromomethcathinone</a>&#160;• <a href="/wiki/4-Fluoroamphetamine" title="4-Fluoroamphetamine">4-FA</a>&#160;• <a href="/wiki/4-Fluoromethamphetamine" title="4-Fluoromethamphetamine">4-Fluoromethamphetamine</a>&#160;• <a href="/wiki/4-Fluoromethcathinone" title="4-Fluoromethcathinone">4-Fluoromethcathinone</a>&#160;• <a href="/w/index.php?title=4-Ethylamphetamine&amp;action=edit&amp;redlink=1" class="new" title="4-Ethylamphetamine (page does not exist)">4-Ethylamphetamine</a>&#160;• <a href="/w/index.php?title=4-Hydroxyephedrine&amp;action=edit&amp;redlink=1" class="new" title="4-Hydroxyephedrine (page does not exist)">4-Hydroxyephedrine (Oxilofrine)</a>&#160;• <a href="/w/index.php?title=4-Methylamphetamine&amp;action=edit&amp;redlink=1" class="new" title="4-Methylamphetamine (page does not exist)">4-Methylamphetamine</a>&#160;• <a href="/w/index.php?title=4-Methylmethamphetamine&amp;action=edit&amp;redlink=1" class="new" title="4-Methylmethamphetamine (page does not exist)">4-Methylmethamphetamine</a>&#160;• <a href="/wiki/4-Methylmethcathinone" title="4-Methylmethcathinone">Mephedrone (4-MMC)</a>&#160;• <a href="/wiki/4-Methylthioamphetamine" title="4-Methylthioamphetamine">4-MTA</a>&#160;• <a href="/wiki/Alfetamine" title="Alfetamine">Alfetamine</a>&#160;• <a href="/w/index.php?title=Alpha-ethyl-phenethylamine&amp;action=edit&amp;redlink=1" class="new" title="Alpha-ethyl-phenethylamine (page does not exist)">Alpha-ethyl-phenethylamine</a>&#160;• <a href="/wiki/Amfepentorex" title="Amfepentorex">Amfepentorex</a>&#160;• <a href="/w/index.php?title=Amphechloral&amp;action=edit&amp;redlink=1" class="new" title="Amphechloral (page does not exist)">Amphechloral</a>&#160;• <a href="/wiki/Amphetamine" title="Amphetamine">Amphetamine</a> (<a href="/wiki/Dextroamphetamine" title="Dextroamphetamine">Dextroamphetamine</a>, <a href="/wiki/Adderall" title="Adderall">Adderall</a>)&#160;• <a href="/wiki/Amphetaminil" title="Amphetaminil">Amphetaminil</a>&#160;• <a href="/wiki/Benfluorex" title="Benfluorex">Benfluorex</a>&#160;• <a href="/wiki/Benzphetamine" title="Benzphetamine">Benzphetamine</a>&#160;• <a href="/wiki/Beta-Methylphenethylamine" title="Beta-Methylphenethylamine">β-Methylphenethylamine</a>&#160;• <strong class="selflink">Bupropion</strong>&#160;• <a href="/wiki/Cathinone" title="Cathinone">Cathinone</a>&#160;• <a href="/wiki/Chlorphentermine" title="Chlorphentermine">Chlorphentermine</a>&#160;• <a href="/wiki/Clenbuterol" title="Clenbuterol">Clenbuterol</a>&#160;• <a href="/wiki/Clobenzorex" title="Clobenzorex">Clobenzorex</a>&#160;• <a href="/wiki/Clortermine" title="Clortermine">Clortermine</a>&#160;• <a href="/wiki/Diethylcathinone" title="Diethylcathinone">Diethylcathinone (Diethylpropion)</a>&#160;• <a href="/wiki/Dimethoxyamphetamine" title="Dimethoxyamphetamine">Dimethoxyamphetamine</a>&#160;• <a href="/wiki/Dimethylamphetamine" title="Dimethylamphetamine">Dimethylamphetamine</a>&#160;• <a href="/wiki/Dimethylcathinone" title="Dimethylcathinone">Dimethylcathinone</a>&#160;• <a href="/wiki/Ephedrine" title="Ephedrine">Ephedrine</a>&#160;• <a href="/wiki/Epinephrine" title="Epinephrine">Epinephrine</a>&#160;• <a href="/wiki/Ethcathinone" title="Ethcathinone">Ethcathinone</a>&#160;• <a href="/wiki/Ethylamphetamine" title="Ethylamphetamine">Ethylamphetamine</a>&#160;• <a href="/w/index.php?title=Fenbutrazate&amp;action=edit&amp;redlink=1" class="new" title="Fenbutrazate (page does not exist)">Fenbutrazate</a>&#160;• <a href="/w/index.php?title=Fencamine&amp;action=edit&amp;redlink=1" class="new" title="Fencamine (page does not exist)">Fencamine</a>&#160;• <a href="/wiki/Fenethylline" title="Fenethylline">Fenethylline</a>&#160;• <a href="/wiki/Fenfluramine" title="Fenfluramine">Fenfluramine</a>&#160;• <a href="/wiki/Fenproporex" title="Fenproporex">Fenproporex</a>&#160;• <a href="/wiki/Fludorex" title="Fludorex">Fludorex</a>&#160;• <a href="/wiki/Furfenorex" title="Furfenorex">Furfenorex</a>&#160;• <a href="/wiki/Levomethamphetamine" title="Levomethamphetamine">Levomethamphetamine</a>&#160;• <a href="/wiki/Lisdexamfetamine" title="Lisdexamfetamine">Lisdexamfetamine</a>&#160;• <a href="/wiki/Methylenedioxymethamphetamine" title="Methylenedioxymethamphetamine">MDMA (Ecstasy)</a>&#160;• <a href="/wiki/Mefenorex" title="Mefenorex">Mefenorex</a>&#160;• <a href="/wiki/Mephentermine" title="Mephentermine">Mephentermine</a>&#160;• <a href="/wiki/Methamphetamine" title="Methamphetamine">Methamphetamine</a>&#160;• <a href="/wiki/Methcathinone" title="Methcathinone">Methcathinone</a>&#160;• <a href="/wiki/Methoxyphedrine" title="Methoxyphedrine">Methoxyphedrine</a>&#160;• <a href="/wiki/Methoxyphenamine" title="Methoxyphenamine">Methoxyphenamine</a>&#160;• <a href="/wiki/Methylenedioxymethcathinone" title="Methylenedioxymethcathinone">Methylone</a>&#160;• <a href="/wiki/Norfenefrine" title="Norfenefrine">Norfenefrine</a>&#160;• <a href="/wiki/Octopamine" title="Octopamine">Octopamine</a>&#160;• <a href="/w/index.php?title=Ortetamine&amp;action=edit&amp;redlink=1" class="new" title="Ortetamine (page does not exist)">Ortetamine</a>&#160;• <a href="/wiki/Parahydroxyamphetamine" title="Parahydroxyamphetamine">Parahydroxyamphetamine</a>&#160;• <a href="/wiki/Parachloroamphetamine" title="Parachloroamphetamine">PCA</a>&#160;• <a href="/w/index.php?title=Paraiodoamphetamine&amp;action=edit&amp;redlink=1" class="new" title="Paraiodoamphetamine (page does not exist)">PIA</a>&#160;• <a href="/wiki/PMA" title="PMA">PMA</a>&#160;• <a href="/wiki/Paramethoxyethylamphetamine" title="Paramethoxyethylamphetamine">PMEA</a>&#160;• <a href="/wiki/Paramethoxymethamphetamine" title="Paramethoxymethamphetamine">PMMA</a>&#160;• <a href="/wiki/(-)-1-Phenyl-2-propylaminopentane" title="(-)-1-Phenyl-2-propylaminopentane">PPAP</a>&#160;• <a href="/wiki/Phendimetrazine" title="Phendimetrazine">Phendimetrazine</a>&#160;• <a href="/wiki/Phenmetrazine" title="Phenmetrazine">Phenmetrazine</a>&#160;• <a href="/wiki/Phenpentermine" title="Phenpentermine">Phenpentermine</a>&#160;• <a href="/wiki/Phenpromethamine" title="Phenpromethamine">Phenpromethamine</a>&#160;• <a href="/wiki/Phentermine" title="Phentermine">Phentermine</a>&#160;• <a href="/wiki/Phenylephrine" title="Phenylephrine">Phenylephrine</a>&#160;• <a href="/wiki/Phenylpropanolamine" title="Phenylpropanolamine">Phenylpropanolamine</a>&#160;• <a href="/wiki/Propylamphetamine" title="Propylamphetamine">Propylamphetamine</a>&#160;• <a href="/wiki/Pseudoephedrine" title="Pseudoephedrine">Pseudoephedrine</a>&#160;• <a href="/wiki/Selegiline" title="Selegiline">Selegiline</a>&#160;• <a href="/wiki/Synephrine" title="Synephrine">Synephrine</a>&#160;• <a href="/wiki/Tiflorex" title="Tiflorex">Tiflorex</a>&#160;• <a href="/wiki/3,4-Dimethylamphetamine" title="3,4-Dimethylamphetamine">Xylopropamine</a></p>
</div>
</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">Phenylaminooxazoles</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em">
<div>
<p><a href="/wiki/4-Methyl-aminorex" title="4-Methyl-aminorex">4-Methyl-aminorex</a>&#160;• <a href="/wiki/Aminorex" title="Aminorex">Aminorex</a>&#160;• <a href="/wiki/Clominorex" title="Clominorex">Clominorex</a>&#160;• <a href="/wiki/Cyclazodone" title="Cyclazodone">Cyclazodone</a>&#160;• <a href="/wiki/Fenozolone" title="Fenozolone">Fenozolone</a>&#160;• <a href="/wiki/Fluminorex" title="Fluminorex">Fluminorex</a>&#160;• <a href="/wiki/Pemoline" title="Pemoline">Pemoline</a>&#160;• <a href="/wiki/Thozalinone" title="Thozalinone">Thozalinone</a></p>
</div>
</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Piperazine" title="Piperazine">Piperazines</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em">
<div>
<p><a href="/wiki/2C-B-BZP" title="2C-B-BZP">2C-B-BZP</a>&#160;• <a href="/wiki/Benzylpiperazine" title="Benzylpiperazine">BZP</a>&#160;• <a href="/w/index.php?title=GBR-12783&amp;action=edit&amp;redlink=1" class="new" title="GBR-12783 (page does not exist)">GBR-12783</a>&#160;• <a href="/wiki/GBR-12935" title="GBR-12935">GBR-12935</a>&#160;• <a href="/w/index.php?title=GBR-13069&amp;action=edit&amp;redlink=1" class="new" title="GBR-13069 (page does not exist)">GBR-13069</a>&#160;• <a href="/w/index.php?title=GBR-13098&amp;action=edit&amp;redlink=1" class="new" title="GBR-13098 (page does not exist)">GBR-13098</a>&#160;• <a href="/w/index.php?title=GBR-13119&amp;action=edit&amp;redlink=1" class="new" title="GBR-13119 (page does not exist)">GBR-13119</a>&#160;• <a href="/wiki/MeOPP" title="MeOPP">MeOPP</a>&#160;• <a href="/wiki/1-Methyl-4-benzylpiperazine" title="1-Methyl-4-benzylpiperazine">MBZP</a>&#160;• <a href="/wiki/Vanoxerine" title="Vanoxerine">Vanoxerine</a></p>
</div>
</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Piperidine" title="Piperidine">Piperidines</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em">
<div>
<p><a href="/wiki/2-Benzylpiperidine" title="2-Benzylpiperidine">2-Benzylpiperidine</a>&#160;• <a href="/w/index.php?title=4-Benzylpiperidine&amp;action=edit&amp;redlink=1" class="new" title="4-Benzylpiperidine (page does not exist)">4-Benzylpiperidine</a>&#160;• <a href="/wiki/Desoxypipradrol" title="Desoxypipradrol">Desoxypipradrol</a>&#160;• <a href="/wiki/Diphemethoxidine" title="Diphemethoxidine">Diphemethoxidine</a>&#160;• <a href="/wiki/Ethylphenidate" title="Ethylphenidate">Ethylphenidate</a>&#160;• <a href="/wiki/HDMP-28" title="HDMP-28">HDMP-28</a>&#160;• <a href="/wiki/(-)-Methyl-1-methyl-4%CE%B2-(2-naphthyl)piperidine-3%CE%B2-carboxylate" title="(-)-Methyl-1-methyl-4β-(2-naphthyl)piperidine-3β-carboxylate">(-)-Methyl-1-methyl-4β-(2-naphthyl)piperidine-3β-carboxylate</a>&#160;• <a href="/wiki/Methylphenidate" title="Methylphenidate">Methylphenidate</a> (<a href="/wiki/Dexmethylphenidate" title="Dexmethylphenidate">Dexmethylphenidate</a>)&#160;• <a href="/wiki/Nocaine" title="Nocaine">Nocaine</a>&#160;• <a href="/wiki/Phacetoperane" title="Phacetoperane">Phacetoperane (Levofacetoperane)</a>&#160;• <a href="/wiki/Pipradrol" title="Pipradrol">Pipradrol (Meretran)</a></p>
</div>
</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Tropane" title="Tropane">Tropanes</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em">
<div>
<p><a href="/w/index.php?title=3%CE%B1-Bis-(4-fluorophenyl)methoxytropane&amp;action=edit&amp;redlink=1" class="new" title="3α-Bis-(4-fluorophenyl)methoxytropane (page does not exist)">3α-Bis-(4-fluorophenyl)methoxytropane</a>&#160;• <a href="/w/index.php?title=3%CE%B1-((4-Chlorophenyl)phenylmethoxy)tropane&amp;action=edit&amp;redlink=1" class="new" title="3α-((4-Chlorophenyl)phenylmethoxy)tropane (page does not exist)">3α-((4-Chlorophenyl)phenylmethoxy)tropane</a>&#160;• <a href="/wiki/3-(p-Fluorobenzoyloxy)tropane" title="3-(p-Fluorobenzoyloxy)tropane">3-Pseudotropyl-4-fluorobenzoate</a>&#160;• <a href="/wiki/Altropane" title="Altropane">Altropane (IACFT)</a>&#160;• <a href="/wiki/Brasofensine" title="Brasofensine">Brasofensine</a>&#160;• <a href="/wiki/(-)-2%CE%B2-Carbomethoxy-3%CE%B2-(4-fluorophenyl)tropane" title="(-)-2β-Carbomethoxy-3β-(4-fluorophenyl)tropane">CFT (WIN 35,428)</a>&#160;• <a href="/wiki/(-)-2%CE%B2-Carbomethoxy-3%CE%B2-(4-iodophenyl)tropane" title="(-)-2β-Carbomethoxy-3β-(4-iodophenyl)tropane">β-CIT (RTI-55)</a>&#160;• <a href="/wiki/Cocaethylene" title="Cocaethylene">Cocaethylene</a>&#160;• <a href="/wiki/Cocaine" title="Cocaine">Cocaine</a>&#160;• <a href="/wiki/3%CE%B2-(4%27-Chlorophenyl)-2%CE%B2-(3%27-phenylisoxazol-5%27-yl)tropane" title="3β-(4'-Chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)tropane">β-CPPIT</a>&#160;• <a href="/wiki/Dichloropane" title="Dichloropane">Dichloropane (RTI-111)</a>&#160;• <a href="/wiki/Difluoropine" title="Difluoropine">Difluoropine</a>&#160;• <a href="/wiki/N-(2%27-Fluoroethyl-)-3%CE%B2-(4%27-chlorophenyl)-2%CE%B2-(3%27-phenylisoxazol-5%27-yl)nortropane" title="N-(2'-Fluoroethyl-)-3β-(4'-chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)nortropane">FE-β-CPPIT</a>&#160;• <a href="/wiki/N-(3%27-Fluoropropyl-)-3%CE%B2-(4%27-chlorophenyl)-2%CE%B2-(3%27-phenylisoxazol-5%27-yl)nortropane" title="N-(3'-Fluoropropyl-)-3β-(4'-chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)nortropane">FP-β-CPPIT</a>&#160;• <a href="/wiki/Ioflupane_(%C2%B9%C2%B2%C2%B3I)" title="Ioflupane (¹²³I)">Ioflupane (FPCIT)</a>&#160;• <a href="/wiki/Norcocaine" title="Norcocaine">Norcocaine</a>&#160;• <a href="/wiki/2-Propanoyl-3-(4-isopropylphenyl)-tropane" title="2-Propanoyl-3-(4-isopropylphenyl)-tropane">PIT</a>&#160;• <a href="/wiki/2%CE%B2-Propanoyl-3%CE%B2-(4-tolyl)-tropane" title="2β-Propanoyl-3β-(4-tolyl)-tropane">PTT</a>&#160;• <a href="/w/index.php?title=(-)-2%CE%B2-Carbomethoxy-3%CE%B2-(4-chlorophenyl)tropane&amp;action=edit&amp;redlink=1" class="new" title="(-)-2β-Carbomethoxy-3β-(4-chlorophenyl)tropane (page does not exist)">RTI-31</a>&#160;• <a href="/w/index.php?title=(-)-2%CE%B2-Carbomethoxy-3%CE%B2-(4-methylphenyl)tropane&amp;action=edit&amp;redlink=1" class="new" title="(-)-2β-Carbomethoxy-3β-(4-methylphenyl)tropane (page does not exist)">RTI-32</a>&#160;• <a href="/w/index.php?title=(-)-2%CE%B2-Carbomethoxy-3%CE%B2-(4-bromophenyl)tropane&amp;action=edit&amp;redlink=1" class="new" title="(-)-2β-Carbomethoxy-3β-(4-bromophenyl)tropane (page does not exist)">RTI-51</a>&#160;• <a href="/w/index.php?title=(-)-2%CE%B2-Carbomethoxy-3%CE%B2-(3-methyl-4-chlorophenyl)tropane&amp;action=edit&amp;redlink=1" class="new" title="(-)-2β-Carbomethoxy-3β-(3-methyl-4-chlorophenyl)tropane (page does not exist)">RTI-112</a>&#160;• <a href="/w/index.php?title=(-)-2%CE%B2-Carbophenoxy-3%CE%B2-(4-chlorophenyl)tropane&amp;action=edit&amp;redlink=1" class="new" title="(-)-2β-Carbophenoxy-3β-(4-chlorophenyl)tropane (page does not exist)">RTI-113</a>&#160;• <a href="/wiki/RTI-121" title="RTI-121">RTI-121 (IPCIT)</a>&#160;• <a href="/wiki/(-)-2%CE%B2-(1,2,4-oxadiazol-5-methyl)-3%CE%B2-phenyltropane" title="(-)-2β-(1,2,4-oxadiazol-5-methyl)-3β-phenyltropane" class="mw-redirect">RTI-126</a>&#160;• <a href="/wiki/(-)-2%CE%B2-Carbocyclobutoxy-3%CE%B2-(4-methylphenyl)tropane" title="(-)-2β-Carbocyclobutoxy-3β-(4-methylphenyl)tropane">RTI-150</a>&#160;• <a href="/w/index.php?title=(-)-2%CE%B2-(3-methylisoxazol-5-yl)-3%CE%B2-(4-methylphenyl)tropane&amp;action=edit&amp;redlink=1" class="new" title="(-)-2β-(3-methylisoxazol-5-yl)-3β-(4-methylphenyl)tropane (page does not exist)">RTI-171</a>&#160;• <a href="/w/index.php?title=(-)-2%CE%B2-(3-phenylisoxazol-5-yl)-3%CE%B2-(4-chlorophenyl)tropane&amp;action=edit&amp;redlink=1" class="new" title="(-)-2β-(3-phenylisoxazol-5-yl)-3β-(4-chlorophenyl)tropane (page does not exist)">RTI-177</a>&#160;• <a href="/wiki/(-)-2%CE%B2-(3-(4-methylphenyl)isoxazol-5-yl)-3%CE%B2-(4-chlorophenyl)tropane" title="(-)-2β-(3-(4-methylphenyl)isoxazol-5-yl)-3β-(4-chlorophenyl)tropane" class="mw-redirect">RTI-336</a>&#160;• <a href="/wiki/Tesofensine" title="Tesofensine">Tesofensine</a>&#160;• <a href="/wiki/Troparil" title="Troparil">Troparil (β-CPT, WIN 35,065-2)</a>&#160;• <a href="/wiki/Tropoxane" title="Tropoxane">Tropoxane</a>&#160;• <a href="/wiki/2%CE%B2-Propanoyl-3%CE%B2-(2-naphthyl)-tropane" title="2β-Propanoyl-3β-(2-naphthyl)-tropane">WF-23</a>&#160;• <a href="/wiki/2%CE%B1-(Propanoyl)-3%CE%B2-(2-(6-methoxynaphthyl))-tropane" title="2α-(Propanoyl)-3β-(2-(6-methoxynaphthyl))-tropane">WF-33</a>&#160;• <a href="/w/index.php?title=2%CE%B2-Propanoyl-3%CE%B2-(2-isopropenyl)-tropane&amp;action=edit&amp;redlink=1" class="new" title="2β-Propanoyl-3β-(2-isopropenyl)-tropane (page does not exist)">WF-60</a></p>
</div>
</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Xanthine" title="Xanthine">Xanthines</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Aminophylline" title="Aminophylline">Aminophylline</a>&#160;• <a href="/wiki/Caffeine" title="Caffeine">Caffeine</a>&#160;• <a href="/w/index.php?title=Dimethazan&amp;action=edit&amp;redlink=1" class="new" title="Dimethazan (page does not exist)">Dimethazan</a>&#160;• <a href="/wiki/Paraxanthine" title="Paraxanthine">Paraxanthine</a>&#160;• <a href="/wiki/Theobromine" title="Theobromine">Theobromine</a>&#160;• <a href="/wiki/Theophylline" title="Theophylline">Theophylline</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">Others</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em">
<div>
<p><a href="/w/index.php?title=2-Aminoindane&amp;action=edit&amp;redlink=1" class="new" title="2-Aminoindane (page does not exist)">2-Aminoindane</a>&#160;• <a href="/w/index.php?title=5-(2-Aminopropyl)indole&amp;action=edit&amp;redlink=1" class="new" title="5-(2-Aminopropyl)indole (page does not exist)">5-(2-Aminopropyl)indole</a>&#160;• <a href="/w/index.php?title=Amfonelic_acid&amp;action=edit&amp;redlink=1" class="new" title="Amfonelic acid (page does not exist)">Amfonelic acid</a>&#160;• <a href="/wiki/Amineptine" title="Amineptine">Amineptine</a>&#160;• <a href="/wiki/Amiphenazole" title="Amiphenazole">Amiphenazole</a>&#160;• <a href="/wiki/Bemegride" title="Bemegride">Bemegride</a>&#160;• <a href="/wiki/Benzydamine" title="Benzydamine">Benzydamine</a>&#160;• <a href="/wiki/(-)-1-(Benzofuran-2-yl)-2-propylaminopentane" title="(-)-1-(Benzofuran-2-yl)-2-propylaminopentane">BPAP</a>&#160;• <a href="/wiki/Bromantane" title="Bromantane">Bromantane</a>&#160;• <a href="/w/index.php?title=1-(1-(1-Benzothiophen-2-yl)cyclohexyl)piperidine&amp;action=edit&amp;redlink=1" class="new" title="1-(1-(1-Benzothiophen-2-yl)cyclohexyl)piperidine (page does not exist)">BTCP</a>&#160;• <a href="/wiki/2-Butyl-3-(p-tolyl)quinuclidine" title="2-Butyl-3-(p-tolyl)quinuclidine">BTQ</a>&#160;• <a href="/wiki/BTS_74,398" title="BTS 74,398">BTS 74,398</a>&#160;• <a href="/w/index.php?title=Chlodantane&amp;action=edit&amp;redlink=1" class="new" title="Chlodantane (page does not exist)">Chlodantane</a>&#160;• <a href="/wiki/Clofenciclan" title="Clofenciclan">Clofenciclan</a>&#160;• <a href="/w/index.php?title=Cropropamide&amp;action=edit&amp;redlink=1" class="new" title="Cropropamide (page does not exist)">Cropropamide</a>&#160;• <a href="/w/index.php?title=Crotetamide&amp;action=edit&amp;redlink=1" class="new" title="Crotetamide (page does not exist)">Crotetamide</a>&#160;• <a href="/wiki/Cypenamine" title="Cypenamine">Cypenamine</a>&#160;• <a href="/wiki/Cyprodenate" title="Cyprodenate">Cyprodenate</a>&#160;• <a href="/wiki/Diclofensine" title="Diclofensine">Diclofensine</a>&#160;• <a href="/wiki/Dimethocaine" title="Dimethocaine">Dimethocaine</a>&#160;• <a href="/wiki/Diphenylprolinol" title="Diphenylprolinol">Diphenylprolinol</a>&#160;• <a href="/wiki/Etamivan" title="Etamivan">Etamivan</a>&#160;• <a href="/wiki/Fencamfamine" title="Fencamfamine">Fencamfamine</a>&#160;• <a href="/wiki/Feprosidnine" title="Feprosidnine">Feprosidnine</a>&#160;• <a href="/wiki/Gilutensin" title="Gilutensin">Gilutensin</a>&#160;• <a href="/wiki/GYKI-52895" title="GYKI-52895">GYKI-52895</a>&#160;• <a href="/wiki/Hexacyclonate" title="Hexacyclonate">Hexacyclonate</a>&#160;• <a href="/wiki/Indanorex" title="Indanorex">Indanorex</a>&#160;• <a href="/wiki/Indatraline" title="Indatraline">Indatraline</a>&#160;• <a href="/wiki/Lefetamine" title="Lefetamine">Lefetamine</a>&#160;• <a href="/w/index.php?title=Leptacline&amp;action=edit&amp;redlink=1" class="new" title="Leptacline (page does not exist)">Leptacline</a>&#160;• <a href="/wiki/LR-5182" title="LR-5182">LR-5182</a>&#160;• <a href="/wiki/Manifaxine" title="Manifaxine">Manifaxine</a>&#160;• <a href="/wiki/Mazindol" title="Mazindol">Mazindol</a>&#160;• <a href="/w/index.php?title=Meclofexonate&amp;action=edit&amp;redlink=1" class="new" title="Meclofexonate (page does not exist)">Meclofexonate</a>&#160;• <a href="/w/index.php?title=Mefexamide&amp;action=edit&amp;redlink=1" class="new" title="Mefexamide (page does not exist)">Mefexamide</a>&#160;• <a href="/wiki/Mesocarb" title="Mesocarb">Mesocarb</a>&#160;• <a href="/wiki/Naphthylisopropylamine" title="Naphthylisopropylamine">Naphthylisopropylamine</a>&#160;• <a href="/wiki/Nikethamide" title="Nikethamide">Nikethamide</a>&#160;• <a href="/wiki/Nomifensine" title="Nomifensine">Nomifensine</a>&#160;• <a href="/wiki/O-2172" title="O-2172">O-2172</a>&#160;• <a href="/wiki/Phthalimidopropiophenone" title="Phthalimidopropiophenone">Phthalimidopropiophenone</a>&#160;• <a href="/wiki/Prolintane" title="Prolintane">Prolintane</a>&#160;• <a href="/wiki/Sibutramine" title="Sibutramine">Sibutramine</a>&#160;• <a href="/wiki/UH-232" title="UH-232">UH-232</a>&#160;• <a href="/wiki/Yohimbine" title="Yohimbine">Yohimbine</a>&#160;• <a href="/wiki/Zylofuramine" title="Zylofuramine">Zylofuramine</a></p>
</div>
</div>
</td>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-abovebelow" style=";font-style:italic" colspan="2">See also <a href="/wiki/Template:Sympathomimetic_amines" title="Template:Sympathomimetic amines">Sympathomimetic amines</a></td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;;border:none;; font-size:xx-small;"><a href="/wiki/Template:Phenethylamines" title="Template:Phenethylamines"><span title="View this template" style=";;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Phenethylamines" title="Template talk:Phenethylamines"><span title="Discussion about this template" style=";;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Phenethylamines&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Phenethylamines&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Phenethylamine" title="Phenethylamine">Phenethylamines</a></span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td colspan="2" style="width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/2C-B" title="2C-B">2C-B</a> • <a href="/wiki/2C-C" title="2C-C">2C-C</a> • <a href="/wiki/2C-D" title="2C-D">2C-D</a> • <a href="/wiki/2C-E" title="2C-E">2C-E</a> • <a href="/wiki/2C-I" title="2C-I">2C-I</a> • <a href="/wiki/2C-N" title="2C-N">2C-N</a> • <a href="/wiki/2C-T-2" title="2C-T-2">2C-T-2</a> • <a href="/wiki/2C-T-21" title="2C-T-21">2C-T-21</a> • <a href="/wiki/2C-T-4" title="2C-T-4">2C-T-4</a> • <a href="/wiki/2C-T-7" title="2C-T-7">2C-T-7</a> • <a href="/wiki/2C-T-8" title="2C-T-8">2C-T-8</a> • <a href="/wiki/3C-E" title="3C-E">3C-E</a> • <a href="/wiki/4-Fluoroamphetamine" title="4-Fluoroamphetamine">4-FMP</a> • <a href="/wiki/Alfetamine" title="Alfetamine">Alfetamine</a> • <a href="/wiki/Amphetamine" title="Amphetamine">Amphetamine</a> • <strong class="selflink">Bupropion</strong> • <a href="/wiki/Cathine" title="Cathine">Cathine</a> • <a href="/wiki/Cathinone" title="Cathinone">Cathinone</a> • <a href="/wiki/Clenbuterol" title="Clenbuterol">Clenbuterol</a> • <a href="/wiki/DESOXY" title="DESOXY">DESOXY</a> • <a href="/wiki/Dextroamphetamine" title="Dextroamphetamine">Dextroamphetamine</a> • <a href="/wiki/Methamphetamine" title="Methamphetamine">Methamphetamine</a> • <a href="/wiki/Diethylcathinone" title="Diethylcathinone">Diethylcathinone</a> • <a href="/wiki/Dimethylcathinone" title="Dimethylcathinone">Dimethylcathinone</a> • <a href="/wiki/4-chloro-2,5-dimethoxyamphetamine" title="4-chloro-2,5-dimethoxyamphetamine" class="mw-redirect">DOC</a> • <a href="/wiki/2,5-dimethoxy-4-bromoamphetamine" title="2,5-dimethoxy-4-bromoamphetamine" class="mw-redirect">DOB</a> • <a href="/wiki/2,5-dimethoxy-4-iodoamphetamine" title="2,5-dimethoxy-4-iodoamphetamine" class="mw-redirect">DOI</a> • <a href="/wiki/2,5-dimethoxy-4-methylamphetamine" title="2,5-dimethoxy-4-methylamphetamine" class="mw-redirect">DOM</a> • <a href="/wiki/Bk-MBDB" title="Bk-MBDB">bk-MBDB</a> • <a href="/wiki/Dopamine" title="Dopamine">Dopamine</a> • <a href="/wiki/Bromo-DragonFly" title="Bromo-DragonFly" class="mw-redirect">Br-DFLY</a> • <a href="/wiki/Ephedrine" title="Ephedrine">Ephedrine</a> • <a href="/wiki/Epinephrine" title="Epinephrine">Epinephrine</a> • <a href="/wiki/Escaline" title="Escaline">Escaline</a> • <a href="/wiki/Etafedrine" title="Etafedrine">Etafedrine</a> • <a href="/wiki/Fenfluramine" title="Fenfluramine">Fenfluramine</a> • <a href="/wiki/Levosalbutamol" title="Levosalbutamol">Levosalbutamol</a> • <a href="/wiki/Levomethamphetamine" title="Levomethamphetamine">Levomethamphetamine</a> • <a href="/wiki/MBDB" title="MBDB">MBDB</a> • <a href="/wiki/3,4-methylenedioxyamphetamine" title="3,4-methylenedioxyamphetamine" class="mw-redirect">MDA</a> • <a href="/wiki/MDMA" title="MDMA">MDMA</a> • <a href="/wiki/MDMC" title="MDMC" class="mw-redirect">MDMC</a> • <a href="/wiki/3,4-methylenedioxy-N-ethylamphetamine" title="3,4-methylenedioxy-N-ethylamphetamine" class="mw-redirect">MDEA</a> • <a href="/wiki/MDPV" title="MDPV">MDPV</a> • <a href="/wiki/Mescaline" title="Mescaline">Mescaline</a> • <a href="/wiki/Methcathinone" title="Methcathinone">Methcathinone</a> • <a href="/wiki/Norepinephrine" title="Norepinephrine">Norepinephrine</a> • <a href="/wiki/Phentermine" title="Phentermine">Phentermine</a> • <a href="/wiki/Salbutamol" title="Salbutamol">Salbutamol</a> • <a href="/wiki/Tyramine" title="Tyramine">Tyramine</a> • <a href="/wiki/Venlafaxine" title="Venlafaxine">Venlafaxine</a></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;;border:none;; font-size:xx-small;"><a href="/wiki/Template:Antidepressants" title="Template:Antidepressants"><span title="View this template" style=";;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Antidepressants" title="Template talk:Antidepressants"><span title="Discussion about this template" style=";;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Antidepressants&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Antidepressants&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Psychoanaleptic" title="Psychoanaleptic">Psychoanaleptics</a>: <a href="/wiki/Antidepressant" title="Antidepressant">antidepressants</a> (<a href="/wiki/ATC_code_N06#N06A_Antidepressants" title="ATC code N06">N06A</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">MAOIs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i>nonselective:</i> <i>non-reversible</i> (<a href="/wiki/Isocarboxazid" title="Isocarboxazid">Isocarboxazid</a>, <a href="/wiki/Iproclozide" title="Iproclozide">Iproclozide</a>, <a href="/wiki/Iproniazid" title="Iproniazid">Iproniazid</a>, <a href="/wiki/Nialamide" title="Nialamide">Nialamide</a>, <a href="/wiki/Phenelzine" title="Phenelzine">Phenelzine</a>, <a href="/wiki/Pheniprazine" title="Pheniprazine">Pheniprazine</a>) • <i>reversible</i> (<a href="/wiki/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a>)
<p><i><a href="/wiki/Monoamine_oxidase_A" title="Monoamine oxidase A">MAOA</a> (<a href="/wiki/Norepinephrine" title="Norepinephrine">N</a>/<a href="/wiki/Serotonin" title="Serotonin">S</a>):</i> <a href="/wiki/Clorgiline" title="Clorgiline">Clorgiline</a> • <a href="/wiki/Minaprine" title="Minaprine">Minaprine</a> • <i><a href="/wiki/Reversible_inhibitor_of_monoamine_oxidase_A" title="Reversible inhibitor of monoamine oxidase A">RIMAs</a></i> (<a href="/wiki/Befloxatone" title="Befloxatone">Befloxatone</a>, <a href="/wiki/Brofaromine" title="Brofaromine">Brofaromine</a>, <a href="/wiki/Cimoxatone" title="Cimoxatone">Cimoxatone</a>, <a href="/wiki/Harmaline" title="Harmaline">Harmaline</a>, <a href="/wiki/Moclobemide" title="Moclobemide">Moclobemide</a>, <a href="/wiki/Pirlindole" title="Pirlindole">Pirlindole</a>, <a href="/wiki/Toloxatone" title="Toloxatone">Toloxatone</a>)</p>
<i><a href="/wiki/Monoamine_oxidase_B" title="Monoamine oxidase B">MAOB</a> (<a href="/wiki/Dopamine" title="Dopamine">D</a>):</i> <a href="/wiki/Rasagiline" title="Rasagiline">Rasagiline</a> • <a href="/wiki/Selegiline" title="Selegiline">Selegiline</a> • <a href="/wiki/Pargyline" title="Pargyline">Pargyline</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Neurotransmitter_uptake_inhibitor" title="Neurotransmitter uptake inhibitor">RIs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Serotonin_uptake_inhibitor" title="Serotonin uptake inhibitor">S RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Selective_serotonin_reuptake_inhibitor" title="Selective serotonin reuptake inhibitor">SS RI</a> (<a href="/wiki/Alaproclate" title="Alaproclate">Alaproclate</a>, <a href="/wiki/Citalopram" title="Citalopram">Citalopram</a>, <a href="/wiki/Dapoxetine" title="Dapoxetine">Dapoxetine</a>, <a href="/wiki/Escitalopram" title="Escitalopram">Escitalopram</a>, <a href="/wiki/Femoxetine" title="Femoxetine">Femoxetine</a>, <a href="/wiki/Fluoxetine" title="Fluoxetine">Fluoxetine</a>, <a href="/wiki/Fluvoxamine" title="Fluvoxamine">Fluvoxamine</a>, <a href="/wiki/Paroxetine" title="Paroxetine">Paroxetine</a>, <a href="/wiki/Sertraline" title="Sertraline">Sertraline</a>, <a href="/wiki/Vilazodone" title="Vilazodone">Vilazodone</a>, <a href="/wiki/Zimelidine" title="Zimelidine">Zimelidine</a>)<br />
<i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a>/<a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetras</a></i> (<a href="/wiki/Cianopramine" title="Cianopramine">Cianopramine</a>, <a href="/wiki/Clomipramine" title="Clomipramine">Clomipramine</a>, <a href="/wiki/Nefazodone" title="Nefazodone">Nefazodone</a>, <a href="/wiki/Trazodone" title="Trazodone">Trazodone</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Norepinephrine_reuptake_inhibitor" title="Norepinephrine reuptake inhibitor">N RI</a> / <a href="/wiki/Adrenergic_uptake_inhibitor" title="Adrenergic uptake inhibitor">A RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Atomoxetine" title="Atomoxetine">Atomoxetine</a> • <a href="/wiki/Ciclazindol" title="Ciclazindol">Ciclazindol</a> • <a href="/wiki/Maprotiline" title="Maprotiline">Maprotiline</a> • <a href="/wiki/Nisoxetine" title="Nisoxetine">Nisoxetine</a> • <a href="/wiki/Oxaprotiline" title="Oxaprotiline">Oxaprotiline</a> • <a href="/wiki/Reboxetine" title="Reboxetine">Reboxetine</a> • <a href="/wiki/Talopram" title="Talopram">Talopram</a> • <a href="/wiki/Viloxazine" title="Viloxazine">Viloxazine</a><br />
<i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a>/<a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetras</a></i> (<a href="/wiki/Amoxapine" title="Amoxapine">Amoxapine</a>, <a href="/wiki/Butriptyline" title="Butriptyline">Butriptyline</a>, <a href="/wiki/Desipramine" title="Desipramine">Desipramine</a>/<a href="/wiki/Lofepramine" title="Lofepramine">Lofepramine</a>, <a href="/wiki/Dibenzepin" title="Dibenzepin">Dibenzepin</a>, <a href="/wiki/Dosulepin_hydrochloride" title="Dosulepin hydrochloride">Dosulepin</a>, <a href="/wiki/Doxepin" title="Doxepin">Doxepin</a>, <a href="/wiki/Imipramine" title="Imipramine">Imipramine</a>, <a href="/wiki/Iprindole" title="Iprindole">Iprindole</a>, <a href="/wiki/Melitracen" title="Melitracen">Melitracen</a>, <a href="/wiki/Nitroxazepine" title="Nitroxazepine">Nitroxazepine</a>, <a href="/wiki/Nortriptyline" title="Nortriptyline">Nortriptyline</a>, <a href="/wiki/Protriptyline" title="Protriptyline">Protriptyline</a>, <a href="/wiki/Trimipramine" title="Trimipramine">Trimipramine</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dopamine_reuptake_inhibitor" title="Dopamine reuptake inhibitor">D RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Medifoxamine" title="Medifoxamine">Medifoxamine</a> • <a href="/wiki/Phenmetrazine" title="Phenmetrazine">Phenmetrazine</a> • <a href="/wiki/Vanoxerine" title="Vanoxerine">Vanoxerine</a><br />
<i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a></i> (<a href="/wiki/Amineptine" title="Amineptine">Amineptine</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Serotonin-norepinephrine_reuptake_inhibitor" title="Serotonin-norepinephrine reuptake inhibitor">SN RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Bicifadine" title="Bicifadine">Bicifadine</a> • <a href="/wiki/Clovoxamine" title="Clovoxamine">Clovoxamine</a> • <a href="/wiki/Desvenlafaxine" title="Desvenlafaxine">Desvenlafaxine</a> • <a href="/wiki/Duloxetine" title="Duloxetine">Duloxetine</a> • <a href="/wiki/Indeloxazine" title="Indeloxazine">Indeloxazine</a> • <a href="/wiki/Milnacipran" title="Milnacipran">Milnacipran</a> • <a href="/wiki/Nefazodone" title="Nefazodone">Nefazodone</a> • <a href="/wiki/Venlafaxine" title="Venlafaxine">Venlafaxine</a><br />
<i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a></i> (<a href="/wiki/Amitriptyline" title="Amitriptyline">Amitriptyline</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Norepinephrine-dopamine_reuptake_inhibitor" title="Norepinephrine-dopamine reuptake inhibitor">ND RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><strong class="selflink">Bupropion</strong> • <a href="/wiki/Nomifensine" title="Nomifensine">Nomifensine</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Serotonin-noradrenaline-dopamine_reuptake_inhibitor" title="Serotonin-noradrenaline-dopamine reuptake inhibitor">SND RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Brasofensine" title="Brasofensine">Brasofensine</a> • <a href="/wiki/Diclofensine" title="Diclofensine">Diclofensine</a> • <a href="/wiki/Tesofensine" title="Tesofensine">Tesofensine</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Selective_serotonin_reuptake_enhancer" title="Selective serotonin reuptake enhancer">SSREs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a></i> (<a href="/wiki/Tianeptine" title="Tianeptine">Tianeptine</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Adrenergic_antagonist" title="Adrenergic antagonist">AAs</a> at <a href="/wiki/Alpha-2_adrenergic_receptor" title="Alpha-2 adrenergic receptor">A2</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetras</a></i> (<a href="/wiki/Mianserin" title="Mianserin">Mianserin</a>, <a href="/wiki/Mirtazapine" title="Mirtazapine">Mirtazapine</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Sigma_receptor#Agonists" title="Sigma receptor">SAs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a></i> (<a href="/wiki/Opipramol" title="Opipramol">Opipramol</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Melatonin_receptor" title="Melatonin receptor">MAs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/Melatonin_receptor#Agonists" title="Melatonin receptor">Melatonin receptor agonists</a></i> (<a href="/wiki/Agomelatine" title="Agomelatine">Agomelatine</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;;border:none;; font-size:xx-small;"><a href="/wiki/Template:Drugs_used_in_addictive_disorders" title="Template:Drugs used in addictive disorders"><span title="View this template" style=";;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Drugs_used_in_addictive_disorders" title="Template talk:Drugs used in addictive disorders"><span title="Discussion about this template" style=";;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Drugs_used_in_addictive_disorders&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Drugs_used_in_addictive_disorders&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;">Drugs used in <a href="/wiki/Addictive" title="Addictive" class="mw-redirect">addictive</a> disorders (<a href="/wiki/ATC_code_N07#N07B_Drugs_used_in_addictive_disorders" title="ATC code N07">N07B</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Nicotine_dependence" title="Nicotine dependence" class="mw-redirect">Nicotine dependence</a>/<br />
(<a href="/wiki/Nicotinic_agonist" title="Nicotinic agonist">Nicotinic agonist</a>)</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Nicotine" title="Nicotine">Nicotine</a> - <strong class="selflink">Bupropion</strong> - <a href="/wiki/Dianicline" title="Dianicline">Dianicline</a> - <a href="/wiki/Varenicline" title="Varenicline">Varenicline</a> - <a href="/wiki/Lobeline" title="Lobeline">Lobeline</a> - <a href="/wiki/Mecamylamine" title="Mecamylamine">Mecamylamine</a> - <a href="/wiki/Clonidine" title="Clonidine">Clonidine</a> - <a href="/wiki/Scopolamine" title="Scopolamine">Scopolamine</a> - <a href="/wiki/Surinabant" title="Surinabant">Surinabant</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Alcohol_dependence" title="Alcohol dependence">Alcohol dependence</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Disulfiram" title="Disulfiram">Disulfiram</a> - <a href="/wiki/Calcium_carbimide" title="Calcium carbimide">Calcium carbimide</a> - <a href="/wiki/Acamprosate" title="Acamprosate">Acamprosate</a> - <a href="/wiki/Naltrexone" title="Naltrexone">Naltrexone</a> - <a href="/wiki/Nalmefene" title="Nalmefene">Nalmefene</a> - <a href="/wiki/Topiramate" title="Topiramate">Topiramate</a> - <a href="/wiki/Clonidine" title="Clonidine">Clonidine</a> - <a href="/wiki/Buprenorphine" title="Buprenorphine">Buprenorphine</a> - <a href="/wiki/Morphine" title="Morphine">Morphine</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Opioid_dependence" title="Opioid dependence" class="mw-redirect">Opioid dependence</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Buprenorphine" title="Buprenorphine">Buprenorphine</a> - <a href="/wiki/Methadone" title="Methadone">Methadone</a> - <a href="/wiki/Levacetylmethadol" title="Levacetylmethadol">Levacetylmethadol</a> - <a href="/wiki/Fentanyl" title="Fentanyl">Fentanyl</a> - <a href="/wiki/Dihydrocodeine" title="Dihydrocodeine">Dihydrocodeine</a> - <a href="/wiki/Dihydroetorphine" title="Dihydroetorphine">Dihydroetorphine</a> - <a href="/wiki/Clonidine" title="Clonidine">Clonidine</a> - <a href="/wiki/Lofexidine" title="Lofexidine">Lofexidine</a> - <a href="/wiki/Naltrexone" title="Naltrexone">Naltrexone</a> - <a href="/wiki/Ibogaine" title="Ibogaine">Ibogaine</a> - <a href="/wiki/18-Methoxycoronaridine" title="18-Methoxycoronaridine">18-Methoxycoronaridine</a> - <a href="/wiki/Morphine" title="Morphine">Extended Release Morphine</a> - <a href="/wiki/Hydromorphone" title="Hydromorphone">Extended Release Hydromorphone</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Stimulant" title="Stimulant">Stimulant</a> <a href="/wiki/Physical_dependence" title="Physical dependence">dependence</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Dexamphetamine" title="Dexamphetamine" class="mw-redirect">Dexamphetamine</a> - <strong class="selflink">Bupropion</strong> - <a href="/wiki/Vanoxerine" title="Vanoxerine">Vanoxerine</a> - <a href="/wiki/Nocaine" title="Nocaine">Nocaine</a> - <a href="/wiki/Vigabatrin" title="Vigabatrin">Vigabatrin</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Benzodiazepine" title="Benzodiazepine">Benzodiazepine</a> <a href="/wiki/Physical_dependence" title="Physical dependence">dependence</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Clonidine" title="Clonidine">Clonidine</a> - <a href="/wiki/Diazepam" title="Diazepam">Diazepam</a> - <a href="/wiki/Phenytoin" title="Phenytoin">Phenytoin</a> - <a href="/wiki/Phenobarbital" title="Phenobarbital">Phenobarbital</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Cocaine" title="Cocaine">Cocaine</a> <a href="/wiki/Physical_dependence" title="Physical dependence">dependence</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><strong class="selflink">Bupropion</strong> - <a href="/wiki/Vanoxerine" title="Vanoxerine">Vanoxerine</a> - <a href="/wiki/Nocaine" title="Nocaine">Nocaine</a> - <a href="/wiki/Baclofen" title="Baclofen">Baclofen</a> - <a href="/wiki/Vigabatrin" title="Vigabatrin">Vigabatrin</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/w/index.php?title=Sedative-Hypnotic&amp;action=edit&amp;redlink=1" class="new" title="Sedative-Hypnotic (page does not exist)">Sedative-Hypnotic</a> <a href="/wiki/Physical_dependence" title="Physical dependence">dependence</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Phenobarbital" title="Phenobarbital">Phenobarbital</a> - <a href="/wiki/Diazepam" title="Diazepam">Diazepam</a> - <a href="/wiki/Lorazepam" title="Lorazepam">Lorazepam</a> - <a href="/wiki/Clonidine" title="Clonidine">Clonidine</a> - <a href="/wiki/Chloral_Hydrate" title="Chloral Hydrate" class="mw-redirect">Chloral Hydrate</a></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;;border:none;; font-size:xx-small;"><a href="/wiki/Template:GlaxoSmithKline" title="Template:GlaxoSmithKline"><span title="View this template" style=";;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/w/index.php?title=Template_talk:GlaxoSmithKline&amp;action=edit&amp;redlink=1" class="new" title="Template talk:GlaxoSmithKline (page does not exist)"><span title="Discussion about this template" style=";;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:GlaxoSmithKline&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:GlaxoSmithKline&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/GlaxoSmithKline" title="GlaxoSmithKline">GlaxoSmithKline plc</a></span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Corporation" title="Corporation">Corporate</a> <a href="/wiki/Board_of_directors" title="Board of directors">Directors</a>:</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/w/index.php?title=Lawrence_Culp&amp;action=edit&amp;redlink=1" class="new" title="Lawrence Culp (page does not exist)">Lawrence Culp</a><span style="font-weight:bold;">&#160;·</span> <a href="/w/index.php?title=Crispin_Davis&amp;action=edit&amp;redlink=1" class="new" title="Crispin Davis (page does not exist)">Crispin Davis</a><span style="font-weight:bold;">&#160;·</span> <a href="/w/index.php?title=Jean-Pierre_Garnier&amp;action=edit&amp;redlink=1" class="new" title="Jean-Pierre Garnier (page does not exist)">Jean-Pierre Garnier</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Chris_Gent" title="Chris Gent">Chris Gent</a><span style="font-weight:bold;">&#160;·</span> <a href="/w/index.php?title=Julian_Heslop&amp;action=edit&amp;redlink=1" class="new" title="Julian Heslop (page does not exist)">Julian Heslop</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Deryck_Maughan" title="Deryck Maughan">Deryck Maughan</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Ian_Prosser" title="Ian Prosser">Ian Prosser</a><span style="font-weight:bold;">&#160;·</span> <a href="/w/index.php?title=Ronaldo_Schmitz&amp;action=edit&amp;redlink=1" class="new" title="Ronaldo Schmitz (page does not exist)">Ronaldo Schmitz</a><span style="font-weight:bold;">&#160;·</span> <a href="/w/index.php?title=Lucy_Shapiro&amp;action=edit&amp;redlink=1" class="new" title="Lucy Shapiro (page does not exist)">Lucy Shapiro</a><span style="font-weight:bold;">&#160;·</span> <a href="/w/index.php?title=Robert_Wilson_(businessman)&amp;action=edit&amp;redlink=1" class="new" title="Robert Wilson (businessman) (page does not exist)">Robert Wilson</a><span style="font-weight:bold;">&#160;·</span> <a href="/w/index.php?title=Tadataka_Yamada&amp;action=edit&amp;redlink=1" class="new" title="Tadataka Yamada (page does not exist)">Tadataka Yamada</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">Products:</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><strong class="selflink">Bupropion (Zyban)</strong><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Co-amoxiclav" title="Co-amoxiclav">Co-amoxiclav (Augmentin)</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Paroxetine" title="Paroxetine">Paroxetine (Paxil, Seroxat, Aropax)</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Rosiglitazone" title="Rosiglitazone">Rosiglitazone (Avandia)</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Sumatriptan" title="Sumatriptan">Sumatriptan(Imitrex)</a></div>
</td>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-abovebelow" style=";" colspan="2"><b>Annual Revenue</b>: $39.0 billion <a href="/wiki/American_dollar" title="American dollar" class="mw-redirect">USD</a> (<span style="color: #0c0; font-size: larger;">▲</span>2% <a href="/wiki/Fiscal_year" title="Fiscal year">FY</a> 2004)<span style="font-weight:bold;">&#160;·</span> <b>Employees</b>: 100,019<span style="font-weight:bold;">&#160;·</span> <b>Stock Symbol</b>: <a href="/wiki/London_Stock_Exchange" title="London Stock Exchange">LSE</a>:&#160;<a href="http://www.londonstockexchange.com/en-gb/pricesnews/prices/Trigger/genericsearch.htm?bsg=true&amp;ns=GSK" class="external text" title="http://www.londonstockexchange.com/en-gb/pricesnews/prices/Trigger/genericsearch.htm?bsg=true&amp;ns=GSK" rel="nofollow">GSK</a> <a href="/wiki/New_York_Stock_Exchange" title="New York Stock Exchange">NYSE</a>:&#160;<a href="http://www.nyse.com/about/listed/lcddata.html?ticker=GSK" class="external text" title="http://www.nyse.com/about/listed/lcddata.html?ticker=GSK" rel="nofollow">GSK</a><span style="font-weight:bold;">&#160;·</span> <b>Website</b>: <a href="http://www.gsk.com/" class="external text" title="http://www.gsk.com/" rel="nofollow">www.gsk.com</a></td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Preprocessor node count: 66793/1000000
Post-expand include size: 682741/2048000 bytes
Template argument size: 271516/2048000 bytes
Expensive parser function count: 0/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:378579-0!1!0!default!!en!2 and timestamp 20090403220529 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Bupropion">http://en.wikipedia.org/wiki/Bupropion</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Tobacco_cessation" title="Category:Tobacco cessation">Tobacco cessation</a></span> | <span dir='ltr'><a href="/wiki/Category:Antidepressants" title="Category:Antidepressants">Antidepressants</a></span> | <span dir='ltr'><a href="/wiki/Category:Dopamine_reuptake_inhibitors" title="Category:Dopamine reuptake inhibitors">Dopamine reuptake inhibitors</a></span> | <span dir='ltr'><a href="/wiki/Category:Amphetamines" title="Category:Amphetamines">Amphetamines</a></span> | <span dir='ltr'><a href="/wiki/Category:Stimulants" title="Category:Stimulants">Stimulants</a></span> | <span dir='ltr'><a href="/wiki/Category:Phenethylamines" title="Category:Phenethylamines">Phenethylamines</a></span> | <span dir='ltr'><a href="/wiki/Category:GlaxoSmithKline" title="Category:GlaxoSmithKline">GlaxoSmithKline</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:Featured_articles" title="Category:Featured articles">Featured articles</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Bupropion" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Bupropion" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Bupropion&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Bupropion&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Bupropion" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Bupropion" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Bupropion" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Bupropion&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Bupropion&amp;oldid=281583062" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Bupropion&amp;id=281583062">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Bupropion">Deutsch</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Bupropion">Español</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Bupropione">Français</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Bupropione">Italiano</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E3%83%96%E3%83%97%E3%83%AD%E3%83%94%E3%82%AA%E3%83%B3">日本語</a></li>
				<li class="interwiki-he"><a href="http://he.wikipedia.org/wiki/%D7%91%D7%95%D7%A4%D7%A8%D7%95%D7%A4%D7%99%D7%95%D7%9F">עברית</a></li>
				<li class="interwiki-hu"><a href="http://hu.wikipedia.org/wiki/Bupropion">Magyar</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Bupropion">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Bupropiom">Português</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Bupropion">Svenska</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 3 April 2009, at 22:05.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv185 in 13.283 secs. --></body></html>
